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ABSTRACT
DEVELOPING AND OPTIMIZING CONDITIONS FOR
SINGLE CELL GENETIC ANALYSIS
Susan Adele Gitlin
May 2005
Director: Dr. Diane M. Duffy

Preimplantation Genetic Diagnosis (PGD) allows for couples to obtain
genetic information at the embryo stage, therefore preventing lethal genetic
diseases in their offspring. A recent multi-center study determined a 17%
amplification failure rate overall and a 3.4% misdiagnosis rate (ESHRE PGD
consortium steering committee, 2002). Experiments presented here were
conducted to decrease those rates by optimizing single cell sensitivity and
specificity of PGD techniques. Primer extension preamplification (PEP) was used
after initial amplification failure, followed by gene specific PCR. Reamplification
experiments yielded 54% amplification rates using blastomeres that previously
failed amplification. In the clinical trial, four of six blastomeres were diagnosed
that had previous amplification failure. PEP and subsequent PCR testing is a
useful means to diagnose samples that previously failed amplification. Different
lysis buffers/techniques were used to determine the amplification efficiencies of
heterozygous single cells (n=100/group). Amplification rates were 38% using
Liquid Nitrogen, 97% using Potassium hydroxide/dithiothreitol (KOH), 41% by
boiling, and 85% for water. Allele drop-out was minimal in the KOH group, but
was high in the water group. KOH lysis is superior in both sensitivity and
specificity to other lysis methods tested. Nuclear and cytoplasmic morphology of
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biopsied blastomeres was evaluated and correlated with subsequent PCR
amplification efficiencies. Cells with a visible nucleus had 100% amplification
versus 36% in cells that did not, regardless of the cytoplasmic integrity. Nuclear
evaluation studies demonstrate the importance of determining nuclear integrity of
biopsied cells. Multiple displacement amplification (MDA) was used to generate
sufficient DNA for eventual use in array comparative genomic hybridization
(CGH) to determine chromosome complement. Sporadic MDA results occurred
at the single cell level; larger cell quantities consistently amplified. MDA can
generate sufficient quantities of DNA for array CGH. Preliminary results show
promise; further optimization will be required to ascertain the use of array CGH.
These studies provide optimization of single cell sensitivity/specificity and lay the
foundation for further studies in single cell diagnosis. It is anticipated that an
entire array of gene defects and chromosomal conditions can be diagnosed by
PGD in the future prevention of severe human disease.
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SECTION 1
INTRODUCTION
Preimplantation genetic diagnosis (PGD) is an accepted option for couples
at risk of passing inherited diseases on to their offspring. The ability to analyze
specific genetic information from a single cell removed from the developing embryo
now allows many at-risk parents to decide the clinical outcome of the embryos that
they have produced through the in vitro fertilization process. In such cases, only
those embryos shown not to have the genetic pre-disposition for the studied
condition are transferred to the uterus in the hope of initiating a pregnancy.
Prior to the advent of PGD, couples had several options to minimize the risk
of having an affected child: not initiating a pregnancy, using donor gametes, or
adoption. However, none of these options result in a biological child, which is
fundamentally important for some people. The alternative for many at-risk couples
is to initiate a pregnancy naturally and elected to have prenatal testing. This
implies that these couples might be faced with the decision of whether to continue
or terminate the pregnancy if tests indicated that their child could be born with a
devastating genetic disease. For other couples, pregnancy termination is not a
morally acceptable option, even if the likelihood of a medical condition is involved.
Those couples that accepted termination as an option were confronted with
other factors when trying to conceive again. It became difficult for many to bond
with the subsequent pregnancy during those initial prenatal months before
chorionic villus sampling or amniocentesis could determine the genetic or
chromosomal status of the fetus. This left them with many psychological issues to
deal with: not knowing if their child would be healthy so that the pregnancy
continued to term, not sharing the joy of pregnancy with family and friends until
after prenatal testing, wondering how many times would they gamble with the roll
of the genetic dice, even when the odds were in their favor (Pergament, 1991). For
these couples, PGD offers a safe option to have genetic information about their
offspring earlier in the process, prior to establishing a pregnancy.
The journal, Human Reproduction, was used as a model for this dissertation.
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Hundreds of healthy children have now been born as a result of PGD
(Verlinsky et al., 2004). Beginning in 2004, the American Medical Association’s
CRT (current procedural terminology) codebook lists procedural coding for the
PGD process. Having CRT codes listed generally sets the standard that a
procedure is no longer considered experimental in nature. That being said, multiple
aspects of the PGD process continue to be evaluated for safety and efficacy.
Counseling and the informed consent process for patients undergoing PGD
focuses on the following aspects of the procedure:
1) The safety of the embryo biopsy procedure. This concern has been previously
addressed by other studies both in our institution and elsewhere (Takeuchi et al.,
1992; Hardy and Handyside, 1992; ESHRE PGD Consortium Steering Committee,
2002). Those studies support the findings that the embryo survives the biopsy
procedure over 98% of the time and that embryo biopsy does not harm the further
cleavage of the embryo in the majority of cases.
2) The sensitivity of single cell analysis. This includes discussion on PCR
amplification rates; there is a chance of an incorrect diagnosis or a chance of no
amplification, and thus, no diagnosis.
3) The specificity of single cell analysis. This includes discussion relating to the risk
of allele dropout and contamination of the results by extraneous DNA that could
interfere with the ability to obtain the correct genetic answer.
The latter two aspects are the main focuses of the studies undertaken here. In
addition, studies were initiated to examine the application of the emerging
technologies of microarray analysis for PGD. In the future, these technologies
could provide more couples the opportunity to have a healthy child.
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SECTION 2
BACKGROUND
The ability to perform PGD emerged as biotechnology advanced in the later
part of the 1980's and into the 1990's. The two main components of PGD, embryo
biopsy and genetic analysis, are explained further below.
2.1 Embryo Biopsy
Micromanipulation and embryo biopsy were first reported using laboratory
animals (Nicholas and Hall, 1942; Tarkowski, 1959, Tarkowski and Wroblewska,
1967). These investigators studied early embryo development after removal of
one or more blastomeres. The technique involved the use of a dissecting
microscope to visualize the manipulated cell that was being held in place by
suction applied to a mouth pipette. Two glass slides were placed at right angles
to provide resistance; a glass needle was attached to those pieces and used to
pierce the zona pellucida. These methodologies seem primitive when compared
to today's technologies, which are listed in the Methods section of this
dissertation.
There are three stages at which biopsy for PGD can be performed (De
Vos and Van Steirtegham, 2001):
1) Polar Body Biopsy. The first polar body (PBI) of the unfertilized oocyte or the
first and second polar body (PBII) of the newly fertilized oocyte is one option for
PGD biopsy.
2) Cleavage Stage Embryo Biopsy. A blastomere can be removed from the
cleavage stage embryo (generally at 6-8 cells 3 days after oocyte retrieval) as
another option for PGD.
3) Trophectoderm Biopsy. Cells from the trophectoderm (TE) layer of the
blastocyst (five days after oocyte retrieval) are biopsied as another option for
PGD.
1) Polar Body Biopsy
Initially, polar body (PB) biopsy of the unfertilized oocyte appeared to be
favorable for couples that wanted to circumvent the ethical issues of biopsying an
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embryo (Vertinsky and Kuliev, 1992). Some couples may feel that life begins at
the moment of fertilization and could have difficulty discarding the fertilized
embryo, even if affected; these same couples may not feel uncomfortable with
discarding a potentially affected unfertilized egg.

However, the moral issue of

testing the unfertilized oocyte no longer held true when it was realized that the
oocyte should be inseminated before the PGD result was available in order to
avoid in vitro aging of the oocyte. In addition, many centers that perform FBI
biopsy now sample the PBII as well. The rationale for testing the PBII was to
improve the accuracy of the genetic diagnosis. The moral objection was then not
circumvented since the oocyte was inseminated and fertilization would have
occurred at the time of testing (Gitlin et al, 2003).
The polar bodies are extracellular material and appear to have no function
in embryo development. Removal of the PBI does not appear to interfere with
fertilization or subsequent cleavage (Vertinsky and Kuliev, 1992). Lastly, an
advantage of PB biopsy is the ability to obtain the genetic information earlier in
the IVF culture process (Wells et al., 2002). Newer technologies such as
comparative genomic hybridization (CGH) or DNA microarrays require a whole
genome amplification (WGA) step in order to have sufficient quantities of DNA
template for testing. Most WGA methods take 8-10 hours to perform, in addition
to the time required for the CGH or microarray process. The testing window from
PB sampling to blastocyst is 4-6 days as compared to 2-3 days when biopsying a
6-8 cell embryo, thus allowing more time for these other techniques. The timing is
important for clinical applications when the embryo must be transferred to the
uterus within the day 5-6 (after oocyte retrieval) window of implantation (Bergh
and Navot, 1992).
The major limitation with PB biopsy is that the genetic material of the PBI
and PBII only reflects the maternal contribution to the subsequent embryo; the
paternal genetic contribution remains unknown (De Vos and Van Steirteghem,
2001). PB biopsy was initially used for screening the maternal contribution to
single gene defects. PB biopsy cannot be used for gender selection in the case
of X-linked diseases, conditions that constitute a paternally-inherited dominant
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disease, or for the diagnosis of conditions where only the paternal mutation is
known. Embryos resulting from oocytes that were diagnosed with an affected
female allele would not be transferred, thus reducing the number of embryos
eligible for transfer. In most autosomal recessive diseases, oocytes reported to
have the mutation still have a 50% chance of resulting in a phenotypically normal
embryo, depending upon the subsequent paternal contribution (Gitlin et al.,
2003). For most patients undergoing a PGD cycle, the more embryos available
for transfer results in a higher chance of conceiving (Vandervost et al., 1998).
Eighty-five percent of chromosomal abnormalities are attributed to
maternal origin (Hassold and Chiu, 1985). Therefore, PB biopsy with subsequent
PGD has the potential to detect the vast majority of chromosomal errors.
However, it is interesting to note that in 75% of Turner syndrome patients (XO),
the lone X is maternal in origin (Hassold et al., 1988). Thus, even though the
overall majority of aneuploidy causes are attributed to maternal nondisjunction,
the majority of XO cases are from sperm missing the sex chromosome by either
paternal meiotic non-disjunction or anaphase lag. This demonstrates another
disadvantage of polar body testing in its ability to detect the majority of sex
chromosome aneuploidies (Gitlin et al., 2003).
One of the most comprehensive reports of PB testing for single gene
defects was described by Rechitsky et al. (2001). Over 1000 oocytes were tested
for single gene defects and linked polymorphic markers by using PCR. Two
hundred thirty seven unaffected oocytes were identified for potential transfer in
114 couples resulting in 34 pregnancies and the birth of 23 healthy children with
no misdiagnoses. These studies demonstrate the successful application of PB
testing for at-risk couples to have healthy children.
2) Cleavage Stage Biopsy (Figure 1)
The majority of embryos biopsied for PGD are at the cleavage stage,
generally consisting of six to eight cells after three days of embryo culture
(ESHRE PGD consortium steering committee, 2002). The biopsy of embryos
consisting of less than six cells appears to decrease the developmental potential
of the embryo in several animal model studies. Krzyminska et al. (1990)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

nucleus

1A

1B
50 microns

Figure 1. Cleavage stage embryo biopsy. Panel 1A demonstrates the biopsy of
a cleavage stage embryo with at least 7 cells visible. The aspiration pipette to
the right has an inner diameter of 40 microns. The biopsied blastomere is shown
after removal from the embryo (Panel 1B). Note the visible nucleus in the center
of the cell.
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biopsied mouse embryos at the four-cell, eight-cell, and morula stage. Embryo
biopsy at the eight-cell stage did not reduce the blastulation rate (95% versus
99% for controls), nor the implantation rate (biopsy 82% versus 87% for
controls). However, at the four-cell stage, the subsequent blastulation rate fell to
76% and the implantation rate decreased to 44%. The authors concluded that
embryo biopsy at the 8-cell or greater appeared to be more successful by not
affecting the subsequent blastulation and implantation rates.
Since embryo biopsy involves the random selection and removal of one to
two cells, totipotency and polarity of blastomeres are important considerations to
study. At this early stage, the embryo is still totipotent, that is, each individual
cell (blastomere) has the theoretical potential to develop into a healthy offspring
(Ziomek et al., 1982). This hypothesis was tested experimentally when Rossant
(1976) separated each blastomere from mouse four to eight cell embryos. Each
individual cell was inserted into an empty zona and returned to the oviduct.
Embryonic development arrested at 5.5 days; the authors suggested that this
was due to a reduction in the total number of cells at the time of embryo
cavitation. One study provided evidence of the totipotency at an earlier stage in
4-cell cattle embryos (Johnson et al., 1995). Individual blastomeres were isolated
and inserted into emptied zona pellucida, then cultured to the blastocyst stage.
Two embryos each were transferred into recipient cows, resulting in the birth of
two sets of identical twin calves, all genetically from the same 4-cell embryo.
Although this study demonstrated the early totipotency of bovine embryos, no
additional studies in the literature have been reported.
To determine the existence of polarity in blastomeres in early human
cleavage stage embryos, Mottla et al. (1995) injected a fluorescent lineage tracer
(Texas Red-lysine-dextran) into individual blastomeres of human two- to eight
cell embryos. The embryos were then cultured to the blastocyst stage at which
time they were fixed and examined using confocal microscopy to identify the
location of the tracer. In successfully injected embryos that developed to
expanded blastocysts, randomly injected blastomeres formed both TE and an
inner cell mass (ICM); however, more labeled cells were found in TE than in ICM.
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These results suggested that early blastomeres are not yet committed to
specifically become either TE or ICM.
An interesting study by Gueth-Hallonet and Maro (1992) involving eight
cell mouse embryos demonstrated that blastomere organization changing from
symmetrical to polarized led to the two different cell lineages - one giving rise to
the TE (generally the cells on the perimeter) and the other giving rise to the ICM
(generally the cells on the inside of the embryo that do not border the inside of
the zona pellucida). However, blastomeres may behave differently in an intact
versus a disrupted embryo. The cell fate may be determined by positioning of the
cell in the embryo; however, it is not irreversibly fixed. The researchers found that
the inside cells which do not normally contribute to TE could become totipotent if
the integrity of the embryo was disturbed. This provided the embryo with a
degree of positional flexibility that may play an important role to compensate for
damage or loss of blastomeres. In a different study (Ciemerych et al., 2000), 8cell mouse embryos were injected with a fluorescent protein and similarly, cells
were traced through blastocyst development. Their findings concurred with the
results of Gueth-Hallonet and Maro (1992) that polarity exists, but is not
irreversibly established.
Other investigators have studied polarity as well (Edwards and Beard,
1997). However, the majority of the research was conducted using animal
models such as the mouse and rabbit while little work exists with human
embryos. Due to difference in the timing of embryonic genome activation (post
first cleavage in the mouse compared with post third cleavage in the human,
Braude et al., 1988, Heikinheimo et al., 1995), it is difficult to discern if evidence
of polarity by the second cleavage stage can be extrapolated to the human. One
such study provides evidence of early polarity by the measurement and tracing of
two proteins, leptin and Stat3, throughout the oocyte and cleavage to the
blastocyst stage in both mice and human (Antczak and Van Blerkom, 1997).
Higher concentrations of both proteins were seen in the outer most cells of the
embryo and in the TE as opposed to the ICM. Presence of these proteins in

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

9
intact ovarian follicles suggest that these proteins may be maternally derived and
have a role in embryo development and the establishment of polarity.
The viability of human cleavage stage embryos after biopsy was assessed
in several different studies. Hardy et al. (1990) examined the effects of the
removal of 1, 2, or 3 cells from an eight-cell human embryo. Additionally, nuclei
from the ICM and TE were differentially labeled and counted to assess the
allocation of cell number. Their studies concluded that removal of two of the eight
cells did not affect subsequent blastocyst development. The ratio of ICM:TE cells
also was not altered even though there was a reduction in the actual total
numbers of cells. Uptake of pyruvate and glucose were also measured in
droplets of spent culture medium to assess metabolism in the aforementioned
studies (pyruvate is an end-product of metabolism in glycolysis). Even though
uptake was reduced in 7/8 embryos and 6/8 biopsied embryos (i.e., 7 of 8 cells
and 6 of 8 cells remaining when one and two cells were removed, respectively),
this was interpreted to be due to the reduction of cellular mass resulting from the
decreased cell number (Hardy and Handyside, 1992). Development to the
blastocyst stage did not appear to be adversely affected by the cell removal.
Tarin et al. (1992) conducted a similar study, removing one quarter of the cells
from human four to eight-cell embryos. Pyruvate uptake and cell number were
measured at the blastocyst stage. The authors concluded that there was no
significant difference in the number of embryos that reached the blastocyst stage
as compared to non-biopsied controls. As expected, the total number of cells and
the pyruvate uptake were markedly reduced.
From these studies, it is concluded that cleavage stage embryo biopsy
can be performed without adversely affecting subsequent embryo development.
3) Trophectoderm biopsy
TE biopsy is another option for embryo biopsy (although rarely used in
PGD). Initial work in animal models demonstrated that biopsied blastocysts could
implant and lead to pregnancies (sheep, Rowson and Moore, 1966; rabbit,
Gardner and Edwards, 1968; mice, Gardner and Johnson, 1972; Monk et al.,
1988; cattle Betteridge et al., 1981; marmosets Summers et al., 1988). The
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greatest advantages of biopsying at the blastocyst stage are that more cells are
available, and that the TE is extraembryonic material (Dokras et a I., 1990). TE
biopsy may also circumvent ethical issues that a couple may have as only
extraembryonic cells are being removed, and the ICM cells that become the fetus
remain intact.
There is limited knowledge on how the TE represents the genetic
constituency of the remaining embryo cells. There is evidence to suggest that the
TE may contain cells that are tetraploid or mosaic from the inner cell mass (it is
known that there are multinucleated trophectoderm cells); the genetic make-up of
these cells might not reflect the true genetic constituency of the eventual fetus
(Everett and West, 1996).
One of the major disadvantages of blastocyst biopsy relates to the timing
of the procedure. Blastocyst formation occurs approximately five days after
fertilization. Although there appears to be no difference in pregnancy rates in
studies of day 5 versus day 6 embryo transfers (de los Santos et al., 2003), there
are logistical issues that must be overcome: will the PGD results be available by
day 6? If the blastocysts hatch, are they more difficult to transfer?
Cryopreservation of the embryos could be considered as an option although
there are limited studies with cryopreserved biopsied blastocysts, and the
subsequent success rates of survival and implantation are also not known. One
anecdotal report described an 80% survival rate with 46 frozen
morula/blastocysts; 35 embryos were transferred and 10 implanted for an
implantation rate of 28.6% (L Veeck-Gosden, personal communication). Many
centers have reported only limited survival at the time of thawing of
cryopreserved cleavage stage biopsied embryos (9%, Magli et al., 1999; 15%,
Joris et al., 1999). Jericho et al. (2003) modified their standard propanediol
cryopreservation protocol by elevating sucrose (0.2M) and serum concentrations
(20% volume:volume), resulting in a 75% survival rate in 185 frozen/thawed
cryopreserved embryos. These results demonstrate promising use of
cryopreservation of biopsied embryos in PGD cycles that may allow for greater
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flexibility of timing of the embryo transfer during the 5-6 day window of
implantation.
2.2 Genetic Analysis
Edwards and Gardner (1967) were among the first to report studies
attempting to determine the genetics in a preimplantation embryo. These
researchers determined the sex of rabbit embryos by identifying the sex chromatin
(Barr body) of the TE from an intact blastocyst. The Barr body, found when more
than one X chromosome is present, is the highly condensed chromatin of the
inactive X chromosome. The following year, these researchers described embryo
biopsy and the ability to excise small pieces of the trophectoderm from a rabbit
blastocyst (Gardner and Edwards, 1968). Under the microscope, suction was
applied to a micropipette holding the blastocyst in place. A second pipette was
placed directly opposite the holding pipette, and suction was applied. This caused
a small amount of trophectoderm to be isolated; a microscissors was then used to
excise the extruding trophectoderm mass from the blastocyst. The biopsied
material was subsequently analyzed by acridine orange staining (a DNA stain)
under fluorescent microscopy to determine the presence of sex chromatin. The
presence of sex chromatin in a high proportion of trophoblast nuclei is indicative of
a female. In those initial studies, 77 embryos were transferred to recipient female
does. Only 3 of 77 implanted; the only assessment at day 13 gestation that was
given was that the fetuses appeared normal, and no sex results were listed. The
low implantation rates were attributed to culture conditions. Embryos were
obtained by flushing the blastocysts from the uterus, excising a portion of
trophectoderm cells, and holding the embryos in serum for 1-2 hours while the
tests were performed. After optimizing the culture conditions, 109 blastocysts were
transferred to recipient does, of which 80 (73%) implanted. From those, 18
offspring were bom. All 18 (100%) were correctly sexed at the blastocyst stage.
Shortly after, changes were made in culture media and culture conditions
(including allowing time for the blastocysts to re-expand) that demonstrated
improved implantation rates (Edwards, 1969). Despite the low rates of live
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offspring, this initial animal work laid the foundation for further animal studies along
with human trials almost twenty years later (Monk et al., 1987).
2.2.1 The Polymerase Chain Reaction
PCR revolutionized biotechnology. The discovery of the PCR technique
(Mullis et al., 1986; Saiki et al., 1988) allowed for millions of copies of specific
genetic information to be replicated from a DNA template. By denaturing the
double-stranded DNA, adding specific synthetic oligonucleotide primers bracketing
the gene locus of interest, and extending new strands of DNA using a
thermostable polymerase, millions of copies of the desired sequence can be
amplified.
The story is well documented of Kary Mullis's late night drive into the
California mountains where the revelation of the PCR process came to him (Mullis,
1990). During the three-hour drive, he analyzed and reanalyzed each step of the
process where he proposed to synthesize millions of copies of DNA from a single
template. At one point, he stopped on the roadside, drawing out DNA molecules,
the strands denaturing, the primers hybridization, and the new strand extension
with DNA polymerase, an enzyme that had been discovered twenty years
previously (Kornberg et al., 1964). The next several months after that trip led him
on the scientific journey, first searching the literature that revealed no one else had
published his idea. Months of laboratory preparation, trial and error with buffer
concentrations, different temperatures, all the optimization steps discussed below,
followed. Finally, Mullis selected what he called his favorite kind of experiment',
one that was run in a single tube and involved a yes/no answer. The answer was
yes. Yes, segments of DNA could be amplified to produce millions of copies.
The story continues as Science magazine awarded its Molecule of the Year
in 1989 to the technique of PCR (Guyer and Koshland, 1989). Mullis received the
Nobel Prize in Chemistry in 1993 for developing the polymerase chain reaction. By
Mullis's own admission (Mullis, 1990), one of the most crucial keys to success with
PCR was the introduction of the thermostable polymerase known as Taq (Saiki et
a I., 1988). The discovery of Thermus aquaticus (Taq), a thermostable bacteria
from which the polymerase is derived was made by Thomas Brock and Hudson
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Freeze (Brock and Freeze, 1969), two names that are not as recognizable nor
given as much credit as that of Mullis, but who certainly made a significant
contribution, nonetheless.
Initially, Brock had the idea to study bacteria in hot springs since at the time,
thermophilic bacteria were thought to have an upper temperature limit of 55°C with
the upper limit for life at 63°C (Kempner, 1963). His pursuits involved a study of
photosynthesis; the hot springs provided a 'steady state' ecosystem that led him to
Yellowstone National Park. Due to its altitude, the boiling temperature of the
springs is actually 92°C. Although he did find an upper limit of photosynthetic life at
70-73°C, he also found bacteria living at higher temperatures. However, it was
difficult to cultivate organisms from these higher temperatures. His focus turned to
a spring with the temperature of 73°C. There, T. aquaticus, among other bacteria
was isolated. Soon after, it was discovered that artificial hot-water systems also
housed bacteria. Indeed, bacteria can survive boiling water temperatures (Brock,
1995).
The original name for bacterium Taq had been Caldobacter trichogenes
after an extensive literature search of thermophilic bacterium (Brock, 1995). Caldo
is Italian for hot, tricho is the Greek for filaments, which the bacterium formed
under certain conditions. The name was changed to Thermus Balnearius (heat +
thermal bath), before Brock decided upon Thermus aquaticus referring to the water
(aquaticus) where the bacterium grew. Brock mused that scientists might not have
known the enzyme as Taq polymerase but rather Cat (caldobacter trichogenes)
polymerase instead.
David Gelfand of Cetus Corporation presented the idea of using the
thermophilic bacterium as the source for DNA polymerase (Saiki et a/.,1988; Innis,
1988). Similarly, researchers in Cincinnati described a thermostable polymerase
from T. aquaticus (Chien et al., 1976). Initially, the experiments designed by Mullis
used the Klenow fragment of Escherichia coli DNA polymerase I as the enzyme to
catalyze the extension step of the process. However, fresh enzyme had to be
added to each tube after each denaturation step of each cycle since the E. Coli
polymerase was not heat stable at the high denaturation temperatures. Also,
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E.Coli polymerases did not appear to synthesize the entire gene segment desired
(Wickner et al., 1972). At that time, the researchers suggested that the
temperature range provided a possibility that Taq polymerase could be used for
gene synthesis. The half-life for Taq polymerase at 92.5°C is 130 minutes, 40
minutes at 95°C, and 5-6 minutes at 97.5°C (Saiki et al., 1988). The thermo-stable
Taq could be added at the beginning and did not need to be replenished as the
E.coli polymerase had.
The substitution of Taq not only simplified the process, it also demonstrated
improved sensitivity, specificity and increased yields (Suzuki et al., 1972; Taylor et
al., 1972; Verma et al., 1972). This was partially due to the fact that the Klenow
fragment was incubated at 37°C while the Taq is incubated around 70°C; the
increased temperatures increase the specificity. In the initial work by Saiki et al.
(1988) comparing the two polymerases, samples with the Klenow fragment
showed non-specific DNA products, assumed to be due to the decreased
stringency at the lower temperature. At the higher temperature of Taq, the non
specific priming templates would dissociate, leaving only the complementary
primer stands annealed. The higher temperature threshold of the Taq made it ideal
since it may have been possible to melt the secondary and tertiary structure of the
template at those higher temperatures. The increased yield was observed due to
the increased efficiency of the Taq polymerase.
A disadvantage of the use of Taq is the misincorporation rate (the rate at
which the wrong nucleoside is inserted into the DNA strand extension). For Taq,
the misincorporation rates were calculated to be once every 2 x104 bases while for
the Klenow fragment the rate was one in every 8 x 105 bases. However, this
difference was overcome by analyzing many different aliquots of the same sample
and coming to a consensus of the resulting sequence.
There are three basic steps to PCR (Figure 2):
1) The denaturation of the template DNA
2) The annealing of the oligonucleotide primers
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3) The extension of the new strands aided by the polymerase and dNTPs. The
strand extension involves the coupling of a dNTP to the free 3'OH group at the
end of the template. (Tindall and Kunkel, 1988).
1) Denaturation
Prior to the cycling, samples can be heated to 100°C to remove impurities
in the DNA sample and proteases (Rolfs et al., 1992). For thermocycling
conditions, one cycle of initial denaturation for three minutes at 95°C is
performed to separate the double-stranded template. Slightly higher
temperatures may be need for G-C rich regions due to the stronger triple bonds
of the G-C. If the denaturation temperature is too low, the partially denatured
strand will snap back together when slightly cooled and thus the primers could
not anneal. Subsequent cycles require less time for denaturation since the
template never completely renatures under themocycling conditions.
2) Primer annealing
The second step of the PCR is the annealing of the complementary
primers. In the initial cycles of the PCR, the primers act as 'scavengers',
performing a genomic screening to find their complementary base sequences.
The probability of the primers annealing is determined by several conditions of
primer design: annealing temperature, time of reaction, and product
concentration (Rolfs etal., 1992). Annealing time and temperatures are
discussed here while the primer design and concentration is discussed in the
section concerning the components of the PCR.
Annealing time
Annealing time is generally between 20-40 seconds. Longer annealing
times are needed for low copy initial templates to allow time for the primers to
find their target.
Annealing Temperature
Higher annealing temperatures increase the stringency of the reaction
(likelihood of specific hybridization) by minimizing the priming events due to DNA
secondary structures such as hairpin loops. However, annealing temperatures
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Figure 2. Polymerase Chain Reaction. Double Stranded DNA is denatured.
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that are too high will reduce the chance of annealing occurring (Innis et al.,
1990). Decreasing the annealing temperature lowers the stringency of the
reaction, but may also increase the likelihood of amplification occurring. The
stringency is decreased because the primers may bind to partial complementarity
not involving the 3' end. The highest annealing temperature possible should be
used to provide the optimum results of sensitivity and specificity.
There are several methods used to calculate the annealing temperature
as described below. The general rule is to start with an annealing temperature
that is 5°C lower than the calculated melting temperature, Tm, of the
oligonucleotide strand (McPherson et al., 1991). The Tm is defined as the
temperature at which 50% of the oligonucleotide is annealed to its
complementary DNA strand. There are several formulas to calculate the melting
temperature.
The Tmcalculation by the nearest-neighbor method is based on similarity of a
random object (temperature) to the object studied (Equation 1; Rychlik et al.,
1990).
Tm=

AH

273.15 + 16.6 log [salt]

(1)

(A + a S) + Rln (Ct/4)
Where:
o

aH

(cal mole-1) is the sum of the nearest-neighbor enthalpy

changes for hybrid formation (<0).
o

A (cal K-1 mole-1) is a constant for helix initiation which is equal to 10.8 cal K-1 mole-1 for nonself-complementary sequences and = 12.4 for self-complementary sequences).

o

aS (cal K-1 mole-1) is the sum of the nearest-neighbor entropy
changes for hybrid formation (<0)

o

R is the molar gas constant (1.987 cal K-1 mole-1)
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o

Ct is the total molar concentration of strands when oligonucleotides
are not self-complementary or it is equal to 4 times this
concentration in the case of self-complementary sequences.

Another method for calculating the melting temperature is shown as Equation 2
(Sambrook and Russell, 1989).

Tm= 81.5 + 16.6 (log10[J+] + 0.41 (%G+C) - (600/I) - 0.63 (%FA)
°

Where J+ = concentration of monovalent ions

°

L = length of nucleotide

°

FA = formamide

(2)

Wu etal., (1991) proposed this calculation for annealing temperature (Equation
3).

T P = 22 + 1.46 (Ln)
°

Where Tp = optimized annealing =/2-5C

0

Ln= length of oligo

(3)

These elaborate formulas have been replaced by the standard method that most
researchers use known as the Wallace formula (Equation 4; Thien andWallace,
1986). This has become a preferred calculation since the Tm is easily calculated
and the results serve as a good basis for optimization experiments.

Tm= 2°C(A+T)+4°C(C+G)

(4)

The actual annealing temperature used for the reaction can vary by as much as
12°C due to differences in primer concentration that will favor hybrid formation
and result in increased melting temperatures (McPherson etal., 1991). Also, the
Tmwill be higher with higher salt concentrations due to the high ionic strength as
cations stabilize the DNA duplexes.
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3) Extension
Strand extension or elongation at 72°C is optimal for reactions using Taq
polymerase. As little as 20 seconds may be needed for strands shorter than 500
base pairs to elongate, while 40 seconds may be enough for strands up to 1.2
kilobases (kb) (Rolfs et al., 1992). The presence of secondary structures
increases elongation time. Many PCR protocols call for a final extension of 5-15
minutes at 72°C after the last PCR cycle to complete extension of all products.
Theoretically, it appeared to be more efficient to increase the extension time after
each cycle, giving the new product time to extend before further denaturation (a
choice employed by our laboratory).
2.2.1.1 The components of the PCR
There are seven essential components of PCR with a discussion of each
component to follow (McPherson et al., 1991):
1) The template DNA
2) The use of a thermostable polymerase
3) The oligonucleotide primers
4) Deoxynucleotide triphosphates (dNTP’s)
5) Divalent Cations
6) Monovalent Cations
7) Buffer to maintain pH
1) The template DNA
The template DNA can consist of as little as a single copy of the segment of
interest. The PCR technique was initially designed with large quantities of starting
template in mind. However, variations of the standard PCR protocols can be used
to achieve greater sensitivity and specificity even when using a limited number of
cells down to the level of a single cell as in PGD (Handyside et al., 1989). One of
the modifications that has enhanced the ability to perform PGD is called nested
PCR (Oste 1988). Nested PCR uses two primer sets encompassing the target
locus in two separate rounds of PCR. The second set is designed downstream
(nested) to the first set. The reasons that nested PCR is advantageous when using
low amounts of initial DNA template are two-fold:
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A) It increases the sensitivity by using two rounds of the amplification
reaction. PCR is a finite reaction; beyond the threshold of amplification (which is
achieved as reagents are expended), non-specific priming/DNA amplification is
seen. By performing approximately 20 cycles of PCR, removing an aliquot of the
product, then revitalizing the reaction with additional components of the DNA
master mix, exponential amplification can continue from the new reaction starting
point.
B) Nested PCR increases the specificity by using two targeted sites on the
gene for amplification. Using an 18-25 base primer set in one PCR reaction not
only amplifies the target loci, it also allows for the possibility that another
homologous sequence in the three billion base pair genome could theoretically
amplify. In order to minimize the chance of that occurrence, another primer pair
within the same area of the specific locus is used in a second PCR reaction. This
substantially decreases the possibility of erroneously amplifying a similar (yet
unsought) area of the genome since the template for the second reaction
consists of only the segments amplified in the first reaction.
The utility of nested PCR is demonstrated in Figure 3. The upper photo is
a gel with samples that were subjected to 50 consecutive cycles of PCR. The
lower photo is a gel with the same samples, but after the first twenty cycles of
PCR, a 2pl aliquot was removed and subjected to an additional 30 cycles of
nested PCR (with the same first primer set). Therefore, both sets of samples
were subjected to 50 cycles of PCR. Two additional samples showed
amplification in the nested reaction that would not have otherwise amplified with
the standard one-step PCR. This gel demonstrates the increased sensitivity seen
in nested PCR.
2) The use of a thermostable polymerase
As discussed above, the substitution of Taq polymerase from the original
E. coli polymerase was one of the most important keys to the development of
PCR. One unit of enzyme is classified as the amount of enzyme that will
catalyze the incorporation of 10nmol of total nucleotide in 30 minutes at 74°C
(McPherson et al., 1991). Too much enzyme can lead to a decrease in
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Figure 3. The sensitivity and specificity of nested PCR. Upper and lower photos
of 7% polyacrylamide gel lanes contain the same controls (C), single cell
samples (S) or negatives (N) along with a DNA marker ladder (M) except that the
reaction tubes in panel A were exposed to 50 continuous cycles of PCR while the
reaction tubes in panel B contain an aliquot that was removed after 20 cycles of
PCR from the corresponding reaction tube. Additional master mix was added and
those tubes continued for an additional 30 cycles. Both groups had a total of 50
cycles, but two additional samples amplified in the nested group that did not in
the non-nested group.
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specificity. When using Taq polymerase, the new DNA strand extends at 35-100
nucleosides/second at 70-80°C. As mentioned before, the half-life for Taq
polymerase at 92.5°C is 130 minutes, 40 minutes at 95°C, and 5-6 minutes at
97.5°C (Saiki et al., 1988).
Processivity of an enzyme is defined as the average numbers of
nucleotides synthesized before the enzyme dissociates from the template
(McPherson et al., 1991). Fidelity refers to the frequency of enzyme-induced
errors. Each error would then be amplified in subsequent PCR reactions. Fidelity
is determined by the ability of the enzyme to discriminate between the dNTPs
and select the proper complementary dNTP based on the sequence of the DNA
template. Fidelity is affected by the balance of the individual dNTP concentration.
Proofreading selectively removes misincorporated nucleosides at the 3' end of
the primer. High dNTP concentration reduces proofreading activity (Kunkel,
1988). Proofreading is also affected by magnesium (Mg2+) concentration, pH,
secondary structure, and the amount of template available. A->C and T-»C are
the most common errors (Tindall and Kunkel, 1988). Taq polymerase has no
proof reading (3'->5'exonuclease) activity. However, those errors will for the
most part be lost because they do not yield full-length DNA products for further
amplification (Tindall and Kunkel, 1988).
Pfu polymerase (pyrococcus furiosus) has a twelve-fold higher fidelity than
Taq polymerase (McPherson et al., 1991). Pfu polymerase has 3' to 5'
exonuclease activity, which Taq polymerase lacks. The temperature range for its
use is 72°-78°C. After 1 hour at 95°C, the Pfu polymerase still has 95% of its
activity. However, it will begin to degrade template DNA in the absence of dNTPs
so it must be added last to the reaction mix, after the dNTPs have been added.
Pfu polymerase requires increased Tris concentrations, and decreased
potassium; the lower salt requires a decrease in annealing temperatures from
what is used for Tag-driven reactions (the importance of these components are
discussed further below).
The Stoffel fragment of Taq polymerase is a deletion of the 289 N-terminal
amino acids of the native Taq (Lawyer et al., 1993). It has approximately 2-times
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the thermostability of Taq polymerase (97.5°C for 20 minutes), but lacks the
5'-*3' exonuclease activity. It requires a broader range of magnesium ion
concentrations. As with the other polymerases other than Taq, inconsistent
amplification results and lack of optimized conditions precluded their use. The
choice of polymerase is dependent upon the type of amplification reaction along
with the sensitivity and reproducibility of the reaction.
3) Oligonucleotide Primers
The oligonucleotide primers are complementary base sequences that
anneal to the specific strand of DNA in order to initiate strand replication (Ehrlich,
1989, McPherson etal., 1991, Rolfs et al., 1992). They are generally 18-30
bases in length and are complementary to the DNA sequence of interest. Primers
are synthesized using an automated DNA synthesizer to direct each letter
(A,T,C,G) in its appropriate place.
Primer optimization is critical for efficient PCR. The primer sequence
determines the length of the final PCR product, the annealing temperature, and
the ultimate yield of the product (McPherson et al., 1991). The primary goal of
primer design is specificity. There are over 3 billion base pairs of DNA in the
human genome; a perfect match has to be found in 18-30 bases. Although
primer design is somewhat empiric, the guidelines discussed below are based on
thermodynamic and structural principles of the DNA. Following the guidelines
discussed below does not guarantee success, but disregarding them usually
leads to failure.
Computer-assisted programs can aid in primer design. These programs
can show complementarity, potential primer-dimer sites, calculate annealing
temperatures, and show restriction enzyme sites. An example of primer design
and the computer assistance is given in Appendix A. The ideal primers contain
45-55% guanine (G) and cytosine (C) nucleotides due to the more stable triple
hydrogen bonds of the GC that will enhance the annealing (Figure 4). This also
sets the annealing temperature around 55-60°C. Run-on bases (a string of the
same nucleotide) should be avoided; GC stretches can promote non-specific
annealing while AT stretches make the primer template complex more vulnerable
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to dissociation since the AT double bonds are weaker. This could lower
amplification efficiency.
Primers should have one of the following - G or C, CG or GC - at the 3'
end (McPherson et al., 1991). This prevents "breathing" of the 3' ends
(dissociation) and increases efficiency of priming. The 3' ends of the primer pair
should not be complementary to each other, otherwise primer dimers will be
extended preferentially to any other product and decrease the yield of the desired
product. Primer dimers are so called because of the complex of the
oligonucleotide with itself or the other primer in the pair, thus forming the dimer.
A primer by itself should also not be self-complementary. This is to avoid having
the primer fold back on itself to form secondary structures such as hair-pin loops.
In that instance, less primer would be available for the desired reaction.
Primer concentration is easily determined by ultraviolet (UV)
spectrophotometry and measuring the optical density at 260nm. One OD is equal
to approximately 33ug of primer (Rolfs et al., 1992). Optimally the primer
concentration is related to the length of the amplified product and can be
calculated as shown in Table I. Generally, it is simpler to dilute the primers to a
working concentration of 0.1 to 1pM than it is to calculate the concentration from
the table. Primer concentrations should be adjusted to as low as possible for
amplification; higher primer concentrations may promote the formation of primer
dimers and other non-specific products.
4) Deoxynucleotide Triphosphates (dNTPs)
Concentrations of 200-250mM of each dNTP (dATP, dCTP, dGTP, dTTP)
are added to the PCR. The lower the dNTP concentration, the lower the error
rate of the base incorporation (Bebenek and Kunkel, 1990). Higher
concentrations of the dNTPs can be inhibitory, perhaps by sequestering too
much of the Mg2+. However, reaction times need to be increased at low dNTP
concentration to increase synthesis and minimizes error as T-G mismatches
(Bebenek and Kunkel, 1990). dNTPS should be pyrophosphate-free (which can
inhibit PCR). The pH of the dNTP solution should be around pH 8.1; the alkalinity
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Table 1. Determination of optimal primer concentrations

Incorporated primers per
strand (molar concentration)

Yield of

200 bp

800 bp

Incorporated dNTPs

produced

fragment

fragment

absolute molecular

double-stranded

concentration/ACT G

fragment

irrespective of length

1 p.g/1 OOjul

3 (j.g/1 OOjLxl

8 pmol

2 pmol

3.2 nmol

(0.08pM)

(0.02pM)

(8pM)

24 pmol

6 pmol

9.6 nmol

(0.24pM)

(O.Q6pM)

(24pM)
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of the solution helps to protect damage during freeze-thaw process. The signal
intensity may decrease if the dNTP solution is older than 2 months.
5) Divalent Cations
Mg2+ is used to stabilize the polymerase; the divalent cation influences the
processivity and Tmof the reaction since oligonucleotides can bind to Mg2+
(Eckert and Kunkel, 1990). Mg2+ is the most efficient cation; manganese has
limited efficiency while calcium is ineffective. Increased fidelity of the reaction can
be achieved by decreasing Mg2+ concentrations to the total dNTP concentration
(Eckert and Kunkel 1990). The concentration of free Mg2+ depends upon the
dNTP concentration and the EDTA concentration which binds stoichiometrically
to the Mg2+. However, too much EDTA or other chelating agents can sequester
too much of the Mg2+ and inhibit the reaction. Generally, a good starting
concentration is 1,5mM MgCh although some reactions can require a
2+

concentration as high as 6mM Mg . The optimal concentration must be
determined for each protocol.
6) Monovalent cations
Potassium chloride (KCI) is a component of the PCR buffer that adds a
monovalent cation to the reaction (McPherson etal., 1991). KCI concentration
should be less than 100 mM or it will decrease the polymerase activity.
Polymerase I actually is insensitive to high salt (Chien etal., 1976).
7) Buffer to maintain pH
Control of the pH is accomplished by using Tris buffer. The pH of the
reaction should be between 8.3-8.8 at room temperature (McPherson et al.,
1991). Since the extension step and new strand extension occurs at 72°C, the
elevated temperature will effectively lower the pH to around 7.2 for the reaction.
Optimal pH increases the polymerase activity and decreases the error rate. An
increase in one point of the pH can increase the error by 60 fold (Eckert and
Kunkel, 1990).

Incubation of DNA at high temp and low pH can change

amplification efficiency by inducing DNA damage due to the deamination of
cytosine to produce uracil, the same as coding for thymine. Also, DNA damage at
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high temperature/low pH can cause spontaneous base release due to increased
hydrolysis of the N-glycosylic bond. (Lindahl, 1979).
Generally the reagent components (the above components other than the
template DNA) are mixed together and added as an aliquot together to each
reaction tube for consistency. This is known as the master mix. The master mix
and the samples are kept on ice, and the thermal cycler is preheated to the initial
denaturation temperature for a more efficient amplification. Leaving the reaction
mixture for 5 minutes at room temperature could have a 1000-fold effect on
decreasing the amplification (Rolfs etal., 1992).
2.2.1.2 PCR Controls
PCR protocols should include both negative and positive controls.
Negative controls contain all reagents but no template DNA and are designed to
detect extraneous DNA contamination (Rolfs etal., 1992). Since no starting
template was added to the reaction, no amplification result should be seen;
amplification should only be seen in reactions where template DNA was added. If
amplification is seen in the negative control, the amplification observed in the
samples may not be valid and may be due to contamination of extraneous DNA
(contamination control is discussed further in Appendix B). Positive controls
contain DNA of interest and verify the occurrence of amplification and should
provide an amplification result. If positive controls do not amplify, possible
explanations may be that inhibitory activity may be present in the reaction, a
reagent was not properly added (omitted or at the wrong concentration), or PCR
conditions may not be optimized. Both positive and negative controls must be
exposed to the same conditions as the reaction samples, including the
preparation and extraction steps, so that the sample results can be compared
with controls for the validity of results.
2.2.1.3 Other types of PCR
A multitude of PCR techniques concurrently exist, still based on the three
basic steps of denaturation, annealing, and extension. Some of the modifications
include the following techniques:
1) Hot-start PCR is a method designed to avoid mispriming by keeping the
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master mix components separate from the template prior to denaturation (Chou
et al., 1992). As the reaction temperature rises to the starting denaturation
temperature, primers could inadvertently anneal as the temperature passes
through the annealing temperature range. The Hot-start PCR tube contains a
wax-barrier that melts when denaturation temperature is reached.
2) Touchdown PCR is the variation of the annealing temperature during
the reaction itself (Don et al., 1991). The initial annealing temperature is set
above the calculated annealing temperature. It is decreased by 1°C increments
every two cycles to below the calculated temperature. This decrease is known as
the 'touch-down'. These variations in temperature will increase the stringency of
the reaction and decrease the non-specific priming over the range of
temperatures. It is used in circumstances with several primers to encompass
different annealing temperatures, or used to overcome instances when it is
difficult to identify the optimal annealing temperature.
3) Fluorescent PCR uses fluorescently labeled primers that can be
detected at a greater sensitivity than conventional PCR primers (Chehab et al.,
1992). The amplified product is detected with the assistance of computer
software rather than conventional gel electrophoresis.
None of these techniques were used in these experiments, or were tested with
little improvements in conditions.
2.2.2 Whole Genome Amplification (WGA)
One of the constraints in performing single cell genetic analysis is the
limited quantity of DNA. A single cell contains approximately 10pg of DNA, which
can limit the number of diagnostic procedures that can be performed to gather
information from the cell. To overcome these limitations, whole genome
amplification techniques such as primer extension preamplification (PEP),
degenerate oligonucleotide primers (DOP), or multiple displacement amplification
(MDA) can be applied to increase the amount of DNA (Zhang et al., 1992; Xu et
al., 1993; Kristjansson et al., 1994). These techniques use primers consisting of
random nucleotides that have the capability of producing multiple copies of
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segments of the genome. An explanation for several whole genome amplification
techniques follows.
2.2.2.1 Primer Extension Preamplification (PEP)
PEP is a PCR-based molecular technique that initially was applied to
spermatozoa to amplify and study several large fragments of DNA (Zhang et al.,
1992). A mixture of 15-base oligonucleotide primers is added, containing random
combinations of the four nucleotide bases. The primer mixture is theoretically
composed of 4 15 sequences (415 = approx 1.07 billion). The cell is lysed and the
primer mixture is added with buffer, dNTPs, and Taq polymerase. The sample is
then thermocycled for 50 cycles with a slow rise (ramping) of annealing
temperatures in the second step to encompass several annealings during that
step. In the initial experiments, Zhang and colleagues (1992) subjected single
human sperm to PEP, then analyzed each of 18 sperm for 12 different loci in 30
aliquots by PCR. From these experiments, the researchers concluded that
approximately 78% of the genome had been copied at least 30 times. Similarly,
several studies were undertaken to demonstrate the ability of blastomeres to
amplify multiple loci post-PEP (Xu et al., 1993; Kristjansson et al., 1994).
2 .2 .2 2 Degenerate Oligonucleotide Primers (POP)
DOP is another W GA PCR-based technique, which differs from PEP in
several ways. The primer mix consists of a random hexamer surrounded by a
known oligonucleotide sequence on either side of the random nucleotides
(5‘ - CCGACTCGAGNNNNNNATGTGG- 3', where N is any nucleotide). This
partial 'degeneracy' is thought to allow for the priming from multiple dispersed
sites along the genome since the ATGTGG sequence should occur once every
4630 base pairs (Telenius et al., 1992). Rather than ramping the annealing
temperature as in PEP, there are two series of steps in the DOP process.
Initially, the annealing temperature is lowered to around 30°C for eight cycles; as
discussed previously, lower annealing temperatures lower the stringency. This
allows more random primer binding, including the chance that any of the six
bases will anneal at the 3' end. The annealing temperature is subsequently
raised to 60°C for more specific annealing.
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Wells et al. (1999) compared the techniques of DOP and PEP, Ninety one
percent (228/250 cells) of the genome amplified post PEP while 89% (223/250)
amplified post-DOP. Furthermore, DOP reactions produced larger quantities of
DNA than PEP as evidenced by the presence of a DNA smear on a 1% agarose
gel. No smear appearance was seen on the gel with the PEP products.
Unfortunately, the study did not specify the quantitation of DNA in their results
although they were able to conduct 90 separate PCR amplifications from a single
cell post DOP. PEP generates approximately 40ng of product while DOP can
generate 1-6pg (Lasken and Egholm, 2003).
There are a few disadvantages of these WGA techniques. The process is
relatively easy to set-up, but the amplification process requires approximately 10
hours. Also the products tended to be less than 500 base pairs which can
introduce bias. Internal regions of previously amplified product would amplify in
subsequent cycles so that whole segments of the genome were either under
represented or not present at all in the final product. This could lead to allele
drop-out (ADO, the amplification of only one allele of the two alleles present)
(Paunio etal., 1996; Wells etal., 1999).
2.2.2.3 Multiple Displacement Amplification (MPA)
A newly introduced WGA technique offers great promise as a
comprehensive technique with minimal bias (Dean et al., 2002). The technique,
MDA, also known as rolling circle amplification, was first proposed by Lizardi et
al. (1998). This WGA technique differs from DOP or PEP in that it does not
require PCR. The technique is isothermal, and amplifications take place entirely
at 30°C. The method involves strand displacement in that the template is
amplified over and over again; the polymerase amplifies a new copy as it
displaces previously synthesized copies. This is in contrast to PCR where the
polymerase dissociates from the previously made copy and new polymerase
starts the next strand synthesis (Figure 5).
The key to the MDA technique, just as in the PCR, is the type of
polymerase used. For MDA, 0 2 9 (Phi 29) polymerase is used. 0 2 9 DNA
polymerase (from the bacteriophage of the same name) is highly processive and
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has the ability to incorporate 70,000 nucleotides in a single binding event (Blanco
et al., 1989.) As the 0 2 9 polymerase encounters a synthesized strand of DNA,
the polymerase displaces the strand, thus inducing single stranded DNA that can
serve as a template for further primer annealing and strand replication. The
products generated from an MDA reaction are generally up to 12 kb in length.
The isothermal technique, while eliminating the cycling, avoids sequencedependent events such as differences in G-C content that favor amplification of
certain regions over others (Lasken and Egholm (2003). The error rate for 0 2 9
is only 1 in 106 to 107 bases (Esteban et al., 1993).
The three primary advantages of MDA are:
1) it is an easy method to perform (and thus can be automated)
2) large quantities of DNA are generated
3) DNA yields are uniform and independent of initial starting material since
the reaction proceeds until reaching a similar quantity endpoint.
Isothermal amplification in human single lymphocytes (n=5) and
blastomeres (n=11) has been reported (Handyside et al., 2004; Hellani et al.,
2004). Individual cells were subjected to MDA, and an aliquot of the sample
post-MDA was then subjected to PCR amplification of 20 different loci. All five
lymphocytes and 10 of 11 blastomeres demonstrated successful WGA as
evidenced by either DNA yield and/or PCR amplification (100% and 91%,
respectively). The lymphocyte aliquots amplified in 92/100 (92%) subsequent
PCR attempts. However, ADO was detected in 22/70 reaction (31%). The 10
blastomeres that were successfully amplified by the isothermal technique were
subjected to subsequent PCR as well. Eight of the ten blastomeres demonstrated
PCR amplification with an Allele drop-out (ADO) rate of 4/25 reactions (16%)
(Handyside et al., 2004). Similarly, Hellani et al. (2004) subjected 45 single
leukocyte cells to the isothermal WGA technique. Successful amplification was
determined in all 45 cells as evidenced by the presence of a smear on a 1%
agarose gel. Forty of the cells were subsequently subjected to PCR for a known
p globin mutation. Thirty-nine of 40 cells amplified by PCR (97.5%). There was
evidence of ADO in 4/39 cells (10.3%). In the Handyside studies (2004), the yield
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Figure 5. Multiple Displacement Amplification. A. Random hexamer primers
anneal to the template DNA at multiple sites. B. Phi 29 DNA polymerase initiates
replication at multiple sites on the denatured DNA simultaneously. C. As
polymerization proceeds, strand displacement of downstream replicated DNA
generates new single stranded DNA. D. Additional primers bind to the newly
synthesized single-stranded DNA. E. Subsequent priming and strand
displacement produce large quantities of high-molecular weight, double-stranded
DNA
Reprinted with permission from the GenomiPhi manual, GE Healthcare.
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of DNA after MDA ranged from 42-53pg as assessed by Picogreen analysis.
Hellani et al. (2004) reported 35± 5pg in their MDA products. From these studies,
the researchers concluded that these data provide the initial steps to the
applications of isothermal WGA techniques in single cell genetic analysis.
2.2.3 Microarrav Analysis
Standard microarray analysis involves the simultaneous use of two
fluorescent dyes, one for the sample of DNA/RNA to be tested, and one for the
normal control. The sample and control are labeled with the separate dyes, then
the two are combined and allowed to hybridize to the microarray. The dye
intensities are compared to determine gene expression or levels of DNA. The
premise is that the measured spot intensity is proportional to the abundance of
corresponding gene or message present (Edwards, 2003).
The first microarray paper studied quantitative gene expression in
Arabidopsis thaliana, a small mustard plant (Schena et al.,1995). The
technology developed rapidly the following year to included gene expression
studies in the yeast, mouse and human (Shalon et al, 1996; Schena et al., 1996;
Lockhart et al., 1996, respectively). To date, microarray technology has now
been used in over 100 organisms (Stears etal., 2003). The technology can be
used to determine and monitor the level of thousands of genes simultaneously
since the DNA or RNA probes are miniaturized onto a small glass or silica slide.
The principles of DNA and RNA detection are that a complementary probe binds
or hybridizes to the sequence of interest; in microarray technology the scale has
changed dramatically in that thousands of sequences can be detected from a
single array. Generally a two-fold change (increase or decrease) is used as the
threshold to determine significance. There are three components to microarray
technology:
1) The array slides containing the target DNA
2) Labeled samples (probes) which that are hybridized to the array
3) A detection system to quantitate the hybridization signal.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

35
1) The array slides containing the target DNA (Figure 6)
Microarray slides are 'spotted' with DNA oligonucleotides (generally 15-30
bases) or PCR amplified cDNA sequences (Stears et al., 2003). The short
oligonucleotide arrays are generally used for SNPs (single nucleotide
polymorphisms) that require single mismatch discrimination. They can also be
used for gene expression analysis although the short oligos may lack the single
gene specificity. cDNAs work well for gene expression analysis. These longer
sequences (0.2- 1.2kb) tend to produce strong signals that are highly specific
(Heller et al., 1997). Either of these elements is deposited (spotted) onto the
surface of a glass slide, generally as 0.5-1 OnL droplets with a concentration of
approximately 500ng/pJ on spots that are 100-150pm in diameter (Wildsmith and
Elcock, 2001). The spots are generally 200-250pm apart, depending on the type
of instrument performing the spotting. The spots are cross-linked and dried
(Sasik et al., 2004). The spots generally are duplicated elsewhere on the slide to
serve as hybridization controls that can aid in determining reproducibility.
Additionally, blank spots with no DNA are used as negative controls and can be
used to detect background fluorescence since they should not exhibit signal.
2) Labeled samples (probes) that are hybridized to the array
In microarray technology, the labeled sample/control is known as the probe.
The sample is labeled with fluorescent dyes as explained below.
2.2.3.1 Dyes
Fluorescence is defined as the molecular absorption of light energy (photon) and
its re-emission at another wavelength. Molecules that can both absorb and emit
light are known as fluorochromes or fluorophores. Fluorescent dyes are used to
label the sample and control. The advantage that fluorescent dyes have is that
more than one can be used and detected at a time. The fundamental principle of
microarray analysis is that there is a presumed relationship between the signal
intensity and the abundance of a gene transcript or target DNA (Cox et al., 2004).
Therefore the ratio of the two dyes should be 1:1 in genes that are equally
expressed (or in DNA present in the same amount). Furthermore, the signals
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Figure 6. Illustration of microarray slide. The microarrays used in these
experiments contained 4 grid columns and 8 rows, each grid with 12 columns
and 10 rows. The grid rows begin 1.75 cm from the non-labeled end of the slide.
Reprinted with permission from University Health Network, Microarray Canada.
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should be tightly distributed along a linear regression line. Higher signal correlation
between the two dyes provides more confidence in detecting smaller changes in
expression levels and allows for greater resolution of the difference between
sample and control. The labeling step is critical and can be the primary cause for
lack of reproducibility of results (Wildsmith etal., 2001).
Cyanine dyes, Cy3™ and Cy5™ dyes (Amersham Biosciences,
Piscataway, NJ) are commonly used in microarray analysis (Schena et al., 1995).
They are water-soluble and pH insensitive (Wildsmith et al., 2001). These dyes
are incorporated by labeling a dCTP with the Cy dye, then incorporating the dye
with a random labeling method. In this method, the Klenow fragment of DNA
polymerase incorporates the fluorescently labeled nucleotide in a DNA synthesis
reaction, which is primed with random hexamer primers. This method is
a practical solution for genomic microarrays although enzymatic reactions do not
copy all nucleic acid sequences (Microarray Handbook, 2004)
Alexa Fluor dyes (Alexa 555 and Alexa 647) have emerged as an
alternative to the Cy dyes. Alexa Fluor 555 and Cy3™ are structurally distinct
dyes that have similar absorption and emission spectra. Their maximum
absorption peak is at 550nm and their maximum emission peak is at 570nm.
Alexa Fluor 647 and Cy5™ dyes are also structurally distinct dyes that have
similar absorption and emission data. Both have a maximum absorption peak at
650nm and maximum emission at 670nm.
The Alexa Fluors are water-soluble dyes as well; this is advantageous
since nucleic acids that are labeled with Alexa Fluors will not precipitate even in
high salt concentrations of hybridizations. They are pH sensitive to the range of
4.0-10.0 (Wildsmith et al., 2001). They are more resistant to quenching (or
photobleaching) than the Cy dyes (Berlier et al., 2003). (Quenching is defined as
the diminishing or extinguishing of signal intensity due to intense light exposure).
The dyes directly label the nucleic acids without using enzymatic incorporation as
the Cy dyes require. This technique is rapid and efficient and provides a reliable
method for labeling DNA. The reagents react with the N7 of the guanine residue
of the DNA, averaging one dye molecule every 20-30 bases (Figure 7). This is
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Figure 7. The Alexa Fluor dyes. The Alexa Fluor label reacts with the N-7
position of guanine residue to provide a complex between the nucleotide and the
fluorochrome. Reprinted with permission/copyright owned by Molecular Probes,
Inc.
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much more efficient labeling and showed higher fluorescent intensity than did the
Cy dyes. A base:dye ratio can be calculated to determine how well the sample is
labeled to ensure that there will be adequate signal prior to array hybridization. A
desired level is a base:dye ratio of less than 25. The absorbance (A) at 260nm is
measured by UV spectrophotometry and the ratio is calculated (Equation 5).

base:dye = (Abase * 2dye) / (Adye * EbaSe)

(5)

where A base = A26o - (Adye * C F 26o)
A26o is the absorbance of the dye/nucleic acid conjugate
CF26o is the correction factor listed in the product information sheet
I dye is the extinction coefficient for the fluorescent dye (found on the
product information sheet)
ZbaSe is the average extinction coefficient for a base in double
stranded DNA (dsDNA) or single-stranded DNA (ssDNA) (found in
the information sheet), (from Molecular Probes product Information
guide, 2004).

Cox et al., (2004) demonstrated that the brightness of the Alexa Fluor dyes
showed a linear increase as the amount of dye labeling increased. In contrast,
the Cy dyes showed a decrease in brightness as the amount of labeling
increased. They concluded that the Cy dyes could be affected by dye-dye
interaction that may be responsible for the increased quenching seen with the Cy
dyes. From this, the researchers determined that an increased sensitivity may be
obtained when using the Alex Fluor dyes, allowing a 95% predictive value to
ascertain a difference at 1.3 fold level rather than the standard two-fold level
difference.
Dye-Swap normalization can be used to avoid artifacts (Rosenzweig et al.,
2004). This involves performing the experiment first with one dye for an aliquot of
sample and the other dye in the set for a second aliquot of the same sample to
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determine the variability in dye intensity since the ratio in the same sample
should be 1:1. Alternatively, the sample can be labeled with one dye and the
control labeled with another, then a second experiment performed with the
opposite dye for the sample and the opposite for the control. For example,
initially the control can be labeled with Cy3™ and the sample with Cy5 ™.
Another experiment 'swaps' the dyes and now the control is labeled with Cy5 ™
and the sample with Cy3 ™. These results are then compared to the results when
the dyes are reversed and the bias is determined.
2.2.3.2 Hybridization time and temperature
The time and temperature of the hybridization are dependent upon the salt
concentration of the hybridization buffer (Wildsmith and Elcock, 2001). Ideally a
hybridization buffer contains the following components:
1) A buffering component that acts to stabilize variations in pH
2) A detergent that lowers the surface tension and allow the buffer to flow easily
under the coverslip
3) Compounds such as formamide that act as rate enhancers, volume excluders,
or to speed up the hybridization and lower the Tm
Formamide is a denaturing reagent that is often used to lower the Tmof
the probe and thus the temperature of hybridization. The optimum hybridization
temperature for microarrays in aqueous buffers can be as high as 65 -75 °C. At
such high temperatures, drying of the slide can become problematic. Likewise,
the probe is more likely to degrade at higher temperatures. The addition of
formamide to a buffer decreases the Tmby 0.65 °C for every 1% concentration
(Casey and Davidson, 1977). The addition of 50% formamide to the hybridization
lowers the optimum temperature to a more reasonable 42 °C. However,
hybridizations carried out in formamide should be left undisturbed for 16 hours
unless the probe concentration is increased. Hybridization temperatures can be
calculated as 20-25° C less than the melting temperature using the Tmcalculation
as previously discussed from Sambrook and Russell (1989):
Tm = 81.5 + 16.6 (log10[J+] + 0.41 (%G+C) - (600/I) - 0.63 (%FA).
Where J+ = concentration of monovalent ions
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L = length of nucleotide

FA = formamide
Hybridizations generally take place for the allotted time in a hybridization
chamber submerged in a water bath.
2.2.3.3 Post hybridization washes
After the hybridization time has elapsed, the microarray is exposed to a
series of post-hybridization washes. The purpose of these washes is to remove
all unattached and/or loosely bound probe molecules. This prevents false
positive signals and removes all components of the hybridization buffer,
preventing background noise that may appear in the form of smearing and/or
speckles when the image is captured. Likewise, it is important not to remove the
bound probe. The wash takes place initially under similar salt concentrations and
temperatures as the hybridization buffer with decreasing concentrations in a
step-wise manner (Wildsmith and Elcock, 2001). The slides remain light sensitive
at this stage so the washing steps should be carried out in the dark to minimize
signal loss due to quenching of the fluorescent dyes. Once the slides have been
washed, they should immediately be dried by centrifugation to prevent smearing
that could occur if they were instead air-dried. The slides should then be stored in
the dark in a desiccator and scanned as soon as possible. After scanning, if it is
determined that the slides have high background or low stringency, rewashing
the slide and re-scanning is recommended.
3) A detection system to quantitate the hybridization signal
The detection system used for data analysis involves image acquisition
and quantification. Image acquisition refers to the scanning of the microarray
while the quantification pertains to the conversion of the image into numerical
data stored on a spreadsheet. The array slide is scanned by a laser; the sites
that are hybridized with the fluorescently labeled DNA will emit light that is
captured and assessed for intensity (Bednar, 2000). Measuring fluorescent light
intensity (emitted photons) can be accomplished with any photosensitive device
such as a photomultiplier tube (PMT) that can be used for low-light intensity.
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This is simply a photoelectric cell with a built-in amplifier. When light of
sufficient energy hits the photocathode in the PMT, electrons are emitted, and
the resulting current is amplified. The strength of the current is proportional to the
intensity of the light detected.
Image acquisition is aided by computer software that can estimate the
background surrounding a spot and subtract that from the fluorescent signal.
There are several potential sources of error here: The array spot has a small
surface area and is therefore representative of a small sample of a background
that could fluctuate. Also, the signal can 'leak' from the spot, i.e., the signal does
not remain within the ring of the spot or fills only part of the area. This is a
frequent cause of expression data seen at low intensity on a scatter plot (Sasik et
a!., 2004). The image is captured as a TIFF file (tagged image file format) that
consists of two-dimensional 16 bit images of the array data.
The general requirements for detecting fluorescent signals in microarray
analysis are:
1) It requires high enough resolution to image a large area (24mm x
60mm) in a short period of time.
2) At least two fluorescent spectra must be distinguished to
accommodate differential gene expression experiments using two
fluorescent dyes.
3) The wide variability of message levels requires an instrument
with a sensitive fluorescent detection threshold to allow detection of rare
messages while also allowing wide linear dynamic range to measure the more
abundant messages.
4) The entire area of the microarray must be scanned uniformly to
ensure reproducibility (The Microarray Handbook, 2004).

To determine the reliability of data obtained from microarrays, both inter
assay and intra-assay variation have been calculated. Standard variation on the
same microarray can exhibit a 5-10% variation in signal intensity (a form of intra

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

43
assay variation). There can be a 10-30% variation evaluating corresponding
components on different microarrays ('inter-assay' variation, Stears et a I., 2003).
2.2.3.4 Normalization
Normalization is the process of applying a correction to data that are
generated from non-biological causes. This typically is used to account for
inherent differences in the intensities of the two different dyes due to their
differences in fluorescent properties. The purpose is to ensure uniformity and
reproducibility of microarray data (Edwards, 2003). Without normalization,
misleading conclusions could be reached. One method of normalization is
known as lowess or loess, which is an abbreviation for linear regression
(Cleveland 1979). Lowess utilizes the best local linear fit of scatter plot data to
detect non-linear points. The application of these methods to oligonucleotide
arrays reduces the relative error between replicates by 5-10% compared with a
standard global normalization method (Workman etal., 2002)
The information workflow
Microarray experiments are divided into several phases. The experimental
design asks the biological question, provides for adequate controls, and
determines the goals and pitfalls of the experiment. The experimental process is
based on the target preparation, printing the arrays, probe preparation and
labeling, hybridization, processing and detection. In order to accomplish these
first two steps, the Internet can serve as a valuable resource for sequence
databases, electronic manuscripts, protocols, etc. Next, the data are extracted,
normalized, quantitated, transformed, then analyzed by scatter plot, expression
maps, cluster analysis, etc.
2.3 Preimplantation Genetic Diagnosis (PGP)
PGD offers an opportunity to increase the odds of having a healthy child for
couples at risk of having offspring with genetic diseases and/or chromosomal
abnormalities. PGD is a combination of two rapidly advancing fields: molecular
biology and assisted reproductive technology. The polymerase chain reaction
made it possible to gather genetic information from small amounts of starting DNA.
Prior to the discovery of PCR, there were no sophisticated methods to be able to
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determine a genetic diagnosis from a single cell within a short turn-around time.
Southern Blotting techniques and DNA sequencing methods that determine DNA
location or sequence were too extensive and not applicable to single cell use due
to limitations in the sensitivity at the single cell level. The Human Genome Project
provided the ability to know the specific genetic sequences for many devastating
heritable conditions. Those scientific advances provided major stepping-stones for
the foundation of diagnosing genetic predispositions in the developing embryo.
The first successful clinical application of PGD was reported by Handyside
et a i, in 1989. The technology was used initially to identify at risk male embryos
from carriers of X-linked diseases; in the reported cases, the women carried either
X-linked ad renoleukodystrophy or X-linked mental retardation. After embryo biopsy
at the 6-8 cell stage, PCR was applied to target a specific repeat region on the Y
chromosome in the removed blastomere; no attempt was made to amplify the X
chromosome since both males and females have the X chromosome. Although
this first report resulted in successful pregnancies in two couples, soon after there
were reports of a pregnancy with a PGD misdiagnosis (Hardy and Handyside,
1992). This was the result of attempting to amplify a segment of the Y
chromosome only. No amplification of the Y-only segment erroneously meant no Y
chromosome; in actuality, the situation was that there was no PCR amplification in
that particular cell that came from an embryo that truly had a Y chromosome as
evidenced by the implantation and gestation of a male fetus. Even though the
controls for that test were normal, the misdiagnosis is indicative of the
experimental nature of the procedure and indicated that further optimization of
techniques was required to determine the cause.
Subsequent methods were developed using primers designed to
simultaneously amplify segments of both the X and Y chromosome to minimize the
possibility of a misdiagnosis (Strom et a i, 1991). The X chromosome serves as an
amplification control in that it should be present in all cells, both male (XY) and
female (XX). In previous methods, the researchers found that the Y-specific
amplification was only 80% reliable; 20% of known male cells did not yield
amplification of the Y chromosome. This prompted the development of a technique
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that simultaneously amplified both X and Y sequences by multiplex PCR to reduce
the possibility of a misdiagnosis due to amplification failure. In multiplex PCR,
more than one set of primers designed to amplify a different gene locus is added to
the same reaction since there is not enough template to conduct a separate
reaction. Trials of 141 single lymphoblasts with known gender showed no errors in
amplification.
Before and after the reported clinical application of PGD, a multitude of
studies were undertaken to determine the efficacy of the procedure. Many of the
initial studies came from work performed at the Jones Institute by my
predecessors. Takeuchi et a i, (1992) demonstrated the efficiency of embryo
biopsy in the mouse and monitored the subsequent development to the blastocyst
stage. More than 80% of biopsied embryos continued development to the
blastocyst stage in culture. At the same time, Morsy et al., (1992) demonstrated
highly accurate and reproducible amplification when analyzing several replicates of
a single lymphoblast for specific gene loci by PCR.
Not only is amplification sensitivity an issue, but accuracy is a concern as
well. Generally, sources of errors can come from two causes, extraneous DNA
contamination and ADO, the amplification of only one of the two alleles present.
2.3.1 Contamination control
The risk of introducing extraneous DNA is a constant presence even
though extraneous DNA contamination has never been a problem in our PGD
laboratory and has only been seen in isolated instances. A PCR technique that is
sensitive to the level of a single cell would only require the smallest amount of
measurable DNA for the original sample to be contaminated. Sources of
extraneous DNA that could affect the PCR reaction include carryover of previous
PCR products, sample cross-contamination, DNA present in the laboratory, and
operator contamination (Kwok and Higuchi, 1989). Several contamination control
measures are undertaken in the laboratory to minimize this risk. These measures
are listed in Appendix B.
Since DNA particles or amplicons can be aerosolized, it is difficult to keep
the laboratory totally DNA-free unless one uses a facility similar to high-level
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containment isolation rooms. For most PGD clinics, those facilities are not
available, may be cost prohibitive, and are somewhat extreme. One of the
strongest allies in controlling surface contamination in the laboratory is the use of
UV light. In a little as five minutes, exposed surfaces can be decontaminated (Ou
et a/., 1991). In our studies, a significant difference was seen in as little as ten
minutes although it required 20-30 minutes for complete inhibition of PCR
amplification (Gitlin and Gibbons, 1995).
UV rays have shorter wavelengths (10-400nm) than visible light (400700nm). Exposure to UV irradiation less than 300nm affects the DNA by
changing the structure of the template; specifically germicidal lamps emit 254
nm. (Sarkar and Sommer, 1990). The pyrimidine bases (thymine - T and
cytosine - C) are particularly sensitive to UV exposure. UV light causes the
formation of dimers -stable bonds between identical molecules or units of
molecules; in this case, T-T or C-C. Polypyrimidine dimers, T-C, can form as
well. The formation of these dimers interferes with the subsequent DNA
replication since the pyrimidine dimer cannot fit into the double helix (Stryer,
1988). The structure of the initial DNA template has now been altered and
subsequent replication would be blocked as well since the DNA polymerase
could not bind.
Successful contamination control using UV light is a function of time and
distance of the UV light source to the exposed surface (Sarkar and Sommer,
1993). In order to determine the risk in our laboratory, a study was designed to
place DNA-containing PCR reaction tubes in strategic and functional settings in
the laboratory, then expose the tubes to ultraviolet light at timed intervals. These
assessments allowed us to determine the limits of potential contamination control
measures. UV irradiation was shown to be ineffective for products as small as
380 base pairs (Belak and Ballagi-Pordany, 1993) although there are little
concurring data available.
UV irradiation is used to minimize the occurrence of contamination. Most
reagents used in the PGD laboratory are aliquoted for individual use. After
preparation and dispensing in microcentrifuge tubes, those aliquots are exposed
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to UV light in the event that inadvertent DNA contamination occurred. The
exception to UV exposure is the Taq polymerase, the oligonucleotide primers,
and the dNTP's. Frothingham et a i (1992) studied the effect of UV light to
decontaminate the components of the PCR master mix. Their study
demonstrated that a longer UV exposure was required when the dNTPs were in
the mixture versus when the dNTPs were absent (64 minutes versus 4 minutes,
respectively). The researchers concluded that the dNTPs had a higher
absorbance of the UV light that effectively decreased the overall efficiency of the
PCR decontamination. Another arm of the study determined the sensitivity of the
polymerase and the primers to the UV light exposure. Mixtures containing the
primers and polymerase ± the dNTPs were exposed to UV light. DNA sample
was then added to the UV-exposed tubes and the samples were subjected to
PCR. Those tubes containing the dNTPS amplified while those tubes without the
irradiated dNTPS did not amplify. This again reflects a protective mechanism of
the dNTPs that have absorbed the UV radiation and demonstrates the sensitivity
of the polymerase and primers to UV light exposure (Frothingham et a i, 1992).
Similar findings were reported that a mixture of dNTPS and primers was not
decontaminated after UV irradiation even though a stock of the primers in
solution by themselves was successfully decontaminated (Ou et a i, 1991)
Additionally, the mineral oil used to overlay the PCR reaction was exposed
to UV light in our laboratory. Caution is exercised when performing the mineral oil
irradiation based on a study performed by Dohner et a i, (1995). Those
researchers determined that an inhibitory effect on PCR amplification could be
achieved in as little time as 30 minutes with a direct exposure of mineral oil in an
open container. However, that effect was diminished when the oil was exposed
through the PCR tubes since the plastic will absorb much of the radiation. The
reason for this was not ascertained; the authors discussed the possibility of either
inhibition being due to oxidation of some component in the mineral oil or perhaps
due to ozone formation as a result of the UV irradiation of oxygen in the air.
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2.3.2 Allele dropout
Of great concern is the occurrence of ADO, defined as the amplification of
only one of the two alleles present in the PCR reaction (Findlay et a i, 1995; Ray
and Handyside, 1996; Rechitsky et a i, 1998). In the heterozygous condition, both
the normal and the abnormal allele are present. If only one of those alleles
amplifies, a misdiagnosis for that cell (and thus subsequent embryo) can occur.
Since the homozygous normal and homozygous affected conditions have the two
copies of the same allele, dropping-out of one of the alleles would not be detected
by conventional PCR.
The allele drop-out rate was determined when analyzing polar bodies in a
study of over 1000 oocytes by Rechitsky et a i, (2001). The ADO was 7.8%. ADO
is one of the greatest concerns for a misdiagnosis in PGD, occurring in the
heterozygous condition when only one of the two alleles present amplifies. One
disadvantage of PB testing is crossing over or genetic recombination. Analyzing
both PBI and PBII in a maternal carrier is a means to avoid undetected ADO.
Rechitsky et a i, (1998, 2001) documented the possible outcomes when
performing PGD on polar bodies. The researchers ascertained that the most
accurate information occurred when PBI was determined to be a heterozygote,
indicating that crossing-over was detected. Results indicating a heterozygous PBI
and a normal wild-type PBII infer that the oocyte is carrying the mutant allele; the
heterozygous PBI has both alleles, and thus the remaining strands in the oocyte
would too. Therefore, upon strand separation, the chromatid in PBII has the
opposite result of the chromatid remaining in the oocyte. Conversely, a
heterozygous PBI and a mutant PBII infers that the oocyte is normal.
Further examination of ADO is in the discussion section for Specific Aim #
2, which studies the effect on amplification specificity when using different DNA
lysis techniques.
2.3.3 Aneuploidv Screening - Assessing chromosome number
From 1923 until 1956, the prevailing opinion was that human cells
contained 48 chromosomes, based on studies by the geneticist Thomas Painter
(Painter, 1923). The fundamental discovery that normal human somatic cells
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contained 46 chromosomes arranged in pairs was made in 1956 (Tjio and Levan,
1956; Ford and Hamerton, 1956). However, those researchers also discovered
that cells and even entire individuals could have a deviation in chromosome
number from the normal 46. Soon after, the field of cytogenetics began. The
oldest technique for enumerating chromosomes (ploidy) and analyzing structural
defects (aberrations) is karyotyping, developed in the late 1950's. As time and
technology progressed, the resolution and sensitivity of cytogenetic analysis
have improved more than 10,000-fold with techniques such as chromosome
banding, fluorescent in situ hybridization (FISH), comparative genomic
hybridization (CGH), multifluor FISH (mFISH), spectral karyotype analysis (SKY),
and array CGH as discussed below.
Ten years after the first use of karyotyping, chromosomal banding
techniques were applied to detect structural abnormalities; metaphase
chromosomes were stained with quinacrine mustard to produce patterns of light
and dark bands (Q-bands) along the chromosome (Caspersson etal,, 1968).
Similarly, the technique of Giemsa staining was used (G-banding); the dark
regions tend to be heterochromatic, late-replicating and A-T rich while the bright
regions tend to be euchromatic, early-replicating and G-C rich (Bosman and
Schaberg, 1973; Comings etal., 1973).
There are two major limitations of karyotyping: the need for cells to be in
metaphase and the need for higher resolution to detect smaller aberrations in the
chromosome structure. This prompted the development of cytogenetic
techniques such as FISH that did not require metaphase chromosomes, (van
Prooijen-Knegt etal., 1982). In FISH, fluorescent-labeled probes are designed
complementary to specific regions along the length of the studied chromosome.
After probe/sample hybridization, the fluorescent signal can easily be detected by
microscopy. The technique is limited in that it requires prior knowledge of the
location of the aberration. Also, FISH is used for only a limited number of
chromosomes due to the ability to detect only a handful of signals. Initially, only
three fluorochromes were commercially available to label chromosomes
(fluoroscein isothiocyanate - FITC, tetramethylrhodamine isothiocyanate - TRITC,
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aminomethylcoumarin - AMCA, respectively emitting in green, red, and blue,
Nederlof et a i, 1990; Dauwerse et at., 1992). To overcome this limitation,
combinations of these dyes in distinct ratios allowed for their use in labeling more
than three chromosomes. Currently, there are two additional fluorochromes
(totaling five) that can be used for labeling. Cells are initially analyzed with one
set of five fluorochromes, then can be re-analyzed with a different set of labeled
probes (Benadiva etal., 1996; Martini etal., 1997; Bahge etal., 2000). The utility
of FISH in PGD has long been debated. Initial reports had determined that there
was no difference in the pregnancy or implantation rate, but newer data suggest
that there is an increase in pregnancy (Werlin et a!., 2003) and implantation rates
(Munne et al., 2002), especially in patients with more than eight pronuclear
embryos, and in those with less than 2 failed IVF cycles (Munne et al., 2003)
Conventional CGH can detect and map changes in DNA copy number
(Kallioniemi etal., 1992; Thompson and Gray, 1993). Sample DNA and normal
reference DNA are labeled with two different fluorochromes. The sample and
reference DNA are then hybridized simultaneously to a slide containing normal
metaphase chromosome spreads. Images of both fluorescent signals are
captured and a ratio of intensities of the two fluorochromes is measured; regions
of DNA sequence loss or gain (such as deletions, duplications, or amplifications)
are detected by the ratios. CGH is limited in that it cannot detect mosaicism,
balanced chromosomal translocations, inversions or whole genome ploidy
changes (Kallioniemi et al., 1994). Additionally, CGH applications with limited
template DNA such as single cell analysis would require a WGA technique as
previously described since most CGH protocols require at least 200ng of DNA
(Wells, 2004).
Other techniques such as SKY (McNeil and Ried, 2000) and mFISH have
overcome these limitations by allowing visualization of the entire chromosome
(as opposed to regions of the chromosome seen in FISH or changes in copy
number as seen by CGH). SKY involves the simultaneous hybridization of 24
differently labeled chromosome-painting probes. After a one to three day
hybridization, images are visualized under fluorescent microscopy and acquired
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via a CCD camera linked to an imaging system. A single image is used to
analyze fluorescently labeled chromosomes to produce a full karyotype. M-FISH
is a technique to label every chromosome, generating a 24-color composite
image (as opposed to the single image in SKY) that can be computer analyzed
by the appropriate software to produce a karyotype.
Array CGH uses a combination of comparative genomic hybridization and
microarray technology to determine variation in DNA copy number or to
determine chromosome aneuploidy (change in chromosome number). The
method has the sensitivity to detect single copy changes, deletions and
duplications in the genome with high precision/resolution (Pinkel etal., 1998,
Pollack et al., 1999; Yu et al., 2003). This technology has been applied to
successfully detect aneuploidies in tumor cells (Gray and Collins, 2000; Phillips
et al., 2001; Wilhelm et al., 2002; Linn et al., 2003). Array CGH was compared
with FISH in 12 patients with known chromosome deletions. One additional
deletion was detected by array CGH that had not been detected by FISH,
demonstrating the higher sensitivity of the array CGH (Daigo et al., 2001).
Array CGH can overcome one of the major limitations of CGH; CGH
requires metaphase chromosomes for hybridization while array CGH utilizes
cloned DNA fragments that will allow aberrations to be determined in greater
detail (Oostlander et al., 2004). As in conventional CGH, the sample and the
normal reference DNA are labeled with two different fluorochromes. The two are
then simultaneously hybridized to a glass slide array containing genomic or
cDNA. As in conventional microarray analysis previously explained, the ratio of
the dye intensities is compared to determine the DNA copy level. One major
limitation with array CGH, as in conventional CGH, is its inability to detect
balanced chromosome translocations since the number of chromosomes is the
same in the balanced state (Daigo et al., 2001)
2.3.3.1 Cytogenetic techniques applied to human oocytes and blastomeres
Advances in cytogenetic techniques have made their use possible in PGD.
Less than half of naturally conceived pregnancies reach full-term, with the
majority of pregnancy losses occurring at the early embryo or shortly after
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implantation stages (Shepard and Fantel, 1979; Byrne et al., 1985). Multiple
factors may be involved in these losses although chromosomal error is
considered to be one of the most significant factors. These errors could result in
altering the regulation of gene expression during the complex process of early
embryo development and implantation. Determining the chromosomal status of
oocytes and/or embryos during an IVF cycle may be beneficial for several types
of patients that are at greater risk for chromosomal abnormalities, including those
over the age of 35 (Hassold et al., 1980; Warburton, 1980; Munne et al., 1995;
Dailey et a I., 1996), women with a history of recurrent miscarriages (Pellicer et
al., 1999), women with a history of repeated IVF failure (Gianaroli et al., 1999),
and/or couples carrying a known chromosomal structural abnormality (Munne et
al., 1998a). In addition, detecting chromosome errors may provide insight into the
frequency of abnormalities during gametogenesis, embryonic development, and
pregnancy (Wells and Levy, 2003).
FISH is the most common technique utilized for detecting an extra or
missing copy of select chromosomes in oocytes and embryos (aneuploidy).
Currently, the standard for chromosome analysis in embryos is to analyze a
single blastomere for nine chromosomes by FISH using two sets of labeled
probes (Munne et al., 1998b). These researchers tested for chromosomes 13,15,
16,17 ,18 , 21, 22, X, and Y which encompass the majority of chromosomal
errors seen in miscarried tissue or in live born. Approximately 85% of the
chromosomal abnormalities seen in embryos are detected by 9-color FISH
(Voullaire et al., 2002). Abdelhadi et al. (2003) performed FISH using probes for
13 chromosomes using three sets of labeled probes with the aforementioned
chromosomes as well as a third probe set with chromosomes 2,3,4, and 11. In a
comparison study of 426 embryos, 181 (42%) were aneuploid for one or more
chromosomes. These researchers detected 97% of the total chromosomal errors
utilizing the first two probe sets while only an additional 3% of aneuploidy was
detected with the third set. From these studies, the researchers concluded that it
may be more efficient to continue with only the first two probe sets and that the
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additional 3% aneuploidy detection may not be time efficient or cost effective for
the benefit received.
Other cytogenetics techniques have been applied to oocytes/embryos as
well. Normally, it is difficult to karyotype the oocyte/embryos since the cell
number is limited and the cell must be in metaphase. In an attempt to karyotype
the PBII, Vertinsky and Evsikov (1999) removed 38 PBII from normally fertilized
zygotes and injected them into individual enucleated oocyte cytoplasm. After
forming a haploid pronucleus, 25 metaphase spreads (66%) could then be
karyotyped by whole chromosome painting. Although the researchers concluded
that this method provided a suitable timetable for chromosome analysis and
utilized extra embryonic material (PBII), the method has not been widely used.
This is presumed to be due to the labor and time intensity for a method that
requires further optimization to achieve greater than 66% success.
Clyde et al. (2001) demonstrated the use of mFISH in the oocyte and PBI.
Marquez et al. (1998) and Sandalinas et al. (2002) applied SKY to analyze the
chromosomes from polar bodies. That study analyzed 131 fresh oocytes from
donors. Of those, only 47 could be used for SKY: of the remaining 84, five were
not metaphase, 11 had incomplete metaphase, and 68 had overlapping
chromosomes. Twenty-four of the 47 oocytes used were normal or haploid
(51.1%), broken down into 64% normal for women under 34 and only 25%
normal in women over 35 years. These studies demonstrated the use of the
technologies on human oocytes (polar bodies), however further optimization
appears to be needed before their practical clinical use.
CGH has been applied to clinical PGD cycles (Voullaire et al., 2002;
Wilton et al., 2003). In the former study, 141 embryos were biopsied and
analyzed by CGH; 126 (89.3%) had analyzable signals. Seventy-six of 126
(60%) of the single biopsied blastomeres from 20 women with repeated IVF
failure were diagnosed as abnormal by CGH. Had those cells been analyzed by
standard 9-chromosome FISH instead, at least 18 of those 76 abnormal embryos
(23.7%) would have been diagnosed as normal since the aneuploidy detected by
CGH was found in a chromosome outside of the standard nine. The researchers
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concluded that by using CGH, additional chromosomal abnormalities were
diagnosed in this patient population that would not have previously been
detected by FISH and may thus help explain their repeated IVF failure.
The use of CGH to analyze a single cell is limited since the technique
generally takes over 72 hours to perform; embryos biopsied on day 3 would need
to be cryopreserved for transfer in a later cycle since results would not be
available during the normal implantation window of 5-6 days after egg retrieval.
In a promising study, Wells et al. (2002) demonstrated that full chromosome
complement information from the PBI could be obtained by CGH. Using an
accelerated CGH protocol, the time was reduced in half from 60 hours to 30
hours, enabling embryo transfer on day 4. In that study, 12 oocytes were
subjected to PBI biopsy. Of the 11 available for analysis, 10 demonstrated CGH
results, yielding only one normal embryo available for transfer. Where possible,
results were confirmed by FISH after subsequent single cell embryo biopsy.
Interestingly, four of the 9 abnormal embryos demonstrated aneuploidy for
chromosomes 2, 5,14, and 20; these chromosomes are not routinely used in
FISH analysis. Had only FISH been used for the aneuploidy screen, those
embryos would have been eligible for transfer. This demonstrated the utility of
the CGH technique in being able to screen for all chromosomes and detect errors
that would have otherwise been undiagnosable with the standard technique.
Array CGH to enumerate chromosomes in human single cells has had
limited use thus far. The first published study obtained single lymphoblast cells
from normal and trisomic cell lines, then subjected individuals cells to array CGH
using DOP as the WGA technique (Hu et al., 2004). Fourteen normal male or
female cells were analyzed with the correct ratio 97% (300/308) of the time for the
22 autosomes. While 93% (13/14) of the X chromosomes were detected, only
29% (4/14) of the Y chromosomes were detected. The trisomic cell lines were all
diagnosed correctly as falling in the correct ratio range of 0.75-1.25 (as previously
discussed, the ratio of dyes should be 1:1. Here the limits of the ratio were 1.0
±0.25). The overall time for the entire procedure was 30 hours. In a separate
study, MDA was used as the WGA prior to array CGH of trisomy 21 single
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lymphocytes (n = 3, Hellani et al., 2004). All three samples demonstrated the
ability to detect trisomy 21. From these studies, the researchers concluded that
array CGH could become a feasible option for aneuploidy studies in human
oocytes/embryos although further optimization is required, especially in the ability
to detect the Y chromosome.
The studies of this dissertation
The largest collection of PGD data to date is from the ESHRE (European
Society for Human Reproduction and Embryology) PGD consortium, collating data
from 25 PGD centers worldwide including our institution (ESHRE PGD consortium
steering committee, 2002). Even though those data support the usefulness of the
technology, a few key points need to be discussed. The overall amplification
efficiency in that report was only 83% for all embryos biopsied (n=14,040). This
suggests there is much room for improvement of amplification efficiencies. Even
more compelling is the misdiagnosis rate for PGD cases utilizing the polymerase
chain reaction as the diagnostic tool. Overall, the misdiagnosis rate was 3.4% for
the 145 cases reported.
Lewis etal., (2001) reported on a mathematical model designed to aid in
determining the accuracy of PGD using single cells. It determines that in any
biological system, variability can occur that can affect clinical decisions. The model
examines values for the probabilities of amplification occurring, the cell's
chromosome content, and the probability for contamination occurring. The authors
state that the major sources of error leading to a misdiagnosis are identifiable.
This dissertation addresses the three main sources of error that Lewis et al. (2001)
and Navidi and Arnheim (1991) list:
1) analyzing the anucleate cell
2) contamination
3) non-amplification of alleles
Further, the authors suggest that acceptable levels of accuracy and
contamination be established. They established a decision-making model as part
of the process to determine which embryos can be transferred and which can be
discarded, knowing that the assessed genotype has a high probability of stemming
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from an affected embryo. The importance of being able to optimize the conditions
for genetic analysis while avoiding the sources of error may translate into the
ability to have more embryos available for transfer. The number of embryos is
positively correlated with the chance of establishing a successful pregnancy
(Vandervost et a/.,1998).
This dissertation presents studies that were conducted to optimize the
conditions involved in the current diagnostic procedure of PGD in addition to
developing new technologies. These efforts to maximize the amplification
efficiency while minimizing the events that could lead to a misdiagnosis are part
of the critical basic science background that lead to the clinical fruition of this
technology. This continues as part of an ongoing effort to offer other single cell
diagnostic procedures for clinical application. To that effect, the specific aims of
these studies are as follows:
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SECTION 3
SPECIFIC AIMS
Specific Aim # 1
Inadequate sensitivity of the PCR reaction may result in amplification failure
when starting from a one or two copy DNA template. If DNA is truly present
in the initial PCR reaction tube yet does not amplify, modification of reaction
conditions or techniques might subsequently produce sufficient quantities
of DNA to demonstrate PCR amplification after gel electrophoresis.
Aim: To increase amplification efficiency to ‘rescue’ those cells fail initial PCR
amplification.
Hypothesis: Whole genome amplification methods (WGA) can be used to
increase the number of target sites of the initial starting template in attempts to
increase amplification results.
Experiments: Experiment # 1 will to use a WGA technique consisting of a mixture
of random primers sequences (in this case, random 15-mers) in PCR cycling
conditions with dNTPS and Taq polymerase, producing multiple copies of DNA
sequences in the genome. It is estimated that 78% of the genome is copied at
least 30 times with the WGA technique, even from a single cell (Zhang et al.,
1992). Having multiple copies of initial starting template can aid in the elimination
of the variable amplification efficiencies seen when starting with a template from
one cell.
Experiment #2 will attempt to provide additional genetic information from
previously PCR-processed DNA by amplification of a different gene in that
reaction. For example, PGD samples that were previously diagnosed for gender
determination will be tested for the specific X-linked mutation that is now known.
The initial starting template is still present in the reaction tube although the
reaction also contains amplified product, dNTPs, primers, etc. Rather than
subjecting embryos to another biopsy procedure, this experiment proposes to
recover the previously PCR'ed reaction tubes, add additional specific primers and
PCR master mix in an attempt to obtain further genetic information from the
initially biopsied cell. Outcomes will be measured by successful PCR
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amplification while negative controls will also be tested to ensure that
contamination has not occurred.

Specific Aim # 2
Allele drop-out (ADO) has been identified as a cause for misdiagnoses in
PGD cycles (Grifo etal., 1998; ESHRE PGD consortium steering committee,
2002). ADO is defined as the amplification of only one of the two alleles
present in a cell.
Aim: To increase the amplification efficiency through optimization of DNA lysis
conditions and to decrease the incidence of ADO .
Hypothesis: DNA contained in the cell may not be fully accessible by the presently
used DNA lysis conditions; alternatively, the template may not be fully denatured.
Consequently, the PCR primers and subsequent polymerase cannot attach to
amplify that segment of the DNA.
Experiments: In these experiments, individual lymphoblast cells known to be
heterozygous at specific DNA loci will be used to compare different methods of
DNA lysis with amplification results, analyzing not only the efficiency of
amplification (as a percentage), but also the accuracy as determined by the
presence of both alleles in these known heterozygous cells. Both heterozygote and
compound heterozygote cells will be used to compare the rates of amplification
efficiency and ADO. The lysis techniques selected were the most commonly used
techniques for DNA lysis in single cell analysis (Handyside etal., 1990; Zhang et
al., 1992; Verlinsky and Kuliev, 1992; Gibbons et al., 1995a; Grifo et al., 1998).

Specific Aim # 3
After the above Specific Aims are addressed, there remain instances when
PCR amplification may be limited when using a single blastomere from the
embryo.
Aim: To identify characteristics of the blastomeres from an embryo before and
after embryo biopsy that can aid in determining the success of obtaining PCR
amplification.
Hypothesis: Defining optimal characteristics of the blastomere in an embryo
before and after biopsy would allow better predictions and determinations of
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obtaining successful amplification results. It is important to be able to choose a
blastomere to biopsy that has a greater chance of providing a genetic result.
Experiments: These experiments will identify conditions relating to morphology of
the removed blastomere and correlate those with amplification efficiencies. The
following morphological criteria will be assessed by microscopy: the presence or
absence of the blastomere nucleus (which may relate to the state of the DNA),
the presence of the cell membrane, the encroachment of the cytoplasm (intact or
not). These assessments will be compared with PCR amplification results.

Specific aim # 4
The diagnosis of having missing or extra chromosomes is known as
aneuploidy. Aneuploidy is common in human embryos studied after in vitro
fertilization (Munne et al., 1998b). Currently, the state of the art to identify
chromosomal information in a single cell is limited to primarily using ninecolor fluorescent in situ hybridization (FISH) for the most common
chromosome abnormalities in either liveborn or miscarried tissues
(chromosomes X,Y, 13,15,16,17 18,21, and 22.)
Aim: To identify the chromosomal complement in a single cell.
Hypothesis: Array CGH can be used to study aneuploidy in single cells including
blastomeres biopsied from human embryos.
Rationale: Array CGH combines the principles of CGH (comparing a normal
control with the unknown sample labeled in a different color fluorochrome), then
hybridizing those samples to a microarray. Array CGH has been proposed in the
field of tumor biology as a reliable method for assessing chromosome number
(Pollack et at., 2002).
Experiment #1: Initial experiments will address the issue of the limited amount of
template DNA in a single cell. Generally 5-1 Opg of DNA is needed for adequate
hybridization of a microarray. To increase the amount of DNA available in a single
cell, WGA technique known as Multiple Displacement Amplification (MDA) will be
used (Lage et at., 2003). In an overnight MDA reaction, over 35pg of DNA can be
produced from the initial starting quantity of 10pg in a single cell to achieve
quantities adequate for microarray analysis.
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Experiment #2: Once the MDA technique is specific and sensitive for use in a
single cell, the DNA will be fluorescently labeled and prepared for microarray
analysis. The experiments proposed here will determine a labeling technique that
is optimal for microarray analysis.
Experiment #3: Third, the labeled DNA will be hybridized to a cDNA microarray
and analyzed to determine the chromosome complement. Initially, normal euploid
cells will be used a controls until proof of concept is established. Once answered,
the feasibility of the use of array CGH for study of aneuploidy in humans will be
addressed, an IRB proposal submitted, and the final aspects of the study with
regards to sensitivity and specificity of the technique will be determined. This will
be accomplished initially by using single cells with known chromosomal
abnormalities (e.g. amniocytes, and/or cancer cell lines obtained from the
cytogenetics laboratory) prior to assessing aneuploidy rates in human
supernumerary embryos donated for research.
3.1 Study models
Three types of cells were used in these experiments as described in the
Material and Methods sections of each Specific Aim. Human cells were used
exclusively since the ultimate object of these studies was to diagnose human
disease. The limited availability of human embryos/blastomeres with the studied
disease necessitated another cell type for study. Human lymphoblast cells
served as an excellent source for optimization studies in Specific Aims # 1 , 2 ,
and 4 since cell lines with and without specific disease mutations were easily
obtained. However, different cell types such as lymphoblasts may behave
differently due to the chromatin arrangement for the particular cell, therefore
supernumerary human embryos that were donated for research were used for
final optimization of studies to control for those differences. Finally, blastomeres
from actual IVF/PGD patients were obtained and studied for Specific Aims # 1
and 3. All procedures were performed under protocols approved by the
Institutional Review Board of Eastern Virginia Medical School as deemed
necessary.
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SECTION 4
STUDIES FOR SPECIFIC AIM # 1
Specific Aim # 1: To increase amplification efficiency by attempting to
‘rescue’ those ceils that show no initial PCR amplification.
4.1 Material and Methods for Specific Aim # 1
Sources of DNA
DNA was obtained from three sources:
1) Single cells were collected using lymphoblast cultures of known DNA
mutations (Coriell Institute, Camden, NJ). Cells were cultured in RPMI-1640
media supplemented with 15% Fetal Bovine Serum (Invitrogen, Carlsbad, CA) in
a 37°C incubator with 5% CO2 and air. Single cells were isolated under a
dissecting microscope and serially rinsed through three microdrops of PCR buffer
to remove any extraneous cells. The individual cell was then visualized under the
dissecting microscope as it was placed in a PCR reaction tube (Gene-Amp,
Perkin-Elmer, Norwalk, CT) containing 60 pi sterile DNAse-free water overlaid
with sterile mineral oil. Similarly, cells from these cultures were pooled to obtain
genomic DNA controls.
2) Individual blastomeres were obtained from growth-arrested abnormally
fertilized human embryos. Embryos were placed in an acidified Tyrode’s medium
to remove the zona pellucida, and then rinsed in culture media. The zona-free
embryo was subsequently placed in a calcium-free/magnesium free phosphate
buffered saline supplemented with 1% Bovine Serum albumin (Sigma, St. Louis,
MO) to dissociate the cells. Individual cells were then collected as described
above for the lymphoblasts.
3) Individual blastomeres were obtained from couples undergoing a PGD
procedure. Individual cells were removed from the embryo by micromanipulation
(embryo biopsy) as described below.
Embryo Biopsy
Embryo biopsy was performed using a Nikon Diaphot Microscope (Nikon,
Melville, NY) with Hoffman optics (Modulation Optics, Greenvale, NY). Three sets
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of Narishige micromanipulators MN-2 (Narishige USA, Greenvale, NY) were
used for the holding pipette, acidified media, and the biopsy pipette.
Micropipettes were prepared with a Sutter P-87 pipette puller that initially pulled
borosilicate capillary tubes. A Nikon MF-9 microforge was then used to fire-polish
the pipettes to their respective diameters listed below.
The embryo was held in place with a 35 micron holding pipette connected
to a Narishige IM-6 microinjector. Acidified Tyrode’s medium was delivered
through a 10 micron I.D. micropipette attached to a similar microinjector. Biopsy
was accomplished through a 35-50 micron micropipette attached to a
picoinjector.
A dish containing acidified Tyrode’s was placed on the microscope stage.
The respective pipette was lowered into the acidified media and filled. That dish
was then replaced on the stage by a square culture dish containing a droplet of
Hepes-buffered Earle’s media supplemented with 7.5 % synthetic serum
substitute (Irvine Scientific, Santa Ana, CA) layered with washed and equilibrated
mineral oil.
Embryos for biopsy were individually removed from their culture dish and
placed into the droplet. The embryo was immobilized by suction applied to the
aforementioned holding pipette. Care was taken to situate the embryo so that a
blastomere would easily be accessible. The acid pipette was then placed next to
the zona pellicuda, and acidified Tyrode’s was slowly released while the pipette
was moved against the zona in an up and down motion. After several seconds,
an opening broke through the zona and the acid flow was stopped. The acid
pipette was moved away from the embryo, and the biopsy pipette was placed
into the field. Embryo biopsy was performed by inserting the biopsy pipette in
through the newly-created opening in the zona and placing the mouth of the
pipette next to the arc of the desired blastomere. Suction was slowly applied so
that the cell could be drawn into the pipette. The pipette was then removed from
the embryo, and the aspirated cell was released into the media. The cell was
then aspirated into a drawn-out Pasteur pipette and rinsed through a series of
three droplets of PCR buffer to remove any potential contaminating extraneous
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cells (from sperm or corona cells). The aspirated blastomere was then placed
into a 0.5|il GeneAmp PCR reaction tube (Perkin Elmer, Norwalk, CT) containing
60pl sterile DNAse free water and layered with sterile mineral oil. A stereo
microscope was used to visualize that the cell was successfully transferred to the
PCR tube. The tube was then frozen/thawed twice in liquid nitrogen and heated
to 100°C for 10 minutes to lyse the cell. All samples that were not analyzed
immediately were stored at -20°C until use.
Initial Polymerase Chain Reaction
For these experiments, the PCR region to be amplified encompassed the
4 base pair (bp) insertion (1278+TATC) of the p-hexosaminidase A gene, the
most common mutation causing Tay-Sachs disease. Outer and nested primer
sequences are listed in Table II.
Reagents
A standard PCR master mix consisted of a 10X reaction buffer (1.5 mM
MgCb, 10 mM Tris-hydrochloric acid, pH 8.3, 50 mM potassium chloride, and
0.01% [wt/vol] gelatin), 200 pM dNTPs (USB, Cleveland, OH), 0.2 pM primers
(Genosys, The Woodlands, Tex.), and 0.5 unit of Tag polymerase (PerkinElmer). The remainder of the 100pl volume consisted of 2pl sample and 60pl of
sterile water overlaid with 60pl oil.
Nested reaction:
A 2 pi aliquot of the initially amplified product was removed and added to a
new PCR reaction tube containing 60pl of sterile water overlaid with 60pl oil,
along with fresh master mix containing the new primer set in addition to the other
master mix components (buffer, dNTPs, Tag polymerase).
Thermocycling conditions continued as described in Table III.
Heteroduplex Formation
A four base pair difference in the PCR product is difficult to distinguish
between the normal and abnormal condition when applied to a fast-running
polyacrylamide gel. Therefore, an artifact known as heteroduplex formation is
used to distinguish between small base pair insertions and deletions (Nagamine
et al., 1989; Triggs-Raine and Gravel, 1990). The rationale for this comes from
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Table II. Oligonucleotide primer sequences

Gene Loci

Outer primers 5’ to 3’

exon 11, 4 bp insertion
p-Hexosaminidase A.
(Tay-Sachs disease)

F - CAACAACAGT CT GGT GAT GG
R - GCCAGACACAATCATACAGG

F- AAGGAGCT GGAACT GGT CAC
R - CTCTCAACCACCTTCCCAAT

A F508 mutation of
cystic fibrosis
transmembrane
regulator gene.

F - GACTTCACTTCTAATGATGAT
R- CT CTT CT AGTT GGCATGC

F- TGGGAGAACTGGAGCCTT
R -GCTTT GAT GACGCTT CT GT AT

Nested primers 5’ to 3’

F= forward primer, R = reverse primer.
Outer primers used for first 20 cycles of PCR at specified annealing temperatures, Nested primers used for remaining 30
cycles of nested PCR. PCR conditions described in Table III.

2

Table III. Thermocycling conditions

Initial reaction

Nested

For the 4bp insertion of the (3-hexosaminidase A gene:
94°C Initial denaturation 3 minutes
20 cycles of:
Denatu ration at 94°C for 1 minute
Annealing at 61 °C for 1 minute
Extension at 72°C for 1 minute
+2 second increase after each cycle

94°C Initial denaturation 3 minutes
30 cycles of:
Denaturation at 94°C for 1 minute
Annealing at 54°C for 1 minute
Extension at 72°C for 1 minute
+2 second increase after each cycle

For the AF508 mutation of cystic fibrosis:
Initial reaction

INested

94°C Initial denaturation 3 minutes
20 cycles of:
Denaturation at 94°C for 1 minute
Annealing at 40°C for 1 minute
Extension at 72°C for 1 minute
+2 second increase after each cycle

94°C Initial denaturation 3 minutes
30 cycles of:
Denaturation at 94°C for 1 minute
Annealing at 50°C for 1 minute
Extension at 72°C for 1 minute
+2 second increase after each cycle
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Figure 8. Gel migration for small insertion or deletion. Polyacrylamide gel (7%)
photo representing the gel migration pattern for the 4 bp insertion in exon 11 of
the p-hexosaminidase A gene (Tay-Sachs, TSD-11).
Lane 1 - negative (no DNA control)
Lane 2 -normal, wild-type
Lane 3 - heterozygous carrier for TSD-11
Lane 4 - affected TSD-11 with the 4 base pair insertion
Lane 5 - negative
Lane 6 - pGEM DNA marker
This gel illustrates the need for further information when attempting to discern the
difference in the four base pair insertion. Although the normal (and thus smaller)
DNA fragment ran slightly faster on the gel, the information is insufficient to make
the critical diagnosis between normal and affected.
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the heterozygous condition that has one normal allele and one abnormal allele
with the extra four base pairs in this particular case. Those alleles do not exactly
match up at the insertion, therefore, an unmatched loop of 4 base pairs is
created. That loop causes a resistance in the migration pattern of the DNA when
applied to a polyacrylamide gel, resulting in the characteristic heteroduplex or
double band formation seen on the gel (Figure 8).
The above example is for the known heterozygous condition. To
distinguish the 4-base pair difference between the normal and abnormal alleles in
an unknown sample, a mixing experiment is performed. Previously amplified
known normal and known abnormal DNA samples is added or mixed with the
unknown sample into separate PCR reaction tubes. This is accomplished by
adding an equal volume of the known amplified product to the unknown PCR
sample in separate aliquots. The mixture is heated to 95°C for 5 minutes to
denature the strands, cooled to 65°C for 5 minutes to allow the new mixed
strands to anneal, and then cooled to 4°C to stop the reaction. Thus each
unknown has 3 lanes on the polyacrylamide gel: the unknown by itself, the
unknown plus known amplified normal PCR product, the unknown plus known
amplified abnormal PCR product. The pattern of the gel migration and
heteroduplex formation will determine the diagnosis (Figure 9).
Post PCR Gel Electrophoresis
Five microliters of a bromophenol blue loading buffer was added to 20pl of
PCR amplified or mixed product and applied to a 7% polyacrylamide gel (29:1
acrylamide:bis), run at 175 V using a Fisher Biotech power supply for 90 minutes.
The gel was dismantled and stained for 15 minutes in 0.5mg/ml ethidium bromide
(Sigma, St. Louis, MO), de-stained with ultrapure water, and photographed under
ultraviolet light trans-illumination.
Reamplification Experiments
PEP was used as the WGA method to ascertain if the amplification failure
was due to lack of sensitivity. Samples that had previously been subjected to
PCR were stored frozen at -2 0°C in the original PCR tubes containing the cell
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1

1

Figure 9. Heteroduplex formation. Polyacrylamide gel (7%) photo representing
heteroduplex formation used for diagnosis of TSD-11 (and other
deletions/insertions). The artifact known as the heteroduplex is present only
when the normal allele and the affected (4bp inserted) allele are in the sample
together and do not match up, causing a slower migration pattern on the gel. The
diagnosis is made by evaluating the migration pattern of three lanes, knowing
that only the normal and affected together will produce the heteroduplex.
Lane 1 - Normal (wild-type) sample
Lane 2 - Normal sample mixed with known normal DNA (+N)
Lane 3 - Normal sample mixed with known affected DNA (+U)
Lane 4 - Negative control
Lane 5 - Heterozygous sample
Lane 6 - Heterozygous sample mixed with known normal DNA (+N)
Lane 7 - Heterozygous sample mixed with known affected DNA (+U)
Lane 8 - Negative control
Lane 9 - Affected sample
Lane 10 - Affected sample mixed with known normal DNA (+N)
Lane 11 - Affected sample mixed with known affected DNA (+U)
Lane 12 - Negative control
Lane 13 - pGEM DNA marker
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until further use. The initial PCR reaction volume was 100 pi and the PEP
reagents were added directly to the initially tested reaction tube. A published
PEP protocol (Zhang et al., 1992) used a smaller reaction volume of 60pl;
reagent volumes in the reamplification process were adjusted accordingly to
maintain the same concentrations. The PEP reaction consisted of 13.5jjJ 10x
Potassium-free buffer (100mM Tris-HCI, pH 8.3, 25mM MgCh, 1mg/ml gelatin),
12[il PEP primers (random 15-mers, Operon Technology, Alameda, CA), 12pl
mixture of the 4 dNTPs at 2mM each (USB, Cleveland, OH), and 2.5pl Taq
polymerase (15 units, Perkin-Elmer). Fifty cycles were carried out using a Perkin
Elmer Thermocycler (Perkin Elmer Cetus, Norwalk, CT) as follows: 1 minute
denaturation at 92°C, 2 minute annealing at 37°C, followed by a timed ramping
segment of 10seconds/degree to 55°C, followed by an extension incubation step
at 55°C for 4 minutes. A 5pl aliquot of the post PEP product was then removed
and subjected to PCR as described above.
Reamplification without PEP using standard PCR
Reamplification was also attempted by simply re-analyzing the sample by
PCR with additional master mix components without the PEP procedure. Since
the volume of the initial failed reaction was 100pl, the volumes of the master mix
components were adjusted accordingly to reflect the same final concentration of
reagents in the increased volume. Reamplification was attempted with either
primers for the 4 base pair insertion of the p-hexosaminidase A gene or for the 3
base pair deletion of the AF508 mutation of the cystic fibrosis transmembrane
conductor regulator gene (CFTR). Primer pairs are listed in Table II; thermal
cycling conditions are listed in Table III.
Contamination Controls
Negative PCR reaction controls that were previously subjected PCR were
simultaneously analyzed in each reamplification reaction to serve as
contamination controls for the reamplification process. Negative controls do not
contain starting DNA template and showed no initial amplification due to lack of
starting template.
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Statistical analysis
Fisher's exact statistical testing was used to compare results of
amplification for the different genes used (Appendix C). The computer program
GRAPHPAD INSTAT (Graphpad Software, San Diego, CA) was used to assist in
analysis.
4.2 Results for Specific Aim # 1
Of the 187 single cell lymphoblasts initially evaluated for Tay-Sachs,
97/187 amplified (51.9%). Of the 107 single cell lymphoblasts initially evaluated
for cystic fibrosis (OF), 87/107 amplified (81.3%). The amplification efficiency for
TSD was significantly lower than for OF (P<0.0095). Since the amplification
efficiency was so low for TSD as compared with the other loci studied, a
sensitivity study was performed. One cell, two cells combined, three, four, five
cells were evaluated. Amplification efficiencies were significantly greater when
analyzing two cells combined as compared to a single cell (97/187 vs. 16/17,
51.9% vs. 94.1% respectively, P=0.0006. Table IV).
Reamplification Studies without Primer Extension Preamplification (PEP)
After the DNA failed to amplify the first time with TSD primers, another
attempt with additional TSD primers and fresh master mix did not improve the
amplification rate as only three in 19 cells attempted demonstrated PCR
amplification. This was in stark contrast to reamplification experiments with CF
primers in cells that initially did not amplify for TSD. Of those, 18/25 (72%)
amplified for the CF locus after failed TSD amplification. These data
demonstrated that DNA was present in at least some of the PCR reaction tubes
that initially failed to amplify and that it is technically possible to reamplify DNA in
the stored PCR reaction tubes from previous amplification failures (Table V). This
could circumvent the need to rebiopsy the embryo to obtain a genetic diagnosis.
Reamplification with PEP
Fifty-nine single lymphoblasts that did not initially amplify using the TaySachs primers were subjected to PEP. An aliquot of the sample after the PEP
reaction was then PCR analyzed using TSD primers. Amplification occurred
52.5% of the time (31/59) cells. This was statistically greater than when
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Table IV. PCR amplification efficiencies

Number of Cells

Amplification efficiency

One cell

97/187 (51%)a

Two cells

16/17 (89%)a

Three cells

17/17(100% )

Four cells

8/9 (89%)

Five cells

7/8 (87.5%)

With 2 cells or greater

32/34 (94%)

aP=0.0006.
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Table V. Results of reamplification experiments

Experiment

Amplification result

Lymphoblast Reamplification by standard
PCR Targeting same gene locus (TSD)

3/19 (16%)a,b,c

Lymphoblast Reamplification by standard
PCR Targeting a different locus (CF)

18/25 (72%)a

Lymphoblast Reamplification by PEP
Targeting the same locus (TSD)

31/59 (53%)b

Blastomere reamplification by PEP
Targeting the same locus

13/24 (54%)°

Blastomere reamplification for PGD
(initially 4/6 amplified, therefore 6 failed)

4/6 (67%)

a P=0.0003.
b P = 0.007.
c P = 0.0127.
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compared with the reamplification attempt not using the PEP procedure at the
TSD gene locus (16% versus 53%, P=0.007).
Reamplification using PEP for failed blastomere diagnosis
Initially, blastomeres (n=54) from supernumerary human embryos that
failed to amplify were reanalyzed by PEP and subsequent PCR testing for TSD.
Blastomeres were re-analyzed to ascertain if the procedure could be done for a
clinical PGD. Thirteen of 24 amplified (54%) which was not statistically different
from the 53% seen in PEP reamplification of the lymphoblasts. With this
knowledge, we proceeded to reanalyze the contents of six PCR tubes from failed
amplification in a PGD cycle. After the PEP protocol and subsequent PCR for the
same TSD mutation, four of the six blastomeres amplified, and a diagnosis was
made. Included in this experiment were three negative (no initial DNA) controls
that were subjected to the same protocols. All three failed to amplify as expected,
thus minimizing the possibility that inadvertent contamination of the PCR tubes
with extraneous DNA was the source of the new amplification seen (Table VI).
4.3 Discussion for Specific Aim # 1
For couples where both partners carry a mutation for a recessive disease,
the risk of having an affected child is 25% based on Mendelian genetics. When
one partner carries the gene for a dominant disease, that risk increases to 50%.
For many couples, especially those who have had a pregnancy and perhaps a
live birth of an affected child, a 25% risk may be too great. The success with the
technology used in PGD must far exceed the anticipated risk in nature, i.e., the
PGD success has to exceed the 75% rate that nature statistically would provide.
The question then becomes, what risks are acceptable? Since there is never a
100% guarantee of success with a scientific technology, how close to 100% must
the test be and still allow a couple to accept that risk? Some of those risk
evaluation issues were addressed by the studies presented here.
The initial pre-clinical studies performed in our laboratory demonstrated
amplification rates over 90% when using individual lymphoblasts and
blastomeres as the source of DNA. However, upon performing a PGD cycle for
our first patient, the diagnosis rate was only 4/7 embryos, a disappointing 57%.
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Table VI. Reamplification of blastomeres from PGD embryos

Embryo number

RA
RA
RA
RA
RA

RA Embryo 2
Embryo 4 blastomere
Embryo 4 blastomere
Embryo 5 blastomere
Embryo 7 blastomere
Embryo 7 blastomere

Blastomere reamplification result
for PGD using PEP

1
2
2
1
2

*************************************************

Reamplification failed
Amplified/normal diagnosis
Amplified/normal diagnosis
Amplified/normal diagnosis
Reamplification failed
Amplified/normal diagnosis
****************************************
Blastomere amplification for a
different loci from previously sexed
embryos

JB Embryo 1
JB Embryo 1A
JB Embryo 2
JB Embryo 5A
JB Embryo 5B
JB Embryo 7
JB Embryo 8

Male - affected muscular
dystrophy
Male - affected muscular
dystrophy
Male - affected muscular
dystrophy
Male - Normal
Male - Normal
Male - reamplification failed
Male - reamplification failed

The reamplification result of Tay-Sachs disease is given on the right. JB embryos
were previously diagnosed for gender only. The amplification result for the
muscular dystrophy deletion is given on the right.
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This led us to address the issues of amplification failure - what
circumstances might cause it to occur and how to alleviate those possibilities.
Once the test had been performed and initial amplification failed, was there
anything that could be done to try to salvage the genetic diagnosis and provide
that couple with the best information and possible opportunity at achieving
pregnancy? That question led us to the experiments that were conducted in
Specific Aim # 1.
One concern in the pre-clinical studies was the limited quantity of DNA in
the starting template from a single cell. Amplification then becomes a sensitivity
issue. Nested PCR was implemented to increase the sensitivity to the level of
DNA in a single cell. Studies performed in our laboratory supported the
hypothesis that 20 cycles of PCR followed by another 30 cycles of nested PCR
was much more sensitive at DNA amplification than 50 cycles together (Figure
3). This supports the concept that PCR is a finite reaction; there is a limit to the
exponential amplification process. The concentration of the dNTP's and Taq
polymerase will begin to decline with subsequent cycles of PCR. Removal of an
aliquot after several PCR cycles and refreshing the reaction with new primers,
buffers, Taq polymerase rather than to just continue with additional cycles of
PCR yielded a greater sensitivity in the detection of target DNA sequences.
After the results of poor amplification were revealed in the first clinical test,
one corrective measure was to determine if having more initial template could
resolve that issue. The original DNA remains in the PCR reaction tube, along
with the PCR reagents and presumably amplified product. In the first phase of
these studies, we used a WGA technique that had been shown to produce a
minimum of 30 copies of at least 78% of the genome (Zhang et al., 1992). The
WGA technique used in the initial experiments is known as PEP. Primers are
designed that randomly contain 15 base sequences of the nucleotides in every
possible combination. When added to an initial DNA template, PCR is carried
out over 50 cycles of denaturation, annealing of these random sequences, then
new strand extension. This technique did not appear to have a practical clinical
application in the initial amplification process since it takes approximately 10
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hours to perform prior to the standard PCR testing for a PGD cycle. However,
after these initial studies were performed, other researchers investigated
methods to decrease the time involved in the procedure (Xu et a i, 1993; Sermon
etal., 1996). Less time could allow for the technique to become more practical
for de novo PGD applications.
In the studies by Xu et a i (1993), the annealing time was decreased from
the initial 150 seconds to 90 seconds and the initial four-minute extension time
was decreased by either 10 seconds or 20 seconds. Those two changes resulted
in a decrease of their overall reaction time from 8 hours to either 5 hours, 45
minutes or 4 hours, 4 minutes. The shortest time period showed no significant
decrease in amplification efficiencies when compared to the longest time period
(26/36 versus 48/60, respectively, P = 0.4543)
Initially, our study was deemed as proof of concept that the initial template
be rescued after having been subjected to PCR amplification. The studies
described here in the first experiments demonstrate that indeed the initial
template can successfully be accessed and that subsequent PCR amplification
can occur.
One of the issues of concern with a small amount of starting template is
that reamplification could introduce contamination, especially in an assay
designed to be sensitive to the level of a single cell. In these studies, negative
controls (no initial starting template) were also subjected to the reamplification
procedure. As expected, there was no amplification in those reactions; those
results helped to rule out contamination or extraneous DNA as a cause for the
amplification seen during the second attempt.
The reason for the inability to achieve successful amplification in the initial
PCR attempt is not known. Clearly, there was DNA present in those tubes that
subsequently amplified on the second attempt. The DNA may be in an
unfavorable conformation and have a certain degree of secondary structure that
may have prevented adequate strand denaturation or primer annealing in the first
reaction. It is interesting to note that the reamplification attempts with a second
set of PCR primers were more successful, even without using the whole genome
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amplification step. This may suggest that the gene structure itself for the phexosaminidase A gene may then abrogate primer annealing or polymerase
extension since amplification was successful 72% of the time when a different
gene was studied in the same tubes.
Another reason for the initial amplification failure could be due to
sensitivity of the PCR. The rationale for using a WGA technique is to increase the
number of copies of the starting template for the PCR reaction. This attempt to
reamplify for the same mutation after using PEP resulted in successful
amplification in 53% of the cells when analyzing the lymphoblasts. Clinically, the
method resulted in obtaining a diagnosis on two of the three embryos that did not
previously have a genetic answer for the gene studied. However, the increase in
time that the procedure requires has limited its clinical use for our laboratory.
Instead, our laboratory chose to focus on other methods that may improve both
the sensitivity and specificity while maintaining the ability to provide a genetic
diagnosis within a day. That led us to perform the experiments listed in Specific
Aim # 2 that follows this discussion.
As stated above, we demonstrated efficient amplification targeting
different loci, even without performing the whole genome amplification. Those
studies served as a model for a clinical application of diagnosing frozen embryos
that had previously been tested for gender determination in the X-linked
diseases. For example, a carrier of X-linked Duchenne Muscular Dystrophy
(DMD) completed a PGD cycle where only the sex was determined for the
embryos. After diagnosis and embryo transfer, the supernumerary embryos were
cryopreserved. The amplified PCR tubes were stored at -20°C. Upon developing
the technique for diagnosing the specific DMD deletion, the PCR tubes
containing the blastomeres from previously-determined male embryos were
thawed and subjected to amplification with the primers for that specific deletion.
Successful amplification occurred in five of seven embryos, with three embryos
being diagnosed as affected with the DMD deletion. This allowed for a
subsequent transfer of the two normal male embryos without the need to re
biopsy the cell (Table VI).
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4.4 Conclusions for Specific Aim # 1
From these studies we conclude that the process of whole genome
amplification and subsequent PCR testing can be performed as a means of
rescuing samples that previously failed to amplify in initial tests of PCR. The time
involved to perform these tests limits the use of the PEP protocol initially, but the
method still can serve as an alternative if amplification fails and the genetic
status of the embryo is not known. This could abrogate the need to re-biopsy the
embryo since an additional non-invasive technique is used to obtain the genetic
answer. In addition, these studies laid the foundation for the clinical application of
a reamplification procedure assessing a different genetic locus that resulted in
the embryo transfer of male embryos whose previous genetic status was
unknown in an at-risk X-linked carrier.
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SECTION 5
Studies for Specific Aim # 2

Specific Aim # 2: To increase the amplification efficiency through
optimization of DNA lysis conditions and to decrease the incidence of allele
drop-out.
5.1 Materials and Methods for Specific Aim # 2
Cell collection
Single and double cells were collected using lymphoblast cultures
(#GM03770 Coriell Institute, Camden NJ) known to be heterozygous for the 4
base pair (bp) insertion on exon 11 of the p-hexosaminidase A gene (TSD-11).
Heterozygous cells were chosen because a single cell contains copies of both
the normal and affected allele. Cells were isolated under a dissecting microscope
either singularly or in groups of two, then serially rinsed through three microdrops
of PCR buffer to remove any extraneous cells. The cells were then placed in a
PCR reaction tube (Gene-Amp, Perkin-Elmer, Norwalk, CT) and 100 samples
were evaluated in each of the following methods of DNA preparation:
1). Liquid Nitrogen (LN2) - cells were placed in 60ja.L of sterile ultrapure water with
a mineral oil layer, frozen-thawed twice in LN2 then boiled at 100°C for 10
minutes (standard procedure).
2). Potassium Hydroxide (KOH) - cells were placed in 5pL of KOH solution,
(200mM potassium hydroxide/50mM dithiothreitol), centrifuged, heated at 65°C
for 10 minutes, then 5 jj,L neutralizing solution (900mM Tris-HCI pH 8.3, 300mM
potassium chloride, 200mM hydrogen chloride ) was added. Fifty microliters of
sterile ultrapure water was added along with a mineral oil layer.
3). Boiling (Bl) - cells were placed in 60

sterile ultrapure water, layered with

mineral oil, then boiled at 100°C for 10 minutes.
4). Water (H20) - cells were placed in 60pL sterile ultrapure water and layered
with mineral oil without further preparation prior to PCR and genetic analysis
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Cells were analyzed by PCR using nested primers as noted above in the
Materials and Methods section for Specific Aim # 1, with the following exception
in the PCR buffer for the first round of amplification: For the KOH group, the
buffer was 10mM Tris-HCI (pH 8.3), 2.5 mM MgCI2 chloride, 0.1% (w/v) gelatin.
(Due to the potassium ions in the KOH, potassium chloride was not used on the
initial buffer). The LN2, Bl, and H20 groups first round PCR, plus all groups
nested round PCR, used the regular PCR buffer (10mM Tris-HCI pH 8.3, 50mM
potassium chloride, 1.5mM MgCI2, 0.1% w/v gelatin). Additional PCR
experiments were performed using the alternate concentrations to control for the
differences in buffers.
PCR products were loaded onto a 7% polyacrylamide gel as described
above in Specific Aim # 1. The appearance of a single band rather than the
characteristic heteroduplex formation indicated the amplification of only one
allele.
Statistical analysis
Amplification rates and accuracy of diagnoses between the different
methods of DNA preparation were compared by Chi-Square, using Yates'
correction for continuity (Appendix C). The computer program GRAPHPAD
INSTAT (Graphpad Software, San Diego, CA) was used to assist in analysis.
5.2 Results for Specific Aim # 2
A representative gel is shown in Figure 10. Results are shown in Table VII
for the single cells. Ninety-seven percent of the KOH group samples
demonstrated amplification of at least one allele. This was significantly greater
than for LN2, Bl, and H20 group where amplification was detected in 38, 41 (both
P<0.00001) and 85% (P <0.006) of samples, respectively. The sensitivity of the
KOH method is even greater when comparing amplification of both alleles in the
heterozygous cell, a requirement for a correct diagnosis. Ninety-one of the 97
single cells that amplified using the KOH method showed the presence of both
alleles. In the LN2 group, not only was the amplification rate low (38%), of those
cells that did amplify only 11 showed amplification of both alleles. Although the
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Figure 10. Two of the DNA preparation techniques. Both 15-lane
polyacrylamide gels (7%) were set up the same with a negative control in the 1st
and 14th lanes and a normal and heterozygous control in the 2nd and 13th lanes,
respectively. Lanes 3-12 display the amplification results from the PCR of known
heterozygous single cells. This upper gel demonstrates the results of the
KOH/DTT lysis method in which all 10 single cells (lanes 3-13) exhibit the
characteristic heteroduplex formation and correctly amplified both the normal and
affected alleles. The lower gel represents the use of the Liquid Nitrogen method.
In this instance only 4 of 10 heterozygous single cells amplified. Of those 4, only
2 (lanes 4,6) correctly displayed the heteroduplex formation, indicating a correct
diagnosis.
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Table VII. Comparison of different iysis methods used in 400 single cells

Amplification Rate/
Lysis Method

LN2

KOH

BL

H2O

Normal allele only

16/100
(16%)

5/100
(5%)

13/100
(13%)

16/100
(16%)

Affected allele only

11/100
(11%)

1/100
(1%)

11/100
(11%)

28/100
(28%)

Both Alleles (expected result)

11/100
(11%)

91/100
(91%)

17/100
(17%)

41/100
(41%)

38/100a
(38%)

97/100a-b
(97%)

41/100a
(41%)

85/100b
(85%)

Total Amplification

aP<0.00001.
bP<0.006.
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Table VIII. Comparison of different lysis methods used in 200 two cells

Amplification Rate/
Lysis Method

LN2

KOH

Normal allele only

14/100
(14%)

1/100
(1%)

Affected allele only

18/100
(18%)

0/100
(0%)

Both Alleles (expected result)

53/100
(53%)

96/100
(96%)

Total Amplification

85/100a
(85%)

97/100a
(97%)

a P = 0.006.
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H20 method had a high amplification rate (85%) for single cells, less than half
(n=41) of the cells amplified both alleles.
When amplification of a single band was seen, heteroduplex formation
determined if the normal or the affected allele was amplified. There was no
significant difference seen in which of the alleles amplified. This also suggests
that the single bands are probably not due to contamination since the laboratory
workers are homozygous normal for TSD-11 DNA. No evidence of
contamination was observed in any of the negatives or media controls for the
experiments used in this study.
Using two cells per reaction did not increase the amplification rate for the
KOH method (97% vs. 97%), but dramatically increased the rate for the LN2
method (85 vs. 38%; P <0.00001). However, only 53 of those cells correctly
amplified both alleles (Table VIII).
5.3 Discussion for Specific Aim # 2
Maximizing the benefits of a PGD cycle relies upon the success rate of its
implementation. Specific Aim # 1 focused on the sensitivity of obtaining a genetic
answer; this study tested both sensitivity and specificity - not only obtaining
amplification, but also ensuring that the information obtained is correct. One of the
greatest concerns is that a misdiagnosis after genetic testing would actually
supersede the PGD in the first place. Most of the couples pursuing PGD cycles are
fertile and are opting for PGD not only to have a child, but to have an unaffected
child.
When studying a heterozygote in the autosomal recessive condition with a
single mutation, amplification of only the normal allele and not the affected allele
would result in making eligible for embryo transfer a true phenotypically normal
embryo (genotypically heterozygous), an event that would not be detrimental for
the resulting offspring. However, amplification of only the abnormal allele would
then remove a true phenotypically normal embryo from the pool of embryos eligible
for transfer, thus decreasing the chances for pregnancy. (Table IX - Condition A).
One cause of misdiagnoses reported in the literature (Grifo et a I., 1998; ESHRE
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Table IX. The effect of Allele Drop-out (ADO)

Condition A - autosomal recessive disease such as Tay-Sachs (T and t alleles)
True
Observed
Eligible for
Impact of
Genotype________ Genotype_________ Transfer?________ Error______________
Tt (normal
phenotype)

T (normal)
t (affected)

Yes
No

Tolerable
Healthy embryo not
transferred

Condition B - ADO in an autosomal dominant disease such as Garner Syndrome
(G and g alleles)
True
Observed
Eligible for
Impact of
Genotype________ Genotype_________ T ransfer?_________ Error_____________
Gg (affected)

G (affected)
g (normal)

No
Yes

Acceptable
Transfer of affected
embryo

Condition C - ADO in an autosomal recessive disease such as Cystic Fibrosis
with two different mutations (C, c, F, f alleles)
True
Observed
Genotype_________ Genotype
CcFf
(affected)

CFf
cFf
CcF
CF
cF
Cf
cf

(normal)
(affected)
(normal)
(normal)
(normal)
(normal)
(affected)

Eligible for
Impact of
T ransfer?______________ Error
Yes
No
Yes
Yes
Yes
Yes
No

Transfer of affected embryo
Acceptable
Transfer of affected embryo
Transfer of affected embryo
Transfer of affected embryo
Transfer of affected embryo
Acceptable

Table modified from Navidi and Amheim, 1991. Capital letters (T,G,C,F)
represent the dominant allele while lower case letters (t,g,c,f) represent the
recessive allele.
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2002) has been attributed to ADO or the random amplification of only one of the
two alleles present in a single cell. The two main considerations regarding ADO
are with either: 1) An autosomal dominant condition where the heterozygous
condition is phenotypically affected. Amplification of only the normal allele in a
heterozygous cell with a dominant condition could result in the transfer of an
affected embryo (Table IX - Condition B), or 2) An autosomal recessive condition
involving two different mutations in the same gene (one from each parent) where
the affected condition actually carries both mutations. This is known as a
compound heterozygote since it is heterozygous for two different mutations in the
same gene. In the case of a compound heterozygote, there are actually four
alleles to amplify - the normal and abnormal at each of the two mutation sites.
Amplification of only a normal allele at either of those sites could also result in a
misdiagnosis and subsequent transfer of a truly affected embryo. (Table IX Condition C)
The first trials of PGD reported in the literature used a lysis method where
the biopsied cell was placed into a tube of sterile water to break the cell
membrane (Strom et a i, 1991; Morsy et a i, 1992; Liu et al., 1993). The
difference in the osmotic pressure was thought to be enough to break the cell
wall and make the DNA more accessible. Trials of amplification efficiencies
produced results with amplification rates over 90% so the method was accepted
as quick and easy.
At the onset of the initial clinical studies performed in our laboratories, the
state of the art for PGD was to lyse the cell by the freeze thaw method (Verlinsky
and Kuliev, 1992) or liquid nitrogen (Handyside et al., 1992), similar to the
protocols outlined in the Materials and Methods section. This method also
appeared to be quick and easy to break open the cell membrane by changes in
temperatures and to allow access to the DNA. However, after several other PGD
clinics reported poor amplification results and misdiagnoses, other methods for
DNA lysis were explored.
Earlier reports of the PEP technique also used the KOH method for lysing
the cells. Zhang et al. (1992) demonstrated the method for individual sperm cells,
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which are known to have highly condensed DNA. The KOH/DTT method was
similar to a sperm lysis technique reported by Cui et al. (1989). It was thought
that that method could be used for the lysis of the blastomere as well. This
concept led to the second phase of our optimization studies and the evaluation of
different lysis methods.
As our results demonstrated, the KOH lysis method proved superior to the
other methods that at the time of the studies were considered the status quo. The
exact mechanism for the superiority of the KOH lysis technique is not known.
Alkaline buffers are known to hydrolyze the cell membrane, thus making the DNA
more accessible. Other DNA protocols use an alkaline lysis buffer to increase
DNA isolation (Sambrook and Russell, 1989). DTT is added to the lysis buffer as
well. DTT reduces disulfide bonds (Cleland, 1964). Reduced sulfide bonds
minimizes the formation of protein aggregates. As stated above, the KOH/DTT
protocol was first used to access the DNA in tightly condensed sperm cells. It
stands to reason then that the use of DTT may aid in the decondensation of the
blastomere DNA as well, thus providing more accessible DNA that can be used
for amplification.
The initial step in PCR is elevating the temperature to just below the
boiling point of water so that the hydrogen bonds of the double stranded DNA will
dissociate and become single stranded DNA. The process is reversible; upon
lowering the temperature, the hydrogen bonds will re-form. In the case of PCR,
before the bonds re-form, oligonucleotide primers will quickly bind to their
complementary sites and extend a newly formed strand in the presence of Taq
polymerase and dNTPs. One explanation for the occurrence of ADO is that there
is insufficient strand separation during the denaturation step. By increasing the
temperature during the initial denaturation steps, it is thought to aid in more
efficient strand separation (Ray and Handyside, 1996).
ADO could be due to DNA degradation (Piyamongkol et al., 2003).
Random breaks in the DNA strands are expected to occur. This may jeopardize
the amplification of larger segments of DNA since there is a greater risk of strand
breakage between the primers. In a study of seven different loci, Piyamongkol et
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al. (2003) compared ADO rates with the size of the PCR product and noted that
ADO rates increased with the size of the amplicon. These researchers found a
linear correlation between the product size and ADO; the greater the size of the
final PCR product, the greater the ADO rate, even in differences of 100 base
pairs. Sermon et al. (1996) and Vrettou et al. (1999) have anecdotally reported
increased rates of ADO and amplification failure with longer amplified products
as well. Vrettou et al., (1999) also concluded from their studies that the DNA
sequence, denaturation temperature (contrary to the findings of Ray and
Handyside, 1996), and cell type had little affect on the ADO rates.
In the study presented here, testing one cell versus two cells had an
inverse effect on the ADO rate. With the superior KOH lysis method, testing two
cells showed a decrease in the ADO rate from 6% to 1%, but that difference was
not statistically different (P = 0.1182) since the ADO rates were low to begin with.
However, when testing two cells rather than one cell using the LN2 method, there
was a significant improvement in amplification rates (85% versus 38%,
respectively, P = 0.008) and decreased ADO rates (71% versus 38%,
respectively, P < 0.0001). Although the ADO rate was still unacceptably high for
this method, these results demonstrated that the ADO rate changes with the
amount of starting DNA. Piyamongkol et al. (2003) corroborated the effect of the
amount of DNA on ADO rates by testing one, two, three cells, and determining
the ADO rate decreased significantly between one and two cells (from 24% for a
single cell to 4% for two cells, 3% for three cells, P < 0.0001 using a proteinase K
lysis technique).
Ray and Handyside (1996) demonstrated that, once the ratio of one allele
versus the other is over 1:4, the reaction would likely not recover from the altered
ratio due to the exponential amplification of both products. These researchers
mixed known quantities of starting template of normal versus affected allele for
the AF508 mutation of CFTR at 1:1, 1:2, 1:4, 1:16, and 1:256 ratios. The 1:1, 1:2,
and 1:4 all showed adequate heteroduplex formation, demonstrating the
amplification of both alleles. However, the samples containing 1:16 ratio or
greater displayed only weak formation of the characteristic heteroduplex bands,
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indicating the amplification of only one allele even though the starting template
contained both alleles. This suggests that once the amplification of one allele
over the other has occurred after as early as three cycles of PCR (4 copies), the
eventual outcome of ADO cannot be altered.
More sensitive techniques such as Fluorescent PCR (F-PCR) may aid in
detecting the occurrence of ADO (Findlay et al., 1995; Piyamongkol et al., 2001).
Fluorescently-labeled primers are added to the PCR master mix. Rather than
using standard gel electrophoresis, the resulting PCR product is quantitated with
the aid of computer-assisted software to determine the presence or absence of
the studied locus. In the instance of ADO, a lower value may be assigned at that
particular locus, but the allele is still present nonetheless.
As demonstrated by Table IX, the impact of ADO can result in a
misdiagnosis and transfer of an affected embryo, the very outcome that couples
who undergo PGD are trying to avoid. ADO and other issues of amplification
efficiency, diagnosis, and outcome were studied by varying for this dissertation by
varying DNA lysis methods in hopes of optimizing the sensitivity and accuracy of
the PGD procedure while minimizing the risk to the patient. Achieving a greater
diagnostic sensitivity and specificity could result in having more embryos available
for transfer which in turn could increase the overall pregnancy rate and giving more
couples the opportunity of having a healthy child.
5.4 Conclusions for Specific Aim # 2
In Specific Aim #2, we concluded that different lysis techniques can affect
both the sensitivity and specificity of single cell diagnosis. The KOH lysis method
produced a significantly higher rate of amplification and higher accuracy when
compared with the other methods tested. Using this method, there was no
statistical difference in amplification rate and diagnostic accuracy when testing
one versus two cells. These studies also demonstrated the importance of
optimizing the PCR conditions by evaluating heterozygous cells that contain both
alleles so that the incidence of ADO can be assessed.
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SECTION 6
STUDIES FOR SPECIFIC AIM # 3
Specific Aim # 3: To identify characteristics of the blastomeres from an
embryo before and after embryo biopsy that can aid in determining the
success of obtaining PCR amplification.
6.1 Materials and Methods for Specific Aim # 3
Individual blastomeres were evaluated from embryos from couples
undergoing a PGD procedure. Individual cells were removed from the embryo by
micromanipulation (embryo biopsy) as described above in the Materials and
Methods section of Specific Aim # 1.
Evaluation of the nuclear and cytoplasm status
The characteristics of the cytoplasm and the nucleus were evaluated
using both a SMZ-10 Nikon stereo microscope and a Nikon diaphot inverted
microscope with Hoffman optics. Nuclei from blastomeres were classified as
present or absent, intact or ruptured. The cytoplasm was classified as either
intact, or ruptured/degenerating (Figure 11).
Polymerase Chain Reaction analysis
The individual blastomeres were analyzed by nested PCR for the patient
specific disease. An example of the protocol for that is listed above in the
Materials and Methods section of Specific Aim # 1.
Statistical analysis
Fisher's exact statistical testing was used to compare results of
amplification for the different nuclear/cytoplasmic characteristics (Appendix C).
The computer program GRAPHPAD INSTAT (Graphpad Software, San Diego,
CA) was used to assist in analysis.
6.2 Results for Specific Aim # 3
Table X illustrates the amplification results when a nucleus is present
compared with when no nucleus is visible. Of the 89 total blastomeres, 59
(66.3%) had a visible nucleus while 30 (33.7%) did not have a visible nucleus. All
59 of those blastomeres with a visible nucleus amplified in the subsequent PCR
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Figure 11. Representation of nuclear and cytoplasmic integrity in human blastomeres. Panel A illustrates a biopsied
balstomere with no visible nucleus. The overall amplification rate of cells in this category was 11/30 (36.7%) Panel B
illustrates a biopsied blastomere with a visible nucleus. Note the defined nuclear membrane. Nucleoli can be seen in the
nucleus as well. Cells in this category demonstrated 100% amplification rates (59/59). Panel C shows the cell membrane
of a biopsied blastomere that has ruptured and the cytoplasm is degenerating. Of the 14 cells that lost cytoplasmic
integrity, the amplification rate followed the pattern of their nuclear status - if the nucleus was intact, the cell amplified
(11/11 = 100%); if the nucleus was not intact, then the amplification rate was poor (0/3 = 0%).

92

Table X. Evaluation of blastomere morphology and amplification rate

Nuclear status

Amplification rate (%)

Visible Nucleus present

59/59 (100%)a

No nucleus seen

11/30 (36.7%)a

Cytoplasm/membrane intact

59/75 (78.7%)

With visible nucleus
No nucleus seen

Cytoplasm /membrane disrupted
With visible nucleus
No nucleus seen

48/48 (100%)b
11/27 (40.7%)b

11/14(78.6% )
11/11 (100%)
0/3(0%)

a'b P < 0.0001.
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reaction while only 11/30 (36.7%) without a visible nucleus subsequently
amplified in the PCR. This difference was statistically significant (P<0.0001). Of
the 30 blastomeres without a visible nucleus, one blastomere initially had a
nucleus seen, but upon biopsy, the cell lost the nuclear integrity and did not
subsequently amplify.
The cytoplasm of nine blastomeres degenerated during or after the biopsy
process and the blastomere membrane ruptured in an additional five cells. These
breaches did not have an effect on the amplification rate; the amplification rates
in the intact versus disrupted cytoplasm groups were equal at almost 79%. Those
categories were further split into the cells that had a visible nucleus versus those
that did not. Of those 14 blastomeres that showed loss of cytoplasmic/membrane
integrity, 11 had a visible nucleus (i.e. nuclear membrane remained intact in spite
of the cytoplasmic integrity). All 11 with a visible nucleus subsequently amplified
while the three with no visible nucleus did not amplify. Again, the amplification
rates followed the pattern of nuclear morphology; regardless of the cytoplasmic
integrity, cells with a visible nucleus amplified 100% of the time.
A total of 89 blastomeres were biopsied from 51 embryos obtained from
couples seeking PGD. Overall, the amplification rate per embryos analyzed was
47/51 (92.2%). The four embryos that showed no PCR amplification had no
visible nucleated cells at the time of the biopsy (One, one, two, and three
blastomeres removed from those four embryos). No other form of nuclear
assessment such as the use of Hoechst dye was performed since these cells
were evaluated immediately after biopsy for clinical PGD.
6.3 Discussion for Specific Aim # 3
Theoretically, it should come as no surprise that blastomeres with visible
nuclei should have greater amplification efficiency than those that do not. In
simplistic terms, the DNA in interphase nuclei (when the nucleus is visible) is
more accessible than the tightly condensed DNA in cells where the nuclear
envelope has broken down as the cell prepares for cytokinesis. Interphase
chromosomes are thin and extended; the chromosomes themselves are not
readily visible under the microscope, but rather the chromatin appears as well
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dispersed fibers and filaments throughout the nucleus. (Comings, 1980) This
dispersion allows the DNA to be more accessible for the regions of the chromatin
in the nucleus that are transcriptionally active. Dispersed DNA strands provide an
accessible template for PCR amplification.
In contrast, metaphase chromosomes are tightly coiled, reducing a 5cm
length of DNA to approximately 5pm. This coiling, mediated by H1 histone
phosphorylation, protects the chromosomes from breakage during segregation.
Mitotic chromosomes are transcriptionally inactive and RNA synthesis is
temporarily halted while the chromosomes are condensed. (Alberts et al., 1994).
The tightly-bound DNA template may consequentially be difficult to access during
the PCR process. Under normal PCR conditions using large quantities of DNA,
this does not appear to be an issue of concern since there will be asynchronous
cell cycles and interphase cells should be present at any given time. However, in
PGD when only one cell is involved, the ability to amplify that single cell is
crucial.
The visible nuclear envelope is composed of two membranes. The inner
surface is associated with the nuclear chromatin. It was first described by
Fleming in 1882 as " the existence of a special achromatinous lamella, that is
real - though in most types of nuclei very thin - layer of substance which is not
merely the expression of the region of contact between nuclear substance and
cytoplasmic structure" (republished as historical work years later, Fleming, 1965).
Thus, the envelope serves as a 'barrier' between the nucleus and the organellecontaining cytoplasm.
Nuclear envelope breakdown is part of the normal cell cycle to allow the
chromosome pairs to migrate to the cell periphery in anticipation of cytokinesis.
Even though it is driven by the mitotic spindle, chromosome segregation is
mediated by nuclear envelope components. The kinetochore is functional once
the envelope has broken down; the pores have disassembled and nuclear pore
components have been transferred to the kinetechore. This may be a fail-safe
mechanism that determines the mitotic status of the cell (Salina et al., 2003)
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When the nuclear envelope is exposed to mechanical stress, the membrane
proper may no longer be visible. (Franke et al., 1981). The basic structural
elements of the pore complex can remain intact under stress conditions. Lack of
a visible nucleus may then reflect some degree of DNA degradation. DNA
degradation can also occur due to changes in temperature, pH, and DNA
secondary structure (Lindahl, 1993). In normal metabolically active cells, there is
some ensuing degree of DNA repair. Although there is evidence for DNA repair
in embryos, those mechanisms are poorly understood (Harrouk et al., 2000;
Menisser-de Murcia et al., 2001; Makarevich and Markkula, 2002; Zeng et al.,
2004). This DNA degradation could lead to a reduced or no PCR amplification.
How does partial DNA degradation affect the PCR signal? If small parts of
the nitrogenous bases are involved in the degradation, the Taq polymerase can
still incorporate the DNA, but the signal will be reduced. This would
consequentially result in a weak signal (Cui and Matthews, 1996). However, if
there is more serious damage to the bases or the base-sugar bonds,
phosphodiester bonds are broken; subsequently the Taq will not incorporate the
bases and extension will stop. This was well illustrated by Cui and Matthews
(1996) who demonstrated that in normal DNA, the Taq polymerase works
efficiently as it incorporates the bases and extends new DNA strands. However,
if there are bases that are degraded (due to hydrolysis, oxidation and/or
methylation, Lindahl, 1993), the incorporation rate is very slow. If the degradation
is severe and the phosphodiester bonds are broken, the Taq will not recognize
the DNA strand to attach to, and extension will cease. These observations were
made in blastomeres with nuclei that were severely abnormal or absent (Cui and
Matthews, 1996).
The ability to perform this study was made possible by first optimizing the
amplification efficiency. Knowing what conditions work well in single cell
amplification provides a strong foundation to try to assess the differences when
optimal conditions are altered. Examples are instances when new reagents or
reaction temperatures are altered to determine the effect of that particular change.
Initial studies in our laboratory to optimize single cell diagnosis set the baseline for
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the ability to discern these differences as clinical studies came to fruition (Morsey
et al., 1992). As in the previous study for Specific Aim # 2 demonstrating lysis
conditions that improved amplification efficiencies, this study provides objective
criteria to select optimal cells for PGD.
6.4 Conclusions for Specific Aim # 3
This set of studies demonstrated the importance of biopsying a
blastomere with a visible nucleus. The integrity of the blastomere membrane or
the integrity of the cytoplasm itself does not affect the amplification results if the
nucleus and nuclear membrane remains intact.
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SECTION 7
Studies for Specific Aim # 4
Specific Aim # 4 : To identify the chromosomal complement in a single cell.
7.1 Materials and Methods for Specific Aim # 4
Cell collection
A male lymphoblast cell line normal for the studied genes and a male cell
line heterozygous for the AF508 mutation of CFTR were obtained from Coriell
Institute for Medical Research, Camden NJ (lines GM 03070 and GM07828,
respectively). Cells were cultured as described in Specific Aim # 1. Lymphoblast
cells were isolated, counted, and collected under a dissecting microscope using
a drawn out sterile Pasteur pipette. Replicates of 1,2,3,4,5,6,8,10, and 20 cells
were placed in individual PCR reaction tubes (USA Scientific, Ocala FL)
containing 0.5pl of the lysis buffer (400mM KOH, 100mM DTT, 10mM EDTA).
The tubes containing the cells were incubated on ice for 10 minutes.
Subsequently 0.5pl of a neutralizing buffer consisting of 400mM HCI, 600mM
Tris-HCI (pH 0.6) was added. The samples were stored on ice if being prepared
for immediate assay or stored long-term at -20°C.
Whole Genome Amplification - Multiple Displacement Amplification (MPA)
The WGA technique of MDA was used to generate sufficient quantities of
DNA for microarray analysis. MDA was accomplished through the use of a
GenomiPhi™ DNA amplification kit (Amersham Biosciences, Piscataway, NJ).
The kit supplied sample buffer, reaction buffer containing the random hexamers
and dNTPs, along with the enzyme mix containing 0 2 9 polymerase. Other
components and concentrations are unknown due to the proprietary nature of the
kit. The kit supplied a 10ng/pl control (lambda DNA) to use as a positive MDA
control. Negative controls were used as well that contained the kit components
and were exposed to the same conditions as the samples, but did not contain
template DNA.
Nine microliters of sample buffer were added to the template. The sample
was denatured at 95°C for 3 minutes, then cooled on ice. Nine microliters of
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reaction buffer and 1pl of enzyme mix were added to each cooled sample. The
sample was then incubated at 30°C for 16-18 hours. After that time, the sample
was heated to 65°C for 10 minutes to inactivate the enzyme, then cooled to 4°C
until subsequent use.
Agarose gel verification
To confirm that amplified product had been generated, a representative
1pl sample was run on a 1% agarose gel and the gel stained with ethidium
bromide. The gel was analyzed and photographed under UV light for evidence of
a streak of DNA to confirm the presence of amplified DNA (see Figure 12). The
streak is represented of the multiple copies of varying sizes of DNA products
generated from the MDA.
Purification of amplified sample
Post-amplification purification or clean-up is recommended to remove any
remaining reagents, enzymes, and oligonucleotides from the MDA process. This
was accomplished by the use of a QiaQuick PCR purification kit (Qiagen,
Valencia, CA) that is 90-95% successful at recovering 100bp-10 kb products
while removing oligonucleotides. The sample was diluted with five times the
volume of supplied buffer, the diluted sample was applied to the silica membrane
of the QiaQuick spin column, and centrifuged to bind the DNA. The column was
then washed with ethanol. Lastly, the DNA was eluted from the column with
sterile water and was ready for subsequent use.
Quantification
Representative samples were quantitated by fluorometry and PicoGreen®
dsDNA reagent kit (Molecular Probes, Eugene, OR) after purification. This
method is preferred over standard UV spectrophotometry (absorbance at 260
nm) that may provide inaccurate readings due to contaminants commonly found
in preparation methods. The PicoGreen is sensitive to the level of 25 pg/ml. A
working stock of control DNA was used to generate a standard curve to
extrapolate the quantitative value of the sample DNA. PicoGreen reagent was
added to all samples and the standard curve stock samples. All were read using
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Figure 12. DNA products after multiple displacement amplification (MDA).
Agarose gel (1%) image demonstrating the ’smear1of DNA in lane 1 in the
product after successful MDA. Lane 2 is a Lambda DNA/Hind III size ladder
(indicating the base pair sizes). The presence of a smear illustrates that large
quantities of DNA in various sizes were produced after the amplification
technique.
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a Versa Fluor fluorometer (Biorad, Hercules, CA) with a 480/20(nm) excitation
filter and a 520/10 (nm) emission filter.
PCR
A V aliquot from each sample was subsequently analyzed by PCR for
one to seven different loci:
1) APC = Adenomatous polyposis coli gene on chromosome 5 (5q21-q22)
2) CF = Cystic fibrosis transmembrane conductance regulator gene on
chromosome 7 (7q 31.2)
3) DYT = Dystonia gene on chromosome 9 (9q34)
4) SC = Sickle cell, IJ-globin gene on chromosome 11 (11 p15.5)
5) TSD = Tay-Sachs disease, ft-hexosaminidase A gene on chromosome 15
(15q23-24)
6) ZFX = Zinc finger region of the X chromosome (Xp22.2-p21.3)
7) ZFY = Zinc finger region of the Y chromosome (Yp11.3)

These loci were chosen since they involve seven different chromosomes
that had primers readily available in our laboratory and were known to efficiently
amplify: this served as a means to determine that separate regions of the
genome were amplified. PCR using nested primers was performed as previously
described in the Material and Methods section of Specific Aim # 1 with the
exception of the different primers and annealing temperatures as listed in Table
XI. The PCR experiments confirmed the presence of DNA on several different
chromosomes and illustrated that multiple loci were amplified by the MDA.
An additional buffer was added during the initial PCR process for single
cells only. This buffer contained 10mM Tris (pH 8.0), 0.1% Tween 20 and
37.5pg/ml BSA.
Restriction Enzyme Digestion
MDA generates DNA fragments ranging from 100bp-10kb in length. In
order to optimize the hybridization of the DNA to the microarray, the fragments
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Table XI. Geni Loci and Primers. Below lists the gene loci and the primers used for the PCR experiments performed after
whole genome amplification by multiple displacement amplification.

Gene Loci

Outer primers 5’ to 3’
(annealing temperature)

Nested primers 5’ to 3’
(annealing temperature)

Adenomatous polyposis
coli chromosome 5q21-q22

F-ACAG AAAGAT GT GG AATT AA
R-TTCTCCAGCAGCTAACTCAT
(55°C)

F-ACAGAAAGAT GT GG AATTAA
R-AT GGCAGAAATAATACATT C
(54°C)

A F508 mutation of cystic
fibrosis transmembrane
regulator gene.
Chromosome 7q31.2

F - GACTTCACTTCTAATGATGAT
R- CTCTTCTAGTTGGCATGC
(40°)

F- T GGGAGAACT GGAGCCTT
R -GCTTTGATGACGCTTCTGTAT
(50°)

Dystonia
Chromosome 9q34

F-CCT GGAATACAAACACCTA
R-GT GGAAGGACT GAGT GTT G
(61 °C)

F-GGCTGCCAAT CAT GACT GT C
R-GT GGAAGGACT GAGT GTT G
(58°C)

Sickle cell
Beta globin gene
Chromosome 11 p15.5

F- GGCTGAGGGTTTGAAGTCCA
R - CCATAGAAAAGAAGGGGAAA
(49°C)

F- ACT CCTAAG CCAGT GCCAGA
R- AT CAAGGGT CCCATAGACT C
(58°C)

Tay-Sachs
p-hexosaminidase A
chromosome 15q23-24

F - CAACAACAGT CT GGT GAT GG
R - GCCAGACACAAT CAT ACAGG
(61 °C)

F- AAGGAGCT GGAACTGGT CAC
R - CT CT CAACCACCTT CCCAAT
(54°C)

Zinc Finger region
X chromosome Xp22.221.3
Y chromosome Yp11.3

F-ACCRCT GT ACT GACT GT GATT ACAC
R-GCACYT CTTT GGT AT CYGAGAAAGT
(49°C)

F-AYAACCACCTGGAGAGCCACAAGCT
R- T GCAGACCTATATT CRCAGT ACT GGCA
(58°C)
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should be reduced in size to bind to the less than 1kb size of the microarray
spotted DNA. In initial experiments, the post-MDA products were incubated at
37°C for 90 minutes with 20 units of the restriction enzyme Dpnl (New England
Biolabs, Beverly, MA) that recognized and cleaved (cut) the sequence GATC. In
later experiments, 20 units of Dpnl and 20 units of EcoRI (New England Biolabs)
that recognized and cut the sequence G'AATTC were used.
Fluorescent labeling of DNA for microarrav analysis
The protocol was followed in low-light or in darkness where applicable to
minimize the photobleaching of the dyes. In the initial phase of microarray
analysis, samples were labeled either using Cy 3 and Cy 5 dyes. For the proof of
concept phase of the experiments, the samples were equally divided, and half
was separately labeled with each dye. (Theoretically, the sample of interest
would be labeled with one dye and the normal control labeled with the other dye).
The Cy dyes were incorporated by random-priming using the BioPrime® DNA
labeling system. The kit supplied several of the reagents needed, including the
random primer solution, the Klenow fragment of DNA polymerase and the stop
buffer. The kit dNTP mixture was not used, but rather Cy3 CTP and Cy5 CTP
(Amersham, Piscataway, NJ) were used along with standard dNTPs (USB,
Cleveland OH). The sample volume was brought up to 20pl after purification and
the sample was placed on ice. Twenty microliters of the supplied 2.5X random
primers solution was added, the sample mixture was denatured for 5 minutes at
100°C, then the mixture was cooled on ice. Two and a half microliters each of
dATP, dGTP, and dTTP(1.2 mM) was added along with 1.25pJ (0.6 mM) dCTP.
Three microliters of Cy5-dCTP or Cy3-dCTP (1 mM stocks) was added, along
with 1pl of the supplied Klenow polymerase. The sample was mixed gently and
briefly centrifuged. The reaction was incubated in the dark at 37°C for 1 to 2
hours. At the end of that time, 5ftl of the supplied stop buffer was added to each
sample. The labeled probe was individually purified using the QiaQuick DNA
purification kit as described above. The final volume for each sample was
adjusted to 30jal with sterile water. The two samples were then combined in a
new microcentrifuge tube.
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Alexa Fluor Dyes
After the initial microarray experiments, Alexa Fluor dyes 546 and 647
were substituted for the Cy dyes and used to directly label the DNA with the
Ulysis® nucleic acid labeling kit (Molecular Probes, Eugene, OR). Rather than
using the random primers for labeling, the following protocol was used. After
Qiaquick clean-up, the sample volume was adjusted to 21 pi and was denatured
at 95°C for 5 minutes, briefly centrifuged and then placed on ice. Four microliters
of the respective Alexa Fluor dye was added for a final volume of 25pl. The
mixture was heated in the dark at 80°C for 15 minutes, briefly centrifuged, then
placed on ice. QiaQuick purification was used individually on each sample as
described above. The final volume for each sample was adjusted to 30pl. The
two samples were then combined in a new microcentrifuge tube.
After the respective labeling method and the combination of the samples,
30-50pg of human Cot-1 DNA (Invitrogen, Carlsbad, CA) was added (to block
hybridization to repetitive DNAs if present on array). One hundred micrograms
yeast tRNA (Invitrogen) was added (to block non-specific DNA hybridization).
Twenty micrograms of poly(dA)-poly(dT) (Sigma, St. Louis, MO) was added (to
block hybridization to polyA tails of cDNA array elements).
The mixture was dried in a Savant Speed Vac Concentrator (Thermo
Electron, Woburn, MA) to a volume of 24pl or less. If less, the volume was
brought up to 24pl total with sterile water. A mixture of 5.1 pi 20X SSC (Fisher
Chemical, Fairlawn NJ) and 0.9pl 10% SDS (Fisher chemical) was added (for a
final conc. of 3.4%SSC and a final conc. of 0.3% SDS).
The hybridization mixture was denatured at 100° C for 1.5 minutes, then
incubated for 30 minutes at 37°C (as a Cot-1 preannealing step). During the 30
minutes, the microarray slide (University Health Network, Toronto, Canada) and
the hybridization chamber were prewarmed to 65°C or 37°C, corresponding to
the eventual hybridization temperature. The microarray slide (GAPII, Coming,
NY) was shipped ready for use, spotted with double stranded DNA as 1718
different ESTs (Expressed Sequence Tags) derived from PCR amplification of
the EST clones which are potential mRNAs. The slide appears as 8 grid rows
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and 4 columns similar to the diagram (Figure 6). Each grid has 10 rows and 12
columns of spots.
The hybridization chamber has a small well in the edge of the lower slide
holder. At the end of the 30 minutes, a 10 pi drop of sterile water was added to
the well to maintain humidity in the chamber. The microarray slide was placed on
the bottom half of the chamber. The probe solution was then added to the center
of the array where the slide is spotted. The final volume of hybridization was
30ul. This volume was appropriate for hybridization under a 30x50 mm2
coverslip. The coverslip was polished with ethanol and dried. The edge of the
coverslip was held at the edge of the drop of the probe mixture and gently
dragged back and laid in place over the microarray with minimal air bubbles. The
top portion of the hybridization chamber was assembled over the slide. The
entire chamber was submerged into a water bath and hybridized overnight (1620 hrs) at either 65°C (following the protocol of Brown,
http://cmgm.stanford.edu/pbrown/protocols/4_genomic.html) or 37°C at the
manufacturer's recommendation. At the end of the hybridization time, the
chamber was removed from the water bath, the chamber's edges were dried, and
the chamber was carefully disassembled so water did not enter the chamber.
The slide was removed and passed through a series of washes in Coplin jars as
outlined in Table XII below. In the first wash (1A) the slide was placed in the
Coplin jar and left undisturbed until the coverslip fell. After the coverslip was
safely removed, a gentle agitation was performed for the allotted time.
It is important that the slides are rinsed well; detergents can form aggregates that
can trap unbound dye. These aggregates can dry on the side and interfere with
interpretation of results. After the series of washes, the slide was spun dry for
one minute in a microcentrifuge equipped with a slide holder. The slide was
either scanned immediately or held in a dark slide box in a desiccator for up to
three days.
Scanning
The microarray slides were scanned using ScanArray® Express microarray
scanner (Perkin Elmer Life Sciences, Boston, MA). Slides were scanned at a
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Table XII. Post-hybridization wash steps
Wash

Vol
Description
(ml)

1A

SDS (10%)

200 ml 2x

0.6 ml

Time/
Temperature
2 min 37°

2x SSC, 0.03%
SDS

SSC

200

or65°C

1B

2x SSC

200

200 ml 2x

—

rinse

2

1x SSC

200

200 ml 1x

- -

2 min 37°

3

0.2x SSC

200

200 ml

2 min 37°
—

0 .2x
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10pm resolution at the appropriate wavelength for the dyes used: Cy3 or Alexa
Fluor 546 versus Cy5 or Alexa Fluor 647. The software package has preset
wavelengths for various fluorophores that are highlighted appropriately. PMT Gain
settings were used that will measure the signal to noise ratio. A good general
starting value is PMT gain of 70-80%. Several settings
were measured and saved so the intensities were available during the
analysis. The spotted portion of the array was defined by moving the mouse to
the edges of the dimensions of the array area.
Quantitation
The software package with Scanarray express assisted with quantitation.
A GAL file (Gene Array List) was supplied with the microarray slide detailing the
contents at each spot, the gene, the corresponding loci, and the accession
number for identification in Genbank (collection of sequences from NCBI - the
National Center for Biotechnology Information). The software package allows for
imaging of each individual spot that can be highlighted in a subarray grid. An
adaptive circle method was used for the software to measure the intensity of
each pixel within a defined spot that is manually circled. In the adaptive method,
the initial spot mask and background mask are constructed as with the fixed
circle method. This method was refined using a modified statistical testing
process (Mann Whitney test) on a pixel by pixel basis. This method compensated
for changes in the spot morphology since not every spot will hybridize as a
perfect circle. Once all spots are highlighted, the software package found the
spots and diagramed each spot on a scatter plot. Normal samples or samples of
equal value should have a 1:1 ratio of each dye. A different PMT gain setting
may be chosen to adjust that ratio as close to 1:1 as possible.
Degenerate Oligonucleotide Primer (POP )
Replicates of 1,5, and 10 lymphoblast cells were collected as decribed
above. The cells were placed into a 0.5ml PCR tube containing the lysis buffer
and neutralized as described above. The reaction contained 2pM DOP primer (5'
- CCGACTCGAGNNNNNNATGTGG- 3', Sigma Genosys, The Woodlands, TX),
200 jiM dNTP mixture, PCR buffer (10mM Tris -H C I pH 9.0, 50mM KCI, 1.5mM
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cells
2 0 cells
2 0 cells
2 0 cells
2 0 cells
2 0 cells
2 0 cells
2 0 cells
2 0 cells
2 0 cells
Control
Control
Blank
20

APC(5)
+

CF(7

o

MDA

CD

Table XIII. PCR amplification after 20 cells were subjected to MDA

SC(11) TSD(15)

ZFX

ZFY

+
+
+

+
+
+

+
+

+
+

+
+

+

+
+
+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+

+
+
+
+
+
+
—

+
+
+
+
+
+
—

+
+
+
+
+
+

+
+
+

+
+
+
+
+
+
+
--

+
+
+
+
+
+
+
—

+

+
+
+
+
faint
faint
—

—

+
—
—

APC = Adenomatous polyposis coli gene on chromosome 5 (5q21-q22).
CF = Cystic fibrosis transmembrane conductance regulator gene on
chromosome 7 (7q 31.2).
DYT = Dystonia gene on chromosome 9 (9q34).
SC = Sickle cell, Rglobin gene on chromosome 11 (11 p15.5).
TSD = Tay-Sachs disease, fc-hexosaminidase A gene on chromosome 15
(15q23-24).
ZFX = Zinc finger region of the X chromosome (Xp22.2-p21.3).
ZFY = Zinc finger region of the Y chromosome (Y11.3).
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Table XIV. Results of PCR amplification after MDA
MDA
# of cells
10 cells
10 cells
10 cells
8 cells
6 cells
4 cells
1 cells*
1 cells*
2 cells
2 cells
3 cells
4 cells
3 cells
1 cell
1 cell
1 cell
1 cell
1 cell
1 cell
2 cell
2 cell
3 cells
1 cell
1 cell
1 cell
1 cell
2 cell
2 cell
3 cell
1 cell
1 cell
1 cell
1 cell
1 cell
1 cell

APC(5)

CF(7)

DYT(9)

SC(11)

TSD(15)

ZFX

ZFY

+

+
+
+
ADO
+
ADO
ADO
+
-

+

+

+

+
+
+
+
+
+
+
-

+
+
+
+
+
+
+
-

+

+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+

ADO
ADO
+
+
+
ADO
ADO
+
+
ADO
ADO
ADO
ADO
+
ADO

+

ADO = allele dropout, only one of the two alleles amplified. * - did not use
additive buffer. (+) represents PCR positive amplification, (-) indicates no PCR
amplification. Blank spaces indicate that those loci were not tested on that cell.
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Mg2+, 0.1% (v/v) Triton X-100 and 0.01% (w/v) gelatin, 2.5 units Amplitaq
polymerase. After an initial denaturation of 5 minutes at 96°C, cycling ensued at
94°C for 1 minute, 30°C for 1.5 minute, then 72°C for three minutes for 8 cycles.
This was followed by 50 cycles of 94°C for 1 minute, 62°C for 1 minute, then
72°C for three minutes. Samples were then cooled to 4°C and held at that
temperature if assayed immediately or stored long-term at 20°C.
7.2 Results for Specific Aim # 4
Initially, 20 cells per reaction tube (n=10 replicates) were subjected to
MDA to determine the reproducibility and reliability of the technique. The samples
were subsequently analyzed by PCR for the seven different loci. Those results
are listed in Table XIII. All 10/10 (100%) showed PCR amplification after MDA,
demonstrating that the MDA reaction was successful at the 20-cell level of
sensitivity. Additionally, seven loci amplified for each of the 10 replicates (100%),
demonstrating that multiple areas of the genome were successfully amplified
(Figure 13).
Three replicates of 10 cells per reaction tube were subjected to MDA and
analyzed by PCR. All samples successfully amplified at all loci tested as
indicated in Table XIV. Subsequently 8,6, or 4 cells respectively were subjected
to MDA, and those demonstrated PCR amplification as well. Results of single cell
amplification were sporadic and only occurred in 11/16 cells (69%). Allele drop
out was seen in 6/11 of the amplified single cells.
DNA Quantitation
Representative samples post amplification were quantified using the Pico
Green Kit. Values for single cells ranged from 2-3.4pg.
Microarravs
Microarray experiments are listed in Table XV with comments on the
hybridization results (Figure 14). After poor hybridization results following the
initial hybridization temperature of 65°C (Microarrays 1 and 2), DNA from an
outside source (MCF7 breast cancer cell line from Dr. Tim Bos of Eastern
Virginia Medical School) was used to confirm the labeling and hybridization
technique. After successful amplification at 37°C, a comparison study was
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Figure 13. Representative gel of PCR amplification after multiple displacement
amplification (MDA). Six single cell replicates for four different loci from each cell
are represented (cystic fibrosis, chromosome 7, zinc finger region of X/Y
chromosome, sickle cell, (i-globin of chromosome 11). An additional restriction
enzyme digest of the ZFX/Y product (not shown here) will determine the
presence of the Y chromosome.
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Figure 14. Microarray resuits. Portions of microarray images illustrating poor
quality (A) versus good quality (B) hybridization. Both image A and B are
composite images of both dyes. Both images illustrate three grids - 10 rows and
12 columns. In poor quality hybridizations, few spots are recognizable and there
is higher background outside the spots. In good quality hybridizations, the
majority of spots are recognized. Some spots are intentionally blank.
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Table XV. Summary of microarray experiments performed
Array
Hyb
#
Temp®

Dyesb

DNA Type/
Quantity

Restriction
Enzyme

Purpose of Expts and comments

Hybridization01

1

65°

Cy3/5

5 cells s/p MDA

Dpnl 20units

Proof of concept

Poor

65°

Cy3/5

5 cells s/p MDA

Dpnl 40units

Increase enzyme for smaller DNA
fragments

Poor

2
3

37°

Cy3/5

genomic s/p MDA

Dpnl/EcoR1 20units

Some
Poor

4

65°

Cy 5

MCF7 DNA 5 ug

Dpnl/EcoR1 20units

Increase enzyme;change hyb temp,
use of 'proven' DNA, no WGA,
compare hyb temp
use of 'proven' DNA, no WGA,
compare hyb temp
optimized conditions, 2 dyes, proven
DNA
optimized conditions with 10 cells,
MDA, 1 dye
optimized conditions, 1 cell, MDA, 1
dye
optimized conditions, 1 cell, MDA ,2
dyes, cells combined/split
optimized conditions, 1 cell, MDA ,2
dyes, cells combined/split
Optimized condition, Alexa Fluors

5
6

37°
37°

Cy 5
Cy 3/5

MCF7 DNA 5 ug
Bos DNA 5 ug

Dpnl/EcoR1 20units
Dpnl/EcoR1 20units

7

37°

Cy 3

10 cells s/p MDA

Dpnl/EcoR1 20units

8

37°

Cy 3

1 cell MDA 2ug

Dpnl/EcoR1 20units

9

37°

Cy3/5

1 cell each 3ug

Dpnl/EcoR1 20units

10
11

37°
37°

Cy 3/5
1 cell each 2.4ug
546/647 1 cell each 3.1 ug

Dpnl/EcoR1 20units
Dpnl/EcoR1 20units

Good
Good
Weak
Weak
Some
Poor
Strong
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Table XV (continued)

Array Hyb
#
Temp25 Dyesb

12

37°

13

37°

546/647

14

37°

546/647

15

37°

546/647

546/647

DNA Type/
Quantity

1 cell each 3.4pg
1 ceil 3.4 ug/
MDA neg
DOP 10 cell/
DOP neg
PEP 5 cell
each - 1ug

Restriction
Enzyme

Purpose of Expts and comments

Dpnl/EcoR1 20units Repeat above - strong
hybridization
Dpnl/EcoR1 20units Test 'neg' MDA
Dpnl/EcoR1 20units Compare DOP with MDA
Dpnl/EcoR1 20units

Test PEP cells
no hybridization

Hybridization21

Strong
Sample- strong
Negative - strong
DOP-strong
Negative -none
None

aHyb temp = Hybridization temperature, bDyes = dyes in labeling Cy 3/Cy5 or Alexa Fluor 546/Alexa Fluor647, CDNA
type/quant - cells were lymphocytes at the quantity indicated except for the MCF7 DNA, which was proven hybridizable
DNA from a cancer line, dExamples of'poor' and 'good' quality hybridizations are shown in Figure 17.

GJ
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performed at 37°C and 65°C. The 65°C array was initially chosen based on
other Array-CGH protocols. However, no hybridization occurred at 65°C in our
studies so the lower stringency of the 37°C was used, resulting in successful
hybridization. Subsequent experiments were performed at 37°C.
Concurrently, the amount of restriction enzyme used to cut the post-WGA
fragments was increased. Poor hybridization was seen after the initial use of 20
units of Dpnl; that amount was doubled with no improvement of results.
Subsequently, an additional restriction enzyme, 20 units of EcoRI was added at
the time when other variables were changed as well. With successful
hybridization results, both enzymes were used for the remaining experiments.
After these initial changes in experimental conditions, the use of MDA
cells continued as in Microarray 7. Two samples were combined and equally split
so that there would not be variation from sample to sample. For example, a
single cell sample and a single cell sample were combined, the DNA measured,
then the sample was equally split and labeled separately. Those arrays still
exhibited weak or minimal hybridization.
Next, the Alexa Fluor dyes were used for the labeling process instead of
the Cy dyes. Microarrays 11 and 12 exhibited strong hybridization signals.
Non-specific DNA is generated after MDA that had minimal amounts of
starting template due to the random primers that are available in the reaction to
amplify fragments of DNA. To test the impact of the non-specific amplification, a
reaction tube that contained only reagents and no template DNA was subjected
to MDA. This 'negative' sample was subsequently assayed by PCR and yielded
no PCR amplification in the seven loci tested. However, due to the nature of DNA
fragments on the microarray, a test was designed to determine if the non-specific
DNA interfered with hybridization. Microarray 13 (Figure 15) shows the results
when a single cell post-MDA was labeled with Alexa 546 and the MDA negative
control were labeled with Alexa 647. Both the sample and the negative control
showed hybridization, indicating that the negative DNA samples did indeed
hybridize to the microarray slide.
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Figure 15. Microarray experiment with Alexa Fluor Dyes. Composite photo of
the microarray results in experiment 13 after multiple displacement amplification
(MDA). The single cell sample post- MDA is labeled with Alexa Fluor 546 while
the sample subjected MDA without added DNA (MDA negative) is labeled with
Alexa Fluor 647. There is a composite from both dyes even though the MDA
negative contained no template DNA. This demonstrates the hybridization of
non-specific DNA generated from the MDA process.

Figure 16. Composite of Microarray 14 with samples from Degenerate
Oligonucleotide Primers (DOP). A ten-cell sample was labeled with Alexa Fluor
546 while a DOP negative containing no template DNA was labeled with Alexa
Fluor 647. In contrast to the sample without starting template (negative) after
MDA in Figure 15, no hybridization was seen with the DOP negative and the
composite to be of uniform color. These results suggest that DOP-generated
products may have a use for future microarray experiments.
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Figure 17. A composite of microarray 15 after single cells were exposed to
primer extension preamplification (PEP). It is difficult to determine where the
spots of the array begin due to the increased background intensity. These results
suggest that PEP by itself is insufficient to generate enough DNA for
hybridization.
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Table XVI. Results of PEP/MDA experiments using single cells

PEP duration
(cycles)

MDA
Duration
(hours)

PEP
volume
used for
MDA

Final PEP
reaction
volume

PEP/PCR
amplification
result of
remaining
sample

PEP/MDA
PCR
amplification
result

50 cycles
(PEP control)

N/A

N/A

60pl

5/10 = 50%

N/A

4 cycles

10 hours

5pl

60jnl

N/A

0/5 = 0%

4 cycles

10 hours

5pl

30pl

N/A

0/5 = 0%

4 cycles

12 hours

5pl

60pl

1/3 = 33%

0/3 = 0%

4 cycles

12 hours

5jxl

30pl

0/3=0%

0/3=0%

10 cycles

10 hours

1pl

60pl

3/5 = 60%

0/5 = 0%

50 cycles

10 hours

5pl

60pl

3/3 = 100%

0/3=0%

N/A = not applicable.
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To determine if the negative sample hybridization was an artifact of the
actual MDA process, a similar experiment was conducted with a sample using
DOP-generated DNA and a DOP negative. Microarray 14 (Figure 16)
demonstrates that the DOP sample hybridized with strong signals while the DOP
negative did not, indicating that the artifact was probably generated from the
MDA process.
Non-specific DNA presumably does not interfere with larger quantities of
starting template in the MDA process since the majority of the reagents will have
template to react with. To compensate for the effect of the non-specific DNA,
experiments were designed that involved the use of PEP to initially produce
several starting copies of the single cell template prior to the initiation of MDA.
Previous experiments demonstrated the effective use of PEP. Microarray
15 (Figure 17) shows the results of using cells after PEP for the microarray
hybridization. No hybridization was seen. The results of those experiments are in
Table XVI. No subsequent PCR amplification was seen in these combination
experiments.
7.3 Discussion for Specific Aim # 4
Cytogenetic techniques allow for the assessment of chromosome
numbers. Classical techniques of karyotyping have given way to newer
techniques such as FISH and CGH. These techniques have been used
successfully to diagnose certain chromosomal aneuploidies in oocytes and
embryos (Delhanty et al., 1993; Munne et a!., 1998b; Verlinsky et a l, 1998;
Wilton et al., 2001, Wells and Delhanty, 2000). FISH is limited to analysis of a
small number of chromosomes (Delhanty et al., 1993; Munne et al., 1998b;
Verlinsky et al., 1998). Interpretation of results can be difficult due to signal
overlap or loss of hybridization signals (Wells and Delhanty, 2000). A major
limitation of CGH is that the technique takes almost 72 hours to complete and
requires the use of metaphase chromosomes. (Wilton et a/.,2001; Wells and
Delhanty, 2000). Microarray technology (array CGH) is emerging as another
molecular technique that can be used to assess chromosome number. Array
CGH can detect all chromosomes, is easier to perform than conventional CGH,
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and does not require metaphase cells (Oostlander et al., 2004). The purpose of
this study was to determine if array CGH can be used to assess chromosome
number in single cells. The work is ongoing as techniques are continually
evaluated.
Initially, the focus of these experiments was to identify a WGA strategy
that would provide an adequate amount of DNA for hybridization in array CGH.
MDA appeared to be an attractive WGA technique because it is a simple
isothermal reaction and reported to amplify up to 35pg quantities of the genome
from a single cell (Handyside et al., 2004; Hellani et al., 2004). Our quantitation
results from a single cell were approximately ten times less than those reports
although still ample amounts to be used in array CGH. Additionally, our results in
single cells were inconsistent, and amplification was seen less than 70% of the
time with half of the cells showing absence of one allele. The reasons that these
results differ from those of other investigators are unclear. One possible
explanation is that there could be DNA degradation in the lymphoblast samples
that were used in these experiments. Another possible explanation is that,
although our protocols and those of Handyside et a/.(2004) and Hellani et al.
(2004) all use the MDA technique with 0 2 9 polymerase, our laboratory used a
different commercially available kit (GenomiPhi™, Amersham Biosciences) than
did other researchers (Repli-G™, Molecular Staging). The differences between
these kits are not known since information regarding reagent concentrations and
quantities is proprietary. The GenomiPhi™ kit was the only kit available when
these studies were initiated, and Repli-G™ was primarily available overseas
where the other studies were conducted. Repli-G™ is now widely available in the
United States, and trials in our laboratory using that kit for MDA are in progress.
Additionally, 0 2 9 polymerase is now commercially available without purchasing
the corresponding reagents. This would allow for more flexibility in optimization
trials. However, the essential components of the reaction will need to be
determined by trial and error; there is little information in the literature to
determine the foundation for MDA protocols outside the use of supplied kit
reagents.
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Nonetheless, even with our WGA results, many of the initial experiments
were deemed proof-of-concept that there were adequate quantities of DNA in
samples that did amplify post-MDA to continue to the array CGH phase. There
were no published protocols for the use of array CGH in single cells at the time
these experiments were initiated so the knowledge of optimal conditions was
limited. Microarrays can cost hundreds of dollars and contain hundreds to
thousands of gene sequences. In addition to cost, the choice of arrays to use in
initial experiments was made based on the reputation and results of the providing
institution. Literature searches provide array CGH protocols with 65°C
hybridization temperatures. That appeared to be a foundation for the protocol
here since higher temperatures translated into higher stringencies; single cell
analysis most certainly requires higher stringencies. However, after two
experiments with poor hybridization results, the hybridization temperature was
changed to 37°C, in accordance with the manufacturer's protocols that were for
standard microarray and not array CGH. Some hybridization signals were seen
at the lower temperature; this prompted a side-by-side temperature comparison
at 37°C and 65°C of two arrays that contained aliquots of the same labeled
sample. In those results, the 37°C exhibited stronger hybridization signals and
was used from that point forward. The 37°C temperature theoretically decreases
the stringency of the reaction; further optimization experiments will determine if
this change has compromised the results and could be the cause of non-specific
binding.
Concurrent with the hybridization temperature change was the addition of
another restriction enzyme to cut the post-MDA product. MDA products can be
as large as 10 kb while the microarray slides are spotted with cDNA fragments
that are generally less than 1kb. A restriction enzyme is used after MDA to
randomly reduce the size of the fragments so that the MDA products are
theoretically not larger than the target DNA on the slide. Initially, Dpnl was
chosen as the restriction enzyme for these experiments. Dpnl recognizes the
sequence GATC and is thus called a '4-cutter', that is, there is a one in 4 chance
that a particular nucleotide will be in a specific position in a DNA sequence and
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this enzyme recognized 4 nucleotides. Theoretically, this sequence should
appear once every 44 or every 256 bases. Four-cutters are used to produce
many small fragments of DNA (Lucito et al., 1998). The first microarray in our
experiments did not hybridize. It was not certain if enough restriction enzyme was
used and the DNA fragments were still too large. Therefore, the amount was
doubled for the next experiment. After another poor hybridization, the
hybridization temperature was changed; concurrently another restriction enzyme,
EcoRI, was added. EcoRI recognizes the sequence GAATTC and is therefore a
6-cutter. Theoretically, the recognized sequence should be present every 46
times or every 4096 bases and would produce larger fragments than the Dpnl.
However, it is possible the Dpnl may actually 'over' cut the sample and cut
essential sequences that recognize the target DNA on the array. Since the
addition of the EcoRI enzyme occurred in the same successful hybridization
experiment as the temperature change, it is not known if the effect was a result of
the temperature change or the new enzyme. This could easily be ascertained by
reverting to one and then subsequently the other previously used method of
enzyme and temperature; these experiments should be performed in the future.
There are many variables in experimental conditions that could also affect
the results including the labeling procedure. The next set of experiments used
DNA from a MCF7 cancer cell that has been successfully hybridized to other
microarrays containing suspected cancer genes. This experiment was conducted
to ascertain if the labeling and hybridization conditions were sufficient to produce
strong hybridization signals and demonstrated that the techniques were
successful for at least 5pg DNA. However, less than 5pg DNA was obtained from
our single cells. The next several attempts at array analysis with similar
conditions using the known cell line did not have consistent results and
hybridizations were weak for the most part. This prompted the switch from the Cy
dyes to the Alexa Fluor dyes since the Alexa Fluor dyes are much more efficient
at labeling and showed higher fluorescent intensity than the Cy dyes (Berlier et
al., 2003). From that point on, strong hybridization signals were seen. This may
be due to the lower resistance to photobleaching seen in the Alexa Fluors. This is
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the first report of the use of Alexa Fluors in single cell analysis. Further
optimization could determine if stronger hybridizations will contribute to their
future use as a preferred dye for labeling.
Phi-29 polymerase is a robust enzyme that can yield higher quantities of
DNA than the standard WGA techniques of PEP or DOP and can provide reliable
representation of the genome (Hosono et al., 2003). Our results support those
findings as demonstrated by the microgram quantities recovered and by the
ability to amplify at least seven loci from a single sample. However, one limitation
of the robust <1>29 is that the enzymatic reaction can create non-specific DNA
products. These are products that randomly amplify segments of bases, even if
no starting template is added to the reaction, due to excess polymerase and
dNTPs in the reaction. Short sequences of DNA can be created that are not
complementary to any specific gene sequence. Low quantities of starting
template could theoretically promote the generation of the non-specific
sequences since there is little template for the reagents to bind to in the initial
phase of the amplification. This does not interfere with subsequent PCR
reactions as evidenced by the lack of PCR amplification. However, there was a
possibility that these sequences would hybridize to the microarray, especially
after restriction enzyme digest into smaller fragments that could anneal to the
DNA targets on the array. An experiment was conducted that demonstrated
these samples could in fact hybridize to the arrays and thus could invalidate the
microarray results by not being able to differentiate between hybridization of true
DNA versus non-specific DNA.
To answer the question if the non-specific hybridization was an artifact of
the MDA technique versus other WGA techniques, samples that were amplified
with either PEP or DOP (as the sole WGA) were labeled and hybridized to the
array along with a negative control exposed to the respective WGA procedure
that showed no PCR amplification (Figure 16). The PEP samples showed poor
hybridization results; this was thought to be due to the low overall quantity of
DNA that was less than 1fig. The DOP-amplified sample did show strong
hybridization signals while the DOP-negative (no template DNA) did not. These
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results suggest that the hybridization of non-specific DNA seen after MDA may
indeed be an artifact of the MDA technique and not of other WGA methods. With
a larger template, MDA generally provides a higher representation of the
genome, but due to the non-specific nature of the low-copy template
amplifications, further research into the use of DOP as an alternative WGA
technique may be warranted.
The possibility that the excess hybridization was an artifact of the stronger
Alexa Fluor dyes was successfully minimized since the negative DOP samples
did not hybrid even when labeled with one Alexa Fluor while the DNA-containing
sample demonstrated strong hybridization signals. There is little scientific basis
to suggest that the dyes could be a cause of non-specific hybridization, but the
possibility of that occurring could concomitantly be ruled out nonetheless.
In attempts to overcome the creation of non-specific DNA, several cycles
of PEP were attempted and an aliquot was removed, then subjected to MDA.
This was performed to enable the MDA reaction to begin with higher quantities of
template DNA than what would be otherwise initially limited from a single cell.
With the higher quantity of DNA in the starting MDA reaction, it was surmised
that less non-specific DNA would be amplified since there is more target
available for the 0 2 9 polymerase to anneal to. Unfortunately, the initial attempts
at amplifying DNA with PEP then MDA failed to demonstrate subsequent PCR
amplification at the attempted volumes and concentrations. The reason for failure
could be as simple as sub-optimal reaction conditions since there are many
variables in both reactions that must be compensated for including differences in
reaction volumes, concentration of reagents, and cycling conditions. Both PEP
and MDA use an alkaline lysis method for template preparation. The PEP
product was not subjected to further lysis since those components will remain in
the aliquot used for MDA. Excess reagent conditions such as potassium and
magnesium can lower amplification efficiencies (Rolfs et al., 1992). It is difficult to
ascertain reagent concentrations due to the proprietary nature of the MDA kit;
reagent concentrations cannot be adjusted accordingly to identify optimal
conditions. PCR clean-up kits such as the QiaQuick kits that are used after a
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complete MDA might have a role in optimization. PCR purification kits remove
components less than 100 bp while recovering 90-95% of the DNA. This could
remove any remaining random hexamers from the PEP reaction, but would not
be effective for removing other reagents in the reaction. Further investigations
into optimization of these variables are warranted as well.
Microarray containing spotted oligonucleotides or bacterial artificial
chromosomes (BAC) are also available. Although oligo arrays have the
advantage of also providing genotyping data as well as DNA copy number (which
could be advantageous in PGD cycles), they appear to have a higher degree of
variability than do the BAC arrays; accurate genotyping has been reported while
changes in chromosome number were not reliably detected which may rule out
their use in our aneuploidy research (Bignell et al., 2004). BAC array CGH is an
alternative to the cDNA arrays as BAC clones are becoming more widely
available (Cheung et al., 2001). Genomic DNA can be cloned in BAC vectors
and spotted onto arrays; the BAC clones serve as a more stable environment for
large fragments of DNA (Shizuya et al., 1992). The preparation of the BACs can
be problematic since BAC cultures yield very low quantities of DNA. Additionally,
it is difficult to maintain ample concentration of DNA to spot the array (Snidjers et
al., 2001). Once these obstacles are overcome, the BAC arrays yield more
intense signals and are superior over the cDNAs at detecting single chromosome
gains and losses (Segraves et al., 2003; Guillaud-Bataille et al., 2004). As a
supplement to the experiments here, two attempts were made at BAC array
hybridization; no signal was detected (data not shown). Although the
manufacturer recommends sophisticated hybridization stations that are not
currently available at our facility, further study is warranted to optimize the
conditions for the use of BAC arrays.
7.4 Conclusions for Specific Aim # 4
These experiments in Specific Aim # 4 lay the foundation for future
experiments as suggested above to continue optimization of the use of
microarrays for single cell analysis. From the results obtained, several
conclusions can be drawn:
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1) MDA can generate microgram quantities of DNA from a single cell
2) Alexa Fluor dyes can be used to produce strong microarray
hybridizations
3) DOP may be a substitute for MDA as the WGA prior to microarray
analysis
It appears that post-MDA samples are not optimized at this time for microarray
analysis due to the generation of non-specific products. However, the larger
quantities of DNA may have other applications that would allow for multiple loci to
be analyzed from a single sample. This could include experiments for DNA
fingerprinting or sequence analysis, which require large amounts of starting DNA
(Fiorentino et al., 2004).
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SECTION 8
SUMMARY
PGD is an option that allows at-risk couples to have their embryos
evaluated for genetic diseases prior to the establishment of pregnancy. The
adaptation of PCR methodologies to amplify DNA from a single-cell has resulted
in limitations of sensitivity and specificity for a technique that was designed for
larger amounts of starting template. The studies presented in this dissertation are
part of an ongoing process to evaluate the sensitivity and specificity, and
optimize single cell diagnosis. Reproducible and reliable single cell diagnoses
can be achieved, and the limitations can be overcome. The development of these
methodologies can be costly and time-consuming, but are of the utmost
importance for a clinic offering the technology of PGD. The knowledge gained
from these studies has contributed both to the direction of research and clinical
applications in the field.
From these experiments, the following conclusions were made:
Specific Aim #1: The process of whole genome amplification and subsequent
PCR testing can be performed as a means of rescuing samples that previously
failed to amplify in initial tests of PCR. The time involved to perform these tests
limits the use of the PEP protocol initially, but the method still can serve as an
alternative if amplification fails and the genetic status of the embryo is not known.
This could abrogate the need to re-biopsy the embryo since an additional noninvasive technique is used to obtain the genetic answer. In addition, these
studies laid the foundation for the clinical application of a reamplification
procedure assessing a different genetic locus that resulted in the embryo transfer
of male embryos whose previous genetic status was unknown in an at-risk Xlinked carrier. The studies of Specific Aim #1 introduced a novel method to
achieve a genetic diagnosis from previous amplification failure in a single cell
(Gibbons et al., 1995b). The techniques have been applied to embryos about
which little was previously known in order to provide further genetic information.
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Specific Aim #2: Different lysis techniques can affect both the sensitivity and
specificity of single cell diagnosis. The KOH lysis method produced a
significantly higher rate of amplification and higher accuracy when compared with
the other methods tested. Using this method, there was no statistical difference
in amplification rate and diagnostic accuracy when testing one versus two cells.
These studies also demonstrated the importance of optimizing the PCR
conditions by evaluating heterozygous cells that contain both alleles so that the
incidence of ADO can be assessed. The study for Specific Aim # 2 was one of
the first and certainly the most comprehensive study investigating different lysis
buffers and their effect on sensitivity and specificity of single cell analysis. Most
PGD clinics today use the alkaline lysis buffer protocol and have referenced
these studies (Gitlin etal., 1996).
Specific Aim #3: This set of studies demonstrated the importance of biopsying a
blastomere with a visible nucleus. The integrity of the blastomere membrane or
the integrity of the cytoplasm itself does not affect the amplification results if the
nucleus and nuclear membrane remains intact. The studies for Specific Aim # 3
have provided insight to the optimal blastomere morphology for the improved
chances of successful amplification (Gitlin et al., 1997). Blastomere morphology
continues to be the preferred method for blastomere selection prior to biopsy.
Specific Aim # 4 : From the results obtained, several conclusions can be drawn:
1) MDA can generate microgram quantities of DNA from a single cell
2) Alexa Fluor dyes can be used to produce strong microarray hybridizations
3) DOP may be a substitute for MDA as the WGA prior to microarray analysis
The experiments for Specific Aim # 4, though preliminary, lay the
foundation for future experiments as the field of detecting chromosome number
expands to include the use of array CGH.
The technology used in PGD is rapidly evolving. New gene sequences
and mutation analyses will increase the repertoire of conditions that can be
diagnosed. With continuing studies to optimize sensitivity and specificity, one
could imagine the future ability to obtain a complete chromosome or genetic
profile from a single cell using microarray technology. Other advances could be

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

128
in the direction of stem cell research and/ or gene therapy. Currently embryos
that are diagnosed as affected are not transferred to the uterus. Most couples
discard those embryos although some elect to have them cryopreserved in the
event that future technology may enable their transfer to initiate a pregnancy.
Technologies for gene therapy and/or embryonic stem cells may provide a
promising role in the study of human diseases and the possibility to actual correct
the cause of these devastating medical conditions.
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APPENDIX A
PRIMER DESIGN REPORT
Molecule Name: TAY SACKS 11

4 9 4 BPS

Report Date: 0 2 /0 5 /0 5

PCR Primer Design Report

----
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-—

--

5 ’-GCCAGACACAATCATACAGG -3 *
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— —
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P R I M E R

-—
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Energy cutoff: 0 ,0 keal;
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-
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-■---------------
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Figure 18. Primer design report. Primer design reports are software generated
after sequence and preference input, in this case for Tay-Sachs disease.
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APPENDIX A (continued)
Largest Duplexes reported in Primer Interactions

Priffier-Mmers with 3* end involvement:

Left:Left:
l s •-G e c m & c h c m 'm & 'r& c m G -i ’
L

3 ’-SGAC&mCTAACACAGACCG -3'

Right:Right:
R 5 1-CMCAaCAGTClSeTCATOG- 3 '
R

3 '- G @ m G T G G T ^ 3 W m c m C - S *

Left:Right:
L 5'-GCCAGACACAATCATACAGG-31
R

3 '-GGTAGlGGTCTOftCMCAAC-- 5 ■

Other Primer-Mmera:

Left:Left:
L
L

5 1-GCCAGAChCAATCATACAGG-3’

3 ’-GGACATACTAACACAGACCG-S ’

Right:Right:
R 5 *-CAACAACAGTCTCGTGATGG-31
R

3 * - GGTAGTCG'TCreACMCAAC- 5 *

Left slight:

L 5' -GCCaGACACM.TCI.TACftSG-3'

R

3 >-S®raflTCGTcisft.CA&CAAC- 5 ’
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APPENDIX B
CONTAMINATION CONTROL
As a complement to the experiments reported here in this dissertation,
extraneous DNA contamination was simulated by adding genomic DNA into PCR
reaction tubes containing 60pL sterile water overlaid with oil (Gitlin and Gibbons,
1995). Tubes were placed in 4 typical PCR lab settings under conditions of timed
exposure to UV germicidal lighting at 254nm: 1) bench top
2 ) microcentrifuge tube rack (tubes were placed in rack as normal)
3) inside a glass beaker, closed with aluminum foil (used for sterilization)
4) inside a plastic beaker (used for storage). Tubes were removed from UV
exposure after 10, 20, 30, 60, 90, 210 minutes and 14 ,18 hours (simulating
overnight irradiation). Ten or twenty tubes were assigned to each datum point
although some data points were not collected if the results were anticipated to be
repetitive. After exposure, all samples along with non-exposed control tubes
were analyzed for a known DNA sequence by nested PCR for greater sensitivity.
PCR was carried out as previously described in the Materials and Methods
section. Fisher's exact statistical test was used to compare results of
amplification for the different genes used. The computer program GRAPHPAD
INSTAT (Graphpad Software, San Diego, CA) was used to assist in analysis.
Results for the UV light exposure studies are shown in Table XVII and
Figure 19. All non-exposed control samples (n=20) demonstrated amplification
at all time durations as expected. A decrease in amplification rates was seen in
the bench top specimens in as little as 10 minutes after UV exposure. Even
though 75% of the samples amplified, the decrease over the 100% amplification
rate of the controls was still significant (P = 0.0471). A 30-minute exposure
completely eliminated PCR amplification in the bench top samples.
Thirty-minute exposure was not sufficient to irradiate the DNA from PCR
tubes that were in a housed in a PCR rack or glass beaker. However, PCR tubes
that were in a plastic beaker for 30 minutes began to display the significant
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APPENDIX B (continued)

effects of UV irradiation and only 40% of those displayed PCR amplification (P =
0.004). It required more than one hour for samples held in the PCR rack to
exhibit the effects of the UV exposure. At one hour, there was 100%
amplification while after a three hour, thirty minute exposure, there was a slight,
but not significant decrease in amplification rates to 85%. Significance was
achieved after a longer exposure that ranged between 3.5 hours to 14 hours. At
14 hours (simulating overnight exposure), the samples in the PCR rack amplified
at a significantly lower rate than the non-exposed controls (20% versus 100%
respectively, P<0.001).
The DNA samples in PCR tubes housed in a glass beaker did not show a
decrease in amplification rates, even after an 18-hour exposure.
These studies were undertaken to minimize the risk of contaminating
DNA. From this set of studies, we conclude that a 30-minute exposure to
ultraviolet irradiation is sufficient to decontaminate most bench top and other
surfaces in the PCR lab. However, caution must be exercised when relying on
UV irradiation, as some laboratory settings will not be affected. The inability of
the UV radiation to penetrate glass should be considered when storing sterile
tubes and reagents in these types of containers.
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APPENDIX B (continued)
Table XVII. Amplification results after timed UV exposure

Time of

Amplification

Amplification

Amplification

Amplification

exposure

of Sample on

of Sample in

of Sample in

of Sample in

Benchtop

Plastic Beaker

PCR rack

Glass Beaker

Time Zero

20/20a,b,c'd’e

(controls)

(100%)

10 minutes

15/20a (75%)

N/A

N/A

N/A

20 minutes

9/20 (45%)

N/A

N/A

N/A

30 minutes

0/ 1 0 (0%)

4/10b (40%)

N/A

N/A

1 hour

N/A

4/20 (20%)

10/ 10° (100%)

10/ 108 (100%)

1.5 hours

N/A

7/20 (35%)

10/ 1 0 (100%)

10/ 1 0 (100%)

3.5 hours

N/A

3/20 (15%)

17/20 (85%)

10/10 (100%)

14.5 hours

N/A

0/ 1 0 (0%)

2/ 10d (20%)

10/ 1 0 (100%)

18 hours

N/A

0/ 1 0 (0%)

3/10(30% )

10/ 10e (100%)

a P = 0.0471.
b P = 0.004.
c,eno significant difference.
d P <0.001.
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Table XVIII. Basic guidelines for quality control
•

Perform Pre- and post- PCR in separate rooms.

•

Maintain sterile/DNA-free techniques.

•

All reagents should be aliquoted for single-use where possible.

•

Centrifuge aliquots prior to use and use microcentrifuge tube opener.

•

Wear caps, masks, gloves. Change Often

•

Restrict PCR laboratory access to minimize traffic.

•

Autoclave and filter water, buffer, oil, etc.

•

Designate aliquoted reagents for clinical use.

•

Randomly test in PCR.

•

Use forceps to handle tubes, use lid openers, etc.

•

Use positive displacement pipettes or use aerosol resistant tips with
standard pipettors

•

Clean and decontaminate lab surfaces, instruments, racks, etc. with 10%
bleach or UV lights.

•

Use underpads or liners on benchtop surfaces for easier containment and
clean-up.

•

Save remaining aliquots of all materials for reference.
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•g
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—i— rack

- s — glass

Figure 19. The effect of Ultraviolet irradiation. Reaction tubes containing DNA
were placed in four common PCR lab settings and time-exposed to UV lights
mounted 18 inches above.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

155

APPENDIX C
STATISTICS
The materials and methods section for each set of experiments lists the
statistical method that was applied for data analysis. The P value is the
probability that a study will show a statistical significance when no real difference
exists (Dawson and Trapp 2004). This is known as a type I error - that a true
null hypothesis (the hypothesis being tested) is rejected or that a difference is
detected when a difference does not truly exist. A P value less than 0.05 means
that there is less than a 5% chance of a type I error - that the results show a
false statistical difference. Thus, the lower the P value, the greater the statistical
significance.
Another aspect of experimental design is power analysis, or the
determination of the ability of the statistical test to an actual difference of effect
(Dawson and Trapp 2004). This is in relation to a Type II error - a false null
hypothesis is not rejected or a difference is concluded when a difference does
not exist. The power is calculated as (1 minus a type II error, or 1-p). This
relates to the number of samples needed to detect a statistical significance when
one truly does exist.
The main statistical test used in this dissertation is Fisher's exact test. This
is used when the sample size is too small for the Chi-Square analysis. An
explanation of both follows. It was Ronald Aylmer Fisher in 1922 that defined
three fundamental issues of statistics:
1) specification of the kind of population that the data came from
2) estimation (choice of the method to calculate)
3) distribution (Fisher 1925).
Fisher arranged experiments into sub-experiments that differ from each other by
several factors, treatments, or other variables. The differences could then be
detected by statistical outcomes; this advance allowed for greater flexibility in
experimental design and allowed for more than one experimental variation rather
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than the inefficient existing approach at the time of only varying one technique at
a time.
Chi-Square is used to test the hypothesis that all classifications or factors
have the same level of frequency or distribution (Armitage 1994). Chi-Square
tests are appropriate for actual numbers of occurrences, not on percentages,
proportions, means of observations, or other derived statistics (Swinscow 1997).
This is one reason why Chi-Square (and Fisher's exact test) are the most
suitable for statistical computation here. Chi Square is an approximate and
versatile test in that it does not matter how a question is stated - it measures the
observed versus the expected frequency. Although most statistical computations
are now calculated by computer software packages, the calculation for Chisquare (x2) is listed in Equation 6.
X2(df) = S (Observed frequencv-Expected frequency)2
Expected frequency

(6)

df= degrees of freedom, calculated as d f= (r-1 )(c-1), the number of rows minus
one times the number of columns minus one (Dawson and Trapp 2004).

Yates correction may be applied to a 2x2 contingency table (Dawson and
Trapp 2004). This correction involves subtracting half the difference between the
observed and expected frequencies before squaring. This makes the x2 value
smaller. Smaller %2 are attractive because it means that the null hypothesis is
rejected less often; thus, it is a more conservative test. Going back to the
definitions, this reduces the chance of a Type I error, although it does increase
the chance of a type II error.
The following demonstrates a 2x2 contingency table used to calculate if
there is a difference in a treatment group, as in the dissertation when a different
lysis method is used. The difference between Chi-Square and Fisher's is
calculated in Table XIX.
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Table XIX. Example of contingency table for statistical calculation

Amplification

No Amplification

Total

Control

a

b

a+b

T reatment

c

d

c+d

Total:

a+c

b+d

a+b+c+d=n

Where Chi-square =
y 2(rif) - 2 (Observed freauencv-Exoected frequency)2
Expected frequency
Following the table:
X2(1) = ......... n(ad-bc)2
(a+c)(b+d)(a+b)(c+d)

And Fisher's exact test is:
P = (a+b)!(c+d)!(a+c)!(b+d)l
alblcldln!
where ! is the symbol for factorial (n-1 )(n-2), etc., (Dawson and Trapp 2004).
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As previously stated, a 2x2 frequency table with small numbers of expected
frequencies (in case the total number of observations is less than 20) should
have the statistics calculated differently. Fisher’s exact test should be used rather
than the Chi-Square. Many times, the computer software will apply the most
appropriate test when the sample size is in question.
There are other statistical tests that compare two data sets as does the
Chi-Square and Fisher's exact (Dawson and Trapp 2004). One is the
Kolmogorov-Smirnov test (KS-test); however, it is not as sensitive. Fisher's exact
test is more appropriate since it retains more power with small sample sizes.
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APPENDIX D

LIST OF COMMON ABBREVIATIONS USED
A
ADO
BAG
Bl
bp
BSA
C
CF
CFTR
CGH
DNTP
DOP
DTT
FISH
G
H20
ICM
IVF
kb
KCI
ln2
MDA
mFISH
Mg2+
MgCI2
PB
PBI
PBII
PCR
PEP
PGD
SDS
SKY
SSC
T
Taq
TE
T
m
TSD
UV
WGA

Adenine
Allele drop-out
Bacteria artificial chromosomes
Boiling
Base pair(s)
Bovine serum albumin
Cytosine
Cystic fibrosis
Cystic fibrosis transmembrane conductor regulator gene
Comparative Genomic Hybridization
Deoxynucleotide triphosphate
Degenerate oligonucleotide primers
Dithiothreitol
Fluorescent in situ hybridization
Guanine
Water
Inner cell mass
In vitro fertilization
Kilobases
Potassium Chloride
Liquid Nitrogen
Multiple displacement amplification
Multifluor fluorescent in situ hybridization
Magnesium
Magnesium chloride
Polar body
First polar body
Second polar body
Polymerase chain reaction
Primer extension preamplification
Preimplantation genetic diagnosis
Sodium dodecyl sulfate
Spectral karyotype analysis
Saline-sodium citrate
Thymine
Thermus aquaticus
T rophectoderm
Melting temperature
Tay-Sachs disease
Ultraviolet
Whole genome amplification
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APPENDIX E
Permissions

Neil Winegarden
University Health Network
Fax:416-340-4004
March 9,2005
I am writing to request permission to reprint the cartoon figure from your website
that shows the array layout of the grids and rows.
If permission is granted, the figure will be used as background information in my
Ph.D. Dissertation “Developing and Optimizing Conditions for Single Cell Genetic
Analysis* through Old Dominion University/Eastern Virginia Medical School. The
dissertation is copyrighted material and I am only seeking permission for this
body of work.
Appropriate reference and acknowledgement will be made to the figure.
Thank you for your consideration. If this is agreeable to you, please sign below
and return to me by fax 757-446-8998 or mail to 601 Colley Avenue #316,
Norfolk, VA 23507.

Sincerely,

Susan A. Gitlin, PhD candidate

forementii

Figure

Comments:
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Sent:

Gloria Batista igloria,batlsta@am®!Bham,eQm!
Wednesday., tflarcb 30,. 200512:10 m

To*.

gptKnsa@ewn9.edu

From:

Ce:

Gloria Batiste

Sulfect:

Permission

TS

genomipM rev at>

2im,qaf

SEND TO:

gfflmsa@evms.edu

SUBJECT:

Permission

TRACING NUMBER:

ALIS-6AXSX3

Dear Dr, Gitllrt:
I understand that i cars ghre permission fcr yon to use pJ of the 28page
document of the GenomipM manual to be used in your dissertation as long
as we are given credit for it.
{See attached file: genomtphi rev ab 2004. pdf|

Gloria Batista
Technical Consultant
GE Healthcare (formerly Amersham
BfosctencesS
Pb 800-528-3593 Ext 8856

Fax 732-457-8643
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01770

te le p h o n e : 9 7 8 -4 4 3 -5 0 0 0 fa x : 9 7 8 -4 4 3 -8 0 0 0

Petmissions Agreement
To obtain copyrightpermission from Jones and Bartlett Publishers you must BU out this form completely. This
agreement grants nonexclusive, one-time use to reproduce the m aterialin the English language. Permission is granted
fo r the number o f copies specified, and does not extend to m aterial that is separately copyrighted. This agreement does
not include future editions or electronic forms o f the work. Please note that it is your responsibility to ensure that the
m aterialyou are requesting has not been referenced to another source. Please allow for a two to three-week nun around
fo r your request.

Requester Information:
Requester's Name ft Company: Susan Gttlln. Eastern Virginia Medical School/Old Dominion University
Complete Address:

401 Collev Avenue 4 314. Norfolk. VA 23507

Phone Number ( 757 1

444-7148

Fax Number 1 7571

444-8998

I wish to borrow material from the following Jones & Bartlett Publishers Product:
T itle:

Essentials of Molecular Biology. 3rd edition

Author:

Maladnskl. George M.

ISBN f located on the back cover (if unknown, go to www.iboub.com>:
If Text material, list page numbers:

0-84270-840-0

Copyright date: 1998

a.41

Total page count: 1

If Illustrations, list table/figure numbers: Figure 3-2

Total number of figures/tables

I plan to use this material in the following way:

Publication

X other Printed document

1______
Course Packet

Online, please provide web site address____________________
Author: —Susan Gitlin

Affiliation; ______Old Dominion University

Title: Dissertation: Developing and Optimizing Conditions for Single Cell Genetic Analysis Publisher: Old Dominion University Press
Total Copies to be printed:______Z__________________________________
T h e fo llo w in g c re d it lin e

mmt be

u s e d : A u th o r , ( E d ito r i f w o rk is p a c t o f a n a n th o lo g y ), T itle o f w o r k , Y e a r o f C o p y r ig h t J o n e s a n d

B a r tle tt P u b lis h e rs , S u d b u ry , M A . W W W .ib p u b .c o m . R e p rin te d w ith p e rm is s io n . I f th is is a n N L N t it le , p le a s e c r e d it d ie N L N
f ir s t , a n d J o n e s a n d B a r tle tt P u b lis h e rs s e c o n d .

I AG R EE TO TH E S E

Susan A, Gitlin

TERMS:

________________

P r in t n a m e

electronically signed_________________ ;________

;_____

S ig n a tu re

F o r J o n e s a n d B a r tle t t P u b lis h e rs u s e :

P e rm is s io n is :

D e n ie d
X

G ra n te d u p o n p a y m e n t o f th e fe e o f I
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0 invitrogen

tm

Molecular Probes Labeling and Detection Technologies
29851 Willow Creek Road, Eugene, OR 97402
(541) 465-8300. (541) 335-0504

PERMISSION FORM
March 11,2005

Molecular Probes, Inc. grants
Sue Gitlin
INSTITUTION: The Jones Institute for Reproductive Medicine
ADDRESS:
Eastern Virginia Medical School
601 Colley Avenue #316
Norfolk, VA 23507
COUNTRY:
USA
NAME:

PHONE:
FAX:
EMAIL:

757-446-7168
757-446-8998
gitlinsa@evms.edu

authorization to use the following materials.
□ Slides

□ Figures

□ Tables

0

Electronic Files

Figure 8.41, Handbook of Fluorescent Probes and Research Products, 9th Edition
Permission is granted for use in the dissertation by Sue Gitlin entitled “Developing and optimizing
conditions for single cell genetic analysis’ only.
Additional Conditions:
• Display of figures must be accompanied by captions (copied from
)
• Captions must acknowledge figure copyright owned by Molecular Probes, Inc.
If you have any questions please contact me.
Phone: +1 541-335-0346
Fax: +1 541-335-0189
Email: dawn.carlile@invitrogen.com

Dawn Carlile
Administrative Assistant
Commercial Marketing

Date

http://Drobes.invitrogen.com
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